<SEC-DOCUMENT>0001808805-22-000085.txt : 20220802
<SEC-HEADER>0001808805-22-000085.hdr.sgml : 20220802
<ACCEPTANCE-DATETIME>20220802162813
ACCESSION NUMBER:		0001808805-22-000085
CONFORMED SUBMISSION TYPE:	POS AM
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20220802
DATE AS OF CHANGE:		20220802

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nautilus Biotechnology, Inc.
		CENTRAL INDEX KEY:			0001808805
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		POS AM
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-258100
		FILM NUMBER:		221129095

	BUSINESS ADDRESS:	
		STREET 1:		2701 EASTLAKE AVE EAST
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
		BUSINESS PHONE:		206-333-2001

	MAIL ADDRESS:	
		STREET 1:		2701 EASTLAKE AVE EAST
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARYA Sciences Acquisition Corp III
		DATE OF NAME CHANGE:	20200408
</SEC-HEADER>
<DOCUMENT>
<TYPE>POS AM
<SEQUENCE>1
<FILENAME>nautilus-posamsx1tosx3.htm
<DESCRIPTION>POS AM
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1e81c8a398e14e3b82517ba4446b0b26_38"></div><div style="min-height:34.56pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:139%">As filed with the Securities and Exchange Commission on August 2,&#160;2022 </font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:139%">Registration No.&#160;333-258100&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:139%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:139%">SECURITIES AND EXCHANGE COMMISSION </font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Washington, D.C. 20549</font></div><div style="padding-left:123.56pt;padding-right:123.56pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:16.813%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:139%">POST EFFECTIVE </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:139%">AMENDMENT NO. 2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:139%">TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:139%">FORM S-1 ON </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:139%">FORM S-3 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:139%">REGISTRATION STATEMENT </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Under </font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">The Securities Act of 1933</font></div><div style="padding-left:123.56pt;padding-right:123.56pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:16.813%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:139%">NAUTILUS BIOTECHNOLOGY, INC.</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">(Exact name of Registrant as specified in its charter) </font></div><div style="padding-left:123.56pt;padding-right:123.56pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:16.813%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Delaware</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">98-1541723</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">incorporation or organization)</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:2.65pt;text-align:center"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identification Number)</font></div></td></tr></table></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">2701 Eastlake Avenue East</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Seattle, Washington 98102</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">(206) 333-2001 </font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">(Address, including zip code, and telephone number, including area code, of Registrant&#8217;s principal executive offices) </font></div><div style="padding-left:123.56pt;padding-right:123.56pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:16.813%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Sujal Patel</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Chief Executive Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">2701 Eastlake Avenue East</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Seattle, Washington 98102 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">(206) 333-2001</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">(Name, address, including zip code, and telephone number, including area code, of agent for service) </font></div><div style="padding-left:123.56pt;padding-right:123.56pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:16.813%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:139%">Copies to&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Robert F. Kornegay</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Michael Nordtvedt</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Zachary B. Myers</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Wilson Sonsini Goodrich&#160;&#38; Rosati, P.C.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">650 Page Mill Road</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Palo Alto, California 94304</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(650) 493-9300</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Matthew Murphy</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">General Counsel </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2701 Eastlake Avenue East</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Seattle, Washington 98102 </font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(206) 333-2001</font></div></td></tr></table></div><div style="margin-top:9pt;text-align:center"><font><br></font></div><div style="padding-left:123.56pt;padding-right:123.56pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:16.813%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Approximate date of commencement of proposed sale to the public&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%"> From time to time after the effective date of  this registration statement. </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box&#58; </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:139%">o</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&#160;415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box.&#160;&#160;</font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:139%">x</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%"> </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If this Form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#160;&#160;</font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:139%">o</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%"> </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If this Form is a post-effective amendment filed pursuant to Rule&#160;462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#160;&#160;</font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:139%">o</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%"> </font></div><div style="height:34.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:34.56pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:139%">o</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:139%">o</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.218%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Large&#160;accelerated&#160;filer</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated&#160;filer</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging&#160;growth&#160;company</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</font></td></tr></table></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act.&#160;&#160;&#9744; </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment that specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="height:34.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_41"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">EXPLANATORY NOTE </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">On June 9, 2021 (the &#8220;Closing Date&#8221;), Nautilus Biotechnology, Inc., a Delaware corporation, now named Nautilus Subsidiary, Inc. (&#8220;Legacy Nautilus&#8221;), consummated a business combination (the &#8220;Business Combination&#8221;) with ARYA Sciences Acquisition Corp III, a special purpose acquisition company (&#8220;ARYA&#8221;). On the Closing Date, (i) ARYA changed its jurisdiction of incorporation by deregistering as a Cayman Islands exempted company and continuing and domesticating as a corporation incorporated under the laws of the State of Delaware (the &#8220;Domestication&#8221;), upon which ARYA changed its name to &#8220;Nautilus Biotechnology, Inc.&#8221; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(together with its consolidated subsidiary, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">the &#8220;Registrant,&#8221; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">the &#8220;Company,&#8221; &#8220;New Nautilus,&#8221; &#8220;Nautilus&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">and (ii) Mako Merger Sub, Inc. merged with and into Legacy Nautilus (the &#8220;Merger&#8221;), with Legacy Nautilus as the surviving company in the Merger and, after giving effect to such Merger, Legacy Nautilus became a wholly-owned subsidiary of New Nautilus. Our common stock is listed on The Nasdaq Global Select Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;NAUT.&#8221;</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">On July 22, 2021, Nautilus Biotechnology, Inc. filed a registration statement on Form S-1 (File No. 333-258100) (the &#8220;Initial Registration Statement&#8221;) with the Securities and Exchange Commission (the &#8220;SEC&#8221;). The Initial Registration Statement was declared effective by the SEC on August 6, 2021 to initially register for resale by the selling securityholders identified in the prospectus up to an aggregate of 95,645,056 shares of common stock, which are held or may be held by the selling securityholders named in the prospectus, as amended, contained in the Initial Registration Statement. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">On February 24, 2022, the Company filed </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">a post-effective amendment on Form&#160;S-1&#160;(&#8220;Post-Effective Amendment No.&#160;1&#8221;) to the Initial Registration Statement to (i)&#160;include information from the Company&#8217;s Annual Report on Form&#160;10-K&#160;for the year ended December&#160;31, 2021 that was filed on February 24, 2022&#59; and (ii)&#160;update certain other information in the Initial Registration Statement. No additional securities were registered under Post-Effective Amendment No.&#160;1, which was declared effective by the SEC on March 1, 2022.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">This post-effective amendment No. 2 to Form S-1 on Form S-3 (&#8220;Post-Effective Amendment No. 2&#8221;) is being filed by the Company (i) to convert the Initial Registration Statement, as amended by Post-Effective Amendment No. 1, into a registration statement on Form S-3, (ii) to include updated information regarding the selling securityholders named in the prospectus, including a reduction in the number of shares of common stock being offered by the selling securityholders to 88,738,387 shares, and (iii) update certain other information based on recent developments. No additional securities are being registered hereunder. All applicable registration fees were paid at the time of the original filing of the Initial Registration Statement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_44"></div><hr style="page-break-after:always"><div style="min-height:34.56pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:3pt"><font style="color:#f1665f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities, nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#f1665f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PRELIMINARY PROSPECTUS</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#f1665f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subject to Completion</font></td><td colspan="3" style="padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#f1665f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">August 2, 2022</font></td></tr></table></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:139%">88,738,387 Shares of Common Stock </font></div><div style="text-align:center"><img alt="nautilus_primarylogoxblue.jpg" src="nautilus_primarylogoxblue.jpg" style="height:82px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"></div><div style="padding-left:92.06pt;padding-right:92.06pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:21.314%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">This prospectus relates to (i) the resale of 4,286,500 shares of common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;) issued in connection with the Domestication by certain of the selling securityholders named in this prospectus (each a &#8220;selling securityholder&#8221; and, collectively, the &#8220;selling securityholders&#8221;), (ii) the resale of 69,655,827 shares of Common Stock issued in connection with the Business Combination by certain of the selling securityholders, (iii) the resale of 13,093,331 shares of Common Stock issued in a private placement (the &#8220;PIPE Financing&#8221;) by certain of the selling securityholders, and (iv) the resale of 1,702,729 shares of Common Stock reserved for issuance upon the exercise of certain outstanding options to purchase Common Stock. This prospectus also covers any additional securities that may become issuable by reason of stock splits, stock dividends or other similar transactions. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are registering the resale of these securities to satisfy certain registration rights we have granted. We will not receive any of the proceeds from the sale of the securities by the selling securityholders. We will pay the expenses associated with registering the sales by the selling securityholders, as described in more detail in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; appearing elsewhere in this prospectus. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The selling securityholders may sell the securities described in this prospectus in a number of different ways and at varying prices. We provide more information about how the selling securityholders may sell their securities in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Plan of Distribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; appearing elsewhere in this prospectus. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The selling securityholders may sell any, all or none of the securities and we do not know when or in what amount the selling securityholders may sell their securities hereunder following the effective date of this registration statement. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our Common Stock is listed on The Nasdaq Global Select Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;NAUT.&#8221; On July 29, 2022, the last quoted sale price for our Common Stock as reported on Nasdaq was $2.91. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">We are an &#8220;emerging growth company,&#8221; as defined under the federal securities laws, and, as such, may elect to comply with certain reduced public company reporting requirements for future filings. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Investing in our securities involves a high degree of risk. Before buying any securities, you should carefully read the discussion of the risks of investing in our securities in the section titled &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_1649267442186" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%;text-decoration:underline">Risk Factors</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">&#8221; beginning on page&#160;7 of this prospectus and under similar headings in any amendments or supplements to this prospectus and the documents incorporated herein by reference. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">You should rely only on the information contained in this prospectus or any prospectus supplement or amendment hereto. We have not authorized anyone to provide you with different information. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Neither the Securities Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </font></div><div style="padding-left:92.06pt;padding-right:92.06pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:21.314%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:34.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:34.56pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">The date of this prospectus is &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022.</font></div><div style="height:34.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_47"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">TABLE OF CONTENTS</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Page</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_50" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">About This Prospectus</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_50" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ii</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_53" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Market and Industry Data</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_53" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ii</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_56" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Trademarks</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_56" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ii</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_59" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">T</a>he Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_59" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_59" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">T</a>he Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_62" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_65" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risk Factors</a> Summary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_65" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_1649267442186" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risk Factors</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_1649267442186" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_68" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Cautionary Note Regarding Forward-Looking Statements</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_68" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_71" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Proceeds</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_71" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_77" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Selling Securityholders</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_77" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_80" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Securities</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_80" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_83" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Plan of Distribution</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_83" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">21</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_86" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Legal Matters</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_86" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">25</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_89" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Experts</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt;text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_89" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">II- 1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_89" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Where You Can Find Additional Information</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt;text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_89" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">II-</a><a href="#i1e81c8a398e14e3b82517ba4446b0b26_89" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> 2</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_89" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Incorporation</a> by Reference</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.02pt;text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_89" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">II- 2</a></font></div></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">You should rely only on the information contained in this prospectus, information incorporated by reference into this prospectus or any supplement to this prospectus prepared by us or on our behalf. We have not authorized any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus is accurate only as of the date on the front cover of this prospectus </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">and that any information incorporated by reference is accurate only as of the date of the document incorporated by reference, unless we indicate otherwise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. Our business, financial condition, results of operations and prospects may have changed since such dates.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">i</font></div></div></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_50"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">ABOUT THIS PROSPECTUS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">This prospectus is part of a registration statement on Form S-3 that we filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) using the &#8220;shelf&#8221; registration process. Under this shelf registration process, the selling securityholders hereunder may, from time to time, sell the securities offered by them described in this prospectus. We will not receive any proceeds from the sale by such selling securityholders of the securities offered by them described in this prospectus. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Neither we nor the selling securityholders have authorized anyone to provide you with any information or to make any representations other than those contained in or incorporated by reference into this prospectus or any applicable prospectus supplement or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. Neither we nor the selling securityholders take responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. Neither we nor the selling securityholders will make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted.</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should assume that the information appearing in this prospectus and the applicable prospectus supplement to this prospectus is accurate only as of the date on its respective cover and that any information incorporated by reference is accurate only as of the date of the document incorporated by reference, unless we indicate otherwise. Our business, financial condition, results of operations and prospects may have changed since those dates.</font></div><div><font><br></font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We may also provide a prospectus supplement or post-effective amendment to the registration statement to add information to, or update or change information contained in, this prospectus. You should read both this prospectus and any applicable prospectus supplement or post-effective amendment to the registration statement together with the additional information to which we refer you in the section of this prospectus titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Where You Can Find Additional Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Incorporation by Reference</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.&#8221;</font></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_53"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">MARKET AND INDUSTRY DATA</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We obtained the industry and market data used throughout this prospectus and the documents incorporated by reference herein from our own internal estimates and research, as well as from independent market research, industry and general publications and surveys, governmental agencies, publicly available information and research, surveys and studies conducted by third parties. Internal estimates are derived from publicly available information released by industry analysts and third-party sources, our internal research and our industry experience, and are based on assumptions made by us based on such data and our knowledge of our industry and market, which we believe to be reasonable. In some cases, we do not expressly refer to the sources from which this data is derived. In addition, while we believe the industry and market data included in this prospectus is reliable and based on reasonable assumptions, such data involve material risks and other uncertainties and are subject to change based on various factors, including those discussed in the section entitled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Risk Factors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.&#8221; These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties or by us.</font></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_56"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">TRADEMARKS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">This prospectus and the documents incorporated by reference herein contain references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus and the documents incorporated by reference herein may appear without the&#160;&#174;&#160;or&#160;TM&#160;symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies&#8217; trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of it by, any other companies.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">ii</font></div></div></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_59"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">THE COMPANY</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">This summary highlights information contained in greater detail elsewhere in this prospectus. This summary is not complete and does not contain all of the information you should consider in making your investment decision. You should read the entire prospectus carefully before making an investment in our Common Stock, including the section entitled &#8220;Risk Factors&#8221; and the documents we have incorporated by reference in this prospectus, along with our consolidated financial statements and related notes incorporated by reference in this prospectus.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">OVERVIEW </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Our mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. We were founded on the belief that incremental advancements of existing technologies are inadequate, and that a bold scientific leap would be required to radically reinvent proteomics and revolutionize precision medicine. Our vision is to integrate our breakthrough innovations in computer science, engineering, and biochemistry to develop and commercialize a </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">proteome analysis platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> of extreme sensitivity and scale. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">To accomplish this, we have built a prototype of our proteome analysis system, an instrument to perform massively parallel single protein molecule measurements which will be further developed to deliver the speed, simplicity, accuracy, and versatility that we believe is necessary to establish a new gold standard in the field.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">  </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The human proteome, the make-up of all the proteins in a human, is among the most dynamic and valuable sources of biological insight in modern-day science. Unlike the genome, which is largely unchanging throughout an individual&#8217;s lifetime, the proteome is an ever-changing source of biological information. Our proteins directly control and determine the functions of our cells, yet we lack the ability to measure all of them with the ease, breadth and sensitivity that is used to measure DNA today. We believe that deep characterization of the proteome will have the potential to unveil an entirely new layer of complexity and valuable biological information that may have significant implications across life sciences, healthcare and drug development. Approximately 95% of FDA-approved drug targets are proteins, and yet today we still lack the ability to routinely read and quantify all of the proteins in our cells, or to fully map the downstream changes and modifications to those proteins which may define their biological function.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">By leveraging our novel design coupled with advanced machine learning software, we believe our Nautilus platform, which includes our end-to-end solution comprised of the proteomic analysis system, consumables, and software, has the potential to rapidly and reproducibly identify approximately 95% of proteins in a sample from virtually any organism, and could have the ability to detect and map the diverse landscape of modifications on those proteins. We believe that unlocking proteomics has the potential to create a long-term transformation of basic science, translational research, and healthcare. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CORPORATE INFORMATION</font></div><div><font><br></font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">On June 9, 2021 (the &#8220;Closing Date&#8221;), Nautilus Biotechnology, Inc., a Delaware corporation (f&#47;k&#47;a ARYA Sciences Acquisition Corp III, a Cayman Islands exempted company and our predecessor company (&#8220;ARYA&#8221;)) (the &#8220;Company&#8221;), consummated the previously announced merger pursuant to that certain Business Combination Agreement, dated as of February 7, 2021 (the &#8220;Business Combination Agreement&#8221;), by and among ARYA, Mako Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of ARYA (&#8220;Mako Merger Sub&#8221;), and Nautilus Subsidiary, Inc., a Delaware corporation (f&#47;k&#47;a Nautilus Biotechnology, Inc.) (&#8220;Legacy Nautilus&#8221;).</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Pursuant to terms of the Business Combination Agreement, on the Closing Date, (i)&#160;ARYA changed its jurisdiction of incorporation by deregistering as a Cayman Islands exempted company and continuing and domesticating as a corporation incorporated under the laws of the State of Delaware (the &#8220;Domestication&#8221;), upon which ARYA changed its name to &#8220;Nautilus Biotechnology, Inc.&#8221; (together with its consolidated subsidiaries, &#8220;New Nautilus&#8221; or &#8220;Nautilus&#8221;) and (ii)&#160;Mako Merger Sub merged with and into Legacy Nautilus (the &#8220;Merger&#8221; and collectively, with the other transactions described in the Business Combination Agreement, the &#8220;Business Combination&#8221;), with Legacy Nautilus as the surviving company in the Merger and, after giving effect to such Merger, Legacy Nautilus becoming a wholly-owned subsidiary of New Nautilus. As of the open of trading on June 10, 2021, the Common Stock of the Company, formerly those of ARYA, began trading on The Nasdaq Global Select Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;NAUT.&#8221;</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our principal executive offices are located at 2701 Eastlake Avenue East, Seattle, WA 98102, and our telephone number is (206) 333-2001. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our website address is http&#58;&#47;&#47;www.nautilus.bio. The information on, or that can be accessed through, our website is not part of this prospectus, and you should not consider information contained on our website in deciding whether to purchase shares of our Common Stock. We have included our website address in this prospectus solely as an inactive textual reference.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We use the Nautilus logo and other marks as trademarks in the United States and other countries. This prospectus contains references to our trademarks and service marks and to those belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus, including logos, artwork and other visual displays, may appear without a trademark symbol, but such references are not intended to indicate in any way that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other entities&#8217; trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other entity.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are an emerging growth company as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;). We will remain an emerging growth company until the earliest to occur of&#58; the last day of the fiscal year in which we have more than $1.07&#160;billion in annual revenues&#59; the date we qualify as a &#8220;large accelerated filer,&#8221; with at least $700&#160;million of equity securities held by non-affiliates&#59; the issuance, in any three-year period, by us of more than $1.0&#160;billion in non-convertible debt securities&#59; and the last day of the fiscal year ending after the fifth anniversary of ARYA&#8217;s initial public offering. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Section&#160;107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section&#160;7(a)(2)(B) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), for complying with new or revised accounting standards. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with certain other public companies difficult or impossible because of the potential differences in accounting standards used. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Additionally, we are a &#8220;smaller reporting company&#8221; as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We may continue to remain a smaller reporting company if either (i) the market value of our stock held by non-affiliates is less than $250 million as of June 30 of the prior </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">fiscal year  or (ii) our annual revenue was less than $100 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700 million as of June 30 of the prior fiscal year.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Unless expressly indicated or the context requires otherwise, the terms &#8220;Nautilus,&#8221; &#8220;New Nautilus,&#8221; the &#8220;Company,&#8221; the &#8220;Registrant,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; in this prospectus refer to Nautilus Biotechnology, Inc., the parent entity formerly named ARYA Sciences Acquisition Corp III, after giving effect to the Domestication and the Business Combination, and as renamed Nautilus Biotechnology, Inc., and where appropriate, our wholly-owned subsidiaries (including Legacy Nautilus). </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">3</font></div></div></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_62"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">The Offering</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font><br></font></div><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of Common Stock Offered Hereunder&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An aggregate of 88,738,387 shares of Common Stock consisting of (a) 13,093,331 shares of Common Stock issued in the PIPE Financing, (b) 4,286,500 shares of Common Stock issued in connection with the Domestication, (c) 69,655,827 shares of Common Stock issued in connection with the Business Combination and (d) 1,702,729 shares of Common Stock issuable upon the exercise of certain outstanding options to purchase Common Stock.</font></div><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font><br></font></div><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All aforementioned shares of Common Stock were initially registered in our Initial Registration Statement, and no new shares are being registered hereunder. </font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Use of Proceeds</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We will not receive any proceeds from the sale of our shares of common stock offered by the selling securityholders under this prospectus (the &#8220;Securities&#8221;). See the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; appearing elsewhere in this prospectus for more information.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Outstanding</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:0.02pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124,562,745 shares of Common Stock as of June 30, 2022.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk Factors</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Risk Factors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; and other information included in this prospectus and the documents incorporated by reference for a discussion of factors that you should consider carefully before deciding to invest in our Common Stock.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nasdaq symbol</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;NAUT&#8221; for our Common Stock.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The number of shares of Common Stock outstanding is based on 124,562,745 shares of Common Stock as of June 30, 2022 and excludes the following, in each case as of June 30, 2022&#58; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">6,148,270 shares of our Common Stock issuable upon the exercise of outstanding options under the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan (the &#8220;2017 Plan&#8221;) as of such date, which were assumed by the Company in connection with the Business Combination, with a weighted average exercise price of $3.50 per share&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">5,502,254 shares of our Common Stock issuable upon the exercise of outstanding options under our 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;) as of such date, with a weighted average exercise price of $5.02 per share&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">17,384,590 shares of our Common Stock reserved for future issuance under our 2021 Plan&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">2.439.577 shares of our Common Stock reserved for future issuance under our 2021 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;).</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">4</font></div></div></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_65"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">RISK FACTORS SUMMARY</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Investing in our common stock involves a high degree of risk. You should consider carefully the risks and uncertainties described below, together with all of the other information contained in this prospectus, including our consolidated financial statements and related notes, before deciding to invest in our securities. If any of the following risks actually occur, our business, operating results, financial condition and prospectus could be materially and adversely affected. In that event, the market price of our common stock could decline, and you could lose part or all of your investment. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that adversely affect our business or results of operations.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our business is subject to numerous risks and uncertainties that you should consider before investing in our company, as more fully described below. The principal factors and uncertainties that make investing in our company risky include, among others&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are a development stage company that has incurred net losses in every period to date, has not yet commercialized any products, and expects to continue to incur significant losses as we develop our business. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business is entirely dependent on the successful development and commercialization of our proteomics platform (the &#8220;Nautilus platform&#8221;), which remains in the development stage and could be subject to delays, technical challenges and market acceptance challenges. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not compete successfully with our initial or future products in the highly competitive life sciences technology market.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are dependent upon third parties for certain aspects of the development and commercialization of the Nautilus platform.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business depends significantly on research and development spending by pharmaceutical companies as well as by academic institutions and other research institutions and any reduction in spending could limit demand for our products.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to launch our Nautilus platform successfully and even if it is successful, we may experience material delays in our commercialization program relative to current expectations.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our operating results may fluctuate significantly in the future, which makes our future operating results difficult to predict and could cause our operating results to fall below expectations or our guidance.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may need to raise additional capital to fund our development and commercialization plans.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Intellectual Property</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be unable to obtain and maintain sufficient intellectual property protection for our products and technology, or if the scope of our intellectual property protection obtained is not sufficiently broad, competitors could develop and commercialize products similar or identical to ours.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to protect our intellectual property and proprietary rights throughout the world. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Litigation</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may become involved in litigation to enforce or defend our intellectual property rights, or to defend ourselves from claims that we infringe the intellectual property rights of others.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may face liability and&#47;or negative publicity for any unknown defects or errors in our products.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Regulatory and Legal Compliance Matters</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our products may, in the future, be subject to regulation by the FDA or other regulatory authorities.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are currently subject to, and may in the future become subject to additional, U.S. federal and state laws and regulations, as well as the laws and regulations of other countries, relating to how we collect, store and process personal information.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Future expansion of our development and commercialization activities outside of the United States, may subject us to an increased risk of inadvertently conducting activities in a manner that violates the U.S. Foreign Corrupt Practices Act and similar laws. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Environmental and health safety laws, including any failure to comply with such laws, may result in liabilities, expenses and restrictions on our operations.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our employees, independent contractors, consultants, commercial partners, distributors and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Operations </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may experience a significant disruption in our information technology systems or breaches of data security.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are highly dependent on our key personnel, and if we are unable to recruit and retain key executives and scientists, we may not be able to achieve our goals.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our operations and financial results could be adversely impacted by global and national events, such as the COVID-19 pandemic, conflicts in Eastern Europe, and general economic downturns.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Global supply chain interruptions may negatively impact the development and commercialization of our products.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Common Stock</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The price of and market for our Common Stock may be volatile, which could result in substantial losses for investors and&#47;or an inability to readily trade in our Common Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We will incur significant increased costs and management resources as a result of operating as a public company.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reports published by analysts, including projections in those reports that differ from our actual results, could adversely affect the price and trading volume of our common shares.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to timely and accurately report our financial results and projections as a public company may be impacted by the effectiveness of our internal controls, and our estimates and judgments relating to critical accounting policies.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">6</font></div></div></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_1649267442186"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">RISK FACTORS </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">An investment in our Common Stock involves a high degree of risk. In addition to the risk and uncertainties described under the section titled &#8220;Cautionary Note Regarding Forward-Looking Statements,&#8221; you should consider carefully the risks and uncertainties incorporated by reference to our most recent Annual Report on Form 10-K, any subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K, and all other information contained in or incorporated by reference into this prospectus, as updated by our subsequent filings under the Exchange Act, and the risk factors and other information contained in any applicable prospectus supplement before acquiring any of such securities.  Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that adversely affect our business or results of operations. The occurrence of any of these risks might cause you to lose all or part of your investment in the offered securities.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">7</font></div></div></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_68"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Certain statements in this prospectus and the documents incorporated by reference herein may constitute &#8220;forward-looking statements&#8221; for purposes of the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our or our management team&#8217;s expectations, hopes, beliefs, intentions or strategies regarding the future, including those relating to the Business Combination and its expected benefits&#59; the success, cost, timing and progress of development of our proteomics platform (the &#8220;Nautilus platform&#8221;)&#59; the potential attributes and benefits of the Nautilus platform&#59; our ability to successfully implement our three phase commercial launch plan&#59; and our ability to obtain funding for our operations. Forward-looking statements include statements relating to our management team&#8217;s expectations, hopes, beliefs, intentions or strategies regarding the future, including those relating to the Business Combination and related transactions. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">These forward-looking statements are based on current expectations and beliefs concerning future developments and their potential effects. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include, but are not limited to, the following&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our dependence on the success of our Nautilus platform, which remains in the development stage and subject to scientific and technical validation&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our expectations regarding the timing and progress of the development of the Nautilus platform&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our estimates of our addressable market, market growth, future revenue, key performance indicators, expenses, capital requirements and needs for additional financing&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our expectations regarding the rate and degree of market acceptance of the Nautilus platform&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the impact of the Nautilus platform on the field of proteomics and the size and growth of the addressable proteomics market&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our ability to manage and grow our business and commercialize our Nautilus platform&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our ability to successfully implement our three phase commercial launch plan&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the implementation of our business model and strategic plans for the Nautilus platform&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our ability to establish and maintain intellectual property protection for our products or avoid or defend claims of infringement&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, our ability to grow and manage future growth effectively, and our ability to retain our key employees&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our expectations regarding the use of proceeds from the Business Combination&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the performance of third-party manufacturers and suppliers&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">changes in applicable laws or regulations&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our ability to raise financing in the future&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our success in retaining or recruiting, or changes required in, our officers, key employees or directors or other key personnel&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the volatility of the trading price of our common stock&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our ability to develop and commercialize new products&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">our expectations about market trends&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the impact of local, regional, national and international economic conditions and events&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the effect of COVID-19 on the foregoing&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the risks and uncertainties described under the heading &#8220;Risk Factors&#8221; and in our current and periodic reports, and other filings, filed from time to time with the SEC that are incorporated by reference into this prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Some of these risks and uncertainties may in the future be amplified by the COVID-19 outbreak and there may be additional risks that we consider immaterial or which are unknown. It is not possible to predict or identify all such risks. </font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements made in this prospectus relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this prospectus to reflect events or circumstances after the date of this prospectus or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make.</font></div><div><font><br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this prospectus, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">9</font></div></div></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_71"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">USE OF PROCEEDS </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">All of the Securities offered by the selling securityholders pursuant to this prospectus will be sold by the selling securityholders for their respective accounts. We will not receive any of the proceeds from the sale of the Securities hereunder. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">With respect to the registration of shares of our Common Stock offered by the selling securityholders pursuant to this prospectus, the selling securityholders will pay any underwriting discounts and commissions and expenses incurred by them for brokerage, accounting, tax or legal services or any other expenses incurred by them in disposing of the Securities. We will bear all other costs, fees and expenses incurred in effecting the registration of the Securities covered by this prospectus, including, without limitation, all registration and filing fees, Nasdaq listing fees, and fees of our counsel and our independent registered public accountants.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">10</font></div></div></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_77"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">SELLING SECURITYHOLDERS </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">This prospectus relates to the resale by the selling securityholders from time to time of up to an aggregate of 88,738,387 shares of Common Stock (consisting of up to an aggregate of (a) 13,093,331 shares of our Common Stock that were issued to the PIPE Investors in the PIPE Financing, (b) 4,286,500 shares of Common Stock issued in connection with the Domestication, (c) 69,655,827 shares of Common Stock issued in connection with the Business Combination and (d) 1,702,729 shares of Common Stock issuable upon the exercise of certain outstanding options to purchase Common Stock). The selling securityholders may from time to time offer and sell any or all of the shares of Common Stock set forth below pursuant to this prospectus and any accompanying prospectus supplement. When we refer to the &#8220;selling securityholders&#8221; in this prospectus, we mean the persons listed in the table below and their permitted transferees who later come to hold any of the selling securityholders&#8217; interest in the Common Stock in accordance with the terms of the applicable agreements governing their respective registration rights, other than through a public sale.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table sets forth, based on written representations from the selling securityholders as of July 29, 2022 and subsequent filings with the SEC, as applicable, the names of the selling securityholders, the aggregate number of shares of Common Stock beneficially owned by the selling securityholders, the aggregate number of shares of Common Stock that the selling securityholders may offer pursuant to this prospectus and the number of shares of Common Stock that would be beneficially owned by the selling securityholders after the sale of the shares of Common Stock offered hereby assuming that the selling securityholders sell all of the shares of Common Stock covered by this prospectus. The percentage of beneficial ownership after the offered shares of Common Stock are sold is calculated based on 124,663,186 shares of Common Stock outstanding as of July 29, 2022.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We have determined beneficial ownership in accordance with the rules of the SEC and the information is not necessarily indicative of beneficial ownership for any other purpose. Unless otherwise indicated below, to our knowledge, the persons and entities named in the tables have sole voting and sole investment power with respect to the shares of Common Stock set forth below, subject to community property laws where applicable.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We cannot advise you as to whether the selling securityholders will in fact sell any or all of such Common Stock. In addition, the selling securityholders may sell, transfer or otherwise dispose of, at any time and from time to time, the Common Stock in transactions exempt from the registration requirements of the Securities Act after the date of this prospectus. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Information about the selling securityholders, including those listed below, may change over time. Since the effectiveness of the initial prospectus, certain securityholders may have sold or otherwise transferred their securities registered thereunder.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> For purposes of this table, we have assumed that the selling securityholders will have sold all of the shares of Common Stock covered by this prospectus upon the completion of the offering.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Selling securityholder information for each additional selling securityholder, if any, will be set forth by a prospectus supplement to the extent required prior to the time of any offer or sale of such selling securityholder&#8217;s shares pursuant to this prospectus. Any prospectus supplement may add, update, substitute, or change the information contained in this prospectus, including the identity of each selling securityholder and the number of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">shares registered on its behalf. A selling securityholder may sell or otherwise transfer all, some or none of such shares in this offering. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Plan of Distribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.&#8221;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.643%"></td><td style="width:0.1%"></td></tr><tr style="height:60pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beneficially</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Owned</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior to</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Offering </font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Being</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Offered </font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beneficially</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Owned&#160;After&#160;the</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Offered Shares</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">are Sold </font></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of Selling Securityholder</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AH Bio Fund II, L.P., for itself and as nominee for AH Bio Fund II-B, L.P.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,298,006</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,298,006</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alexandria Venture Investments, LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ally Bridge MedAlpha Master Fund L.P.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080,566</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080,566</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Andreessen Horowitz LSV Fund II, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355,911</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355,911</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARYA Sciences Holdings III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,146,500</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,146,500</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AVMI Investments, Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bain Capital Life Sciences Fund II, L.P.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,782,858</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891,429</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891,429</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BCIP Life Sciences Associates, LP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,142</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,571</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,571</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blackwell Partners LLC &#8211; Series A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,793</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,278</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,515</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bradley L. Campbell</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(29)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Decheng Capital Global Healthcare Fund (Master), LP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Farzad Nazem</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,010,893</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,924,426</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,467</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Funds Managed by RTW Investments, LP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(11)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hand Capital LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(12)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,888,146</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,888,146</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Madrona Venture Fund VI-A, LP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(13)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,376</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,376</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Madrona Venture Fund VI, LP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(13)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,798,394</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,798,394</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Matthew and Elizabeth Posard Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(14)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Matthew McIlwain</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(15)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,602,592</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,379,155</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,437</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Matthew Posard</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(16)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504,943</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,476</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,467</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Melissa Epperly</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(17)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,028</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,561</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,467</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nantahala Capital Partners Limited Partnership</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,727</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,502</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,225</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nantahala Capital Partners SI, LP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,321</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,326</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,995</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nantahala Capital Partners II Limited Partnership</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,621</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,459</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,162</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NCP RFM LP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,200</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,200</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Parag Mallick</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(18)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,423,911</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,143,911</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Perceptive Life Sciences Master Fund, Ltd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(19)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,111,151</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,414,113</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697,038</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PFV I, LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(20)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,280,476</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,280,476</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Saqib Islam</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(29)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sujal Patel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(21)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,247,832</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,497,732</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750,100</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sujal Patel 2020 Children&#8217;s Trust, u&#47;a&#47;d&#47; December 3, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(22)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,814,035</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,814,035</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Todd Wider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(29)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.643%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VCVC V LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(23)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,586,492</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,586,492</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vijay Pande</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(24)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,747</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,280</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,467</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VC Capital Holdings Columbia LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,586,493</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,586,493</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WS Investment Company, LLC (21A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(25)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Dream Finder Foundation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(26)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jesus A Zavaleta III C&#47;F Janhavi Amrita Singhal UTMA&#47;TX until Age 21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(27)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jesus A Zavaleta III C&#47;F Janhavi Amrita Singhal UTMA&#47;TX until Age 21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(28)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Shares</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,870,727</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,738,387</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132,340</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3%</font></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">__________________</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:15.2pt">Less than 1%</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:8.68pt">AH Equity Partners Bio II, L.L.C (&#8220;AH EP Bio II&#8221;) has sole voting and dispositive power with regard to the securities held by AH Bio Fund II, L.P. (&#8220;AH Bio Fund II&#8221;) and AH Bio Fund II-B, L.P. (&#8220;AH Bio Fund II-B,&#8221; and together with AH Bio Fund II, the &#8220;AH Bio Fund II Entities&#8221;). The managing members of AH EP Bio II are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz share voting and dispositive power with respect to the shares held by the AH Bio Fund II Entities. Vijay Pande, a member of the board of directors of the Company, is a general partner of entities affiliated with Andreessen Horowitz. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:8.68pt">The selling securityholder is a subsidiary of Alexandria Real Estate Equities, Inc., a publicly held corporation.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:8.68pt">Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC manages&#160;Ally&#160;Bridge&#160;MedAlpha&#160;Master&#160;Fund&#160;L.P.&#8217;s (&#8220;Ally Bridge&#8221;) investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by Ally Bridge. Each of them disclaims any such beneficial ownership.&#160;  </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;padding-left:8.68pt">AH Equity Partners LSV II, L.L.C. (&#8220;AH EP LSV II&#8221;) has sole voting and dispositive power with regard to the securities held by Andreessen Horowitz LSV Fund II, L.P. (&#8220;AH LSV Fund II&#8221;), Andreessen Horowitz LSV Fund II-B, L.P. (&#8220;AH LSV Fund II-B&#8221;) and Andreessen Horowitz LSV Fund II-Q, L.P. (&#8220;AH LSV Fund II-Q,&#8221; and together with AH LSV Fund II and AH LSV Fund II-B, the &#8220;AH LSV Fund II Entities&#8221;). The managing members of AH EP LSV II are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz share voting and dispositive power with respect to the shares held by the AH LSV Fund II Entities. Vijay Pande, a member of the board of directors of the Company, is a general partner of entities affiliated with Andreessen Horowitz. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Adam Stone and Michael Altman are members of the board of directors of the selling securityholder and have voting and investment power over the shares held by the selling securityholder. Each of Mr. Altman and Mr. Stone disclaim beneficial ownership of such securities except to the extent of his pecuniary interest therein. Mr. Altman is a member of the board of directors of the Company. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Wanda M. Cook and Michael J. McCullough share voting and investment power over the shares held by the selling securityholder. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Bain Capital Life Sciences Investors, LLC (&#8220;BCLSI&#8221;) is the manager of the general partner of Bain Capital Life Sciences Fund II, L.P. and governs the investment strategy and decision-making process with respect to investments held by BCIP Life Sciences Associates, LP. As a result, BCLSI may be deemed to share voting and dispositive power over the shares held by Bain Capital Life Sciences Fund II, L.P. and BCIP Life Sciences Associates, LP. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Nantahala Capital Management, LLC may be deemed to beneficially own 86,136 additional shares of Common Stock in the Company on behalf of managed funds and&#47;or accounts not listed above as selling securityholders. Nantahala Capital Management, LLC is a registered investment adviser and has been delegated the legal power to vote and&#47;or direct the disposition of such securities on behalf of the selling securityholder as a general partner or investment manager and would be considered the beneficial owner of such securities. The above shall not be deemed to be an admission by the record owners or the selling securityholder that they are themselves beneficial owners of these securities for purposes of section 13(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or any other purpose. Wilmot Harkey and Daniel Mack are managing members of Nantahala Capital Management, LLC and may be deemed to have voting and dispositive power over the shares held by the selling securityholder. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Xiangmin Cui has voting and investment power over the shares held by the selling securityholder. The selling securityholder is an investment company registered under the Investment Company Act of 1940, as amended. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(10)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Consists of (i) 122,747 shares of Common Stock issuable upon exercise of options held by Mr. Nazem and (ii) 1,888,146 shares of Common Stock held by HAND Capital, LLC. 57,896 options to purchase shares of common stock are exercisable within 60 days of July 29, 2022. The remaining options to purchase shares of Common Stock vest evenly on the 15th day of each month through June 15, 2023, subject to Mr. Nazem&#8217;s continued status as a service provider through each vesting date.  Mr. Nazem is the manager of HAND Capital, LLC and as such has voting and investment power over the shares held by HAND Capital, LLC. Mr. Nazem is a member of the board of directors of the Company. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Consists of (i) 298,128 shares of Common Stock held by RTW Innovation Master Fund, Ltd. (&#8220;RTW Innovation Fund&#8221;), (ii) 744,682 shares of Common Stock held by RTW Master Fund, Ltd. (&#8220;RTW Master Fund&#8221;), and (iii) 57,190 shares of Common Stock held by RTW Venture Fund Limited (&#8220;RTW Venture Fund,&#8221; and together with RTW Master Fund and RTW Innovation Fund, the &#8220;RTW Funds&#8221;). RTW Investments, LP is the investment manager to the RTW Funds. Roderick Wong, M.D., is the managing partner and chief investment officer of RTW Investments, LP. and as such has sole voting and investment control over such shares. Dr. Wong disclaims beneficial ownership of the reported securities held by the RTW Funds, except to the extent of any pecuniary interest therein. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(12)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Farzad Nazem and Noosheen Hashemi have voting and investment power over the shares held by the selling securityholder. Mr. Nazem is a member of the board of directors of the Company. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(13)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Madrona Investment Partners VI, L.P. (&#8220;Madrona Partners VI&#8221;) is the general partner of each of Madrona Venture Fund VI-A, LP (&#8220;Madrona Fund VI-A&#8221;) and Madrona Venture Fund VI, LP (&#8220;Madrona Fund VI&#8221;), and Madrona VI General Partner, LLC (&#8220;Madrona VI LLC&#8221;) is the general partner of Madrona Partners VI. Matthew McIlwain, together with Tom Alberg, Paul Goodrich, Scott Jacobson, Len Jordon, Tim Porter, and Soma Somasegar, are the managing members of Madrona VI LLC, and each may be deemed to share voting and investment power over the securities held by Madrona Fund VI and Madrona Fund VI-A. Each of such individuals disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein.&#160;Mr. McIlwain is a member of the board of directors of the Company. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(14)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Matthew Posard and Elizabeth Posard share voting and investment power over the shares held by the selling securityholder. Mr. Posard is a member of the board of directors of the Company. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(15)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Consists of (i) 459,075 shares of Common Stock held directly by Mr. McIlwain (322,105 of which are registered for resale pursuant to this prospectus), (ii) 122,747 shares of Common Stock issuable upon exercise of options held by Mr. McIlwain, (iii) 5,798,394 shares of Common Stock held by Madrona Fund VI, and (iv) 222,376 shares of Common Stock held by Madrona Fund VI-A. 57,896 options to purchase shares of common stock are exercisable within 60 days of July 29, 2022. The remaining options to purchase shares of Common Stock vest evenly on the 15th day of each month through June 15, 2023, subject to Mr. McIlwain&#8217;s continued status as a service provider through each vesting date. Mr. McIlwain is a member of the board of directors of the Company. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(16)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Consists of (i) 354,943 shares of Common Stock issuable upon exercise of options held by Mr. Posard, (ii) 100,000 shares of Common Stock held by the Matthew and Elizabeth Posard Trust (the &#8220;Posard Trust&#8221;) and (iii) 50,000 shares of Common Stock held by Mr. Posard (which are not registered for resale under this prospectus). 257,451 options to purchase shares of Common Stock are exercisable within 60 days of July 29, 2022. Of the remaining options to purchase shares of Common Stock (i) 32,641 shares of Common Stock that are issuable upon the exercise of options vest evenly on the 1st of each month through September 1, 2024, and (ii) 64,851 shares of Common Stock that are issuable upon the exercise of options vest evenly on the 15th of each month through June 15, 2023, subject to Mr. Posard&#8217;s continued status as a service provider through each vesting date. Mr. Posard is a member of the board of directors of the Company. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(17)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Consists of 159,028 shares of Common Stock issuable upon exercise of options held by Ms. Epperly. 59,912 options to purchase shares of common stock are exercisable within 60 days of July 29, 2022. Of the remaining options to purchase shares of Common Stock (i) 34,265 shares of Common Stock that are issuable upon the exercise of options vest evenly on the last day of each month through January 31, 2024 and (ii) 64,851 shares of Common Stock that are issuable upon the exercise of options vest evenly on the 15th of each month through June 15, 2023, subject to Ms. Epperly&#8217;s continued status as a service provider through each vesting date. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(18)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Consists of (i) 20,479,892 shares of Common Stock directly owned by Dr. Mallick, (ii) 200,000 shares of Common Stock owned by The Dream Finder Foundation, as described in footnote 27 below, and (iii) 744,019 shares of Common Stock issuable upon exercise of options held by Dr. Mallick. 183,670 shares of Common Stock issuable upon exercise of options are exercisable within 60 days of July 29, 2022. Of the remaining options to purchase shares of Common Stock (i) 280,349 shares of Common Stock that are issuable upon the exercise of options vest evenly on the last day of each month through January 31, 2025 and (ii) 280,000 shares of Common Stock that are issuable upon the exercise of options vest as follows&#58; 25% vest on February 25, 2023 and the remaining shares subject to the option vest evenly on the 25th of each month through February 25, 2026, subject to Dr. Mallick&#8217;s continued status as a service provider through each vesting date. If, during the period beginning three months before a change in control through the one-year anniversary of a change in control, Dr. Mallick&#8217;s employment with the Company is terminated either (x) by the Company without cause, and excluding by reason of Dr. Mallick&#8217;s death or disability or (y) by Dr. Mallick for good reason, then 100% of any unvested shares shall immediately vest. Dr. Mallick is the Chief Scientist and a member of the board of directors of the Company. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(19)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Perceptive Advisors LLC (&#8220;Perceptive&#8221;) is the investment advisor to Perceptive Life Sciences Master Fund, Ltd (the &#8220;Master Fund&#8221;). Joseph Edelman is the managing member of Perceptive. Perceptive and Mr. Edelman may be deemed to beneficially own the shares held by the Master Fund.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(20)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Mr. Patel is the manager of PFV I, LLC (&#8220;PFV&#8221;) and as such has voting and investment control over the shares held by PFV. Mr. Patel is the President, Chief Executive Officer, Secretary and a member of the board of directors of the Company.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(21)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Consists of (i) 9,964,488 shares of Common Stock directly owned by Mr. Patel (9,614,388 of which are registered for resale under this prospectus), (ii) 5,280,476 shares of Common Stock held by PFV, (iii) 1,814,035 shares of Common Stock held by the Patel Trust, and (iv) 1,188,833 shares of Common Stock issuable upon exercise of options held by Mr. Patel. 312,145 of the shares of Common Stock issuable upon exercise of options are exercisable within 60 days of July 29, 2022. Of the remaining options to purchase shares of Common Stock (i) 476,688 shares of Common Stock that are issuable upon the exercise of options vest evenly on the last day of each month through January 31, 2025 and (ii) 400,000 shares of Common Stock that are issuable upon the exercise of options vest as follows&#58; 25% vest on February 25, 2023 and the remaining shares subject to the option vest evenly on the 25th of each month through February 25, 2026, subject to Mr. Patel&#8217;s continued status as a service provider through each vesting date. If, during the period beginning three months before a change in control through the one-year anniversary of a change in control, Mr. Patel&#8217;s employment with the Company is terminated either (x) by the Company without cause, and excluding by reason of Mr. Patel&#8217;s death or disability or (y) by Mr. Patel for good reason, then 100% of any unvested shares shall immediately vest. Mr. Patel is the President, Chief Executive Officer, Secretary and a member of the board of directors of the Company. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(22)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Mr. Patel is a trustee of the Sujal Patel 2020 Children&#8217;s Trust, u&#47;a&#47;d December 3, 2020 (the &#8220;Patel Trust&#8221;) and as such has voting and investment control over the shares held by the Patel Trust. Mr. Patel disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities held by the Patel Trust, except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that Mr. Patel is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Mr. Patel is the President, Chief Executive Officer, Secretary and a member of the board of directors of the Company. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(23)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">VCVC Management V LLC (&#8220;VCVC Management&#8221;) serves as the Manager of VCVC V LLC (&#8220;VCVC&#8221;) and Cercano Management LLC (&#8220;Cercano&#8221;) serves as the investment manager of VCVC Management. VCHC Management LLC (&#8220;VCHC Management&#8221;) serves as the Manager of VC Capital Holdings Columbia LLC (&#8220;VCHC&#8221;) and Cercano serves as the investment manager of VCHC Management. Cercano has sole voting and dispositive power over the shares held by VCHC and VCVC. Each of VCVC Management, VCHC Management and Cercano disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">securities, except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that any of VCVC Management, VCHC Management or Cercano is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Stuart Nagae, an affiliate of Vulcan Capital, was a member of the board of directors of Legacy Nautilus until June 9, 2021.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(24)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Consists of 122,747 shares of Common Stock issuable upon exercise of options held by Mr. Pande. 57,896 options to purchase shares of Common Stock are exercisable within 60 days of July 29, 2022. Of the remaining options to purchase shares of Common Stock 64,851 shares of Common Stock that are issuable upon the exercise of options vest evenly on the 15th of each month through June 15, 2023, subject to Mr. Pande&#8217;s continued status as a service provider through each vesting date. Mr. Pande has no voting or investment control over the shares held by entities affiliated with Andreessen Horowitz that are included in footnotes 1 and 5. Mr. Pande is a member of the board of directors of the Company.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(25)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">WS Investment Management Company, a California corporation (&#8220;WSIMCo.&#8221;) is the Manager of WS Investment Company, LLC (&#8220;WS&#8221;) and has sole voting and dispositive power with respect to the shares held by WS. The managing members of WSIMCo. are Mario Rosati, Robert Latta, Donald Bradley and James Terranova. By virtue of these relationships, the managing members may be deemed to have voting and investment power over the shares held by WS.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(26)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Dr. Mallick has voting and investment control over the shares held by The Dream Finder Foundation. Dr. Mallick disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities held by The Dream Finder Foundation, except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that Dr. Mallick is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Dr. Mallick is the Chief Scientist and a member of the board of directors of the Company.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(27)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Jesus A Zavaleta III, custodian, has the power to vote and dispose of the common shares being registered on behalf of Janhavi Amrita Singhal UTMA&#47;TX.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(28)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Jesus A Zavaleta III, custodian, has the power to vote and dispose of the common shares being registered on behalf of Jaya Nirmala Singhal UTMA&#47;TX.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(29)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">The selling securityholder was a member of the board of directors of ARYA Sciences Acquisition Corp III prior to the consummation of the Business Combination.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">15</font></div></div></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_80"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">DESCRIPTION OF SECURITIES</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following summary of certain provisions of our securities does not purport to be complete and is subject to our Certificate of Incorporation, our Bylaws and the provisions of applicable law. </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Authorized Capitalization</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">General</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our authorized capital stock consists of 1,000,000,000 shares of our Common Stock, par value $0.0001 per share, and 200,000,000 shares of our Preferred Stock, par value $0.0001 per share. As of June 30, 2022, we have 124,562,745 shares of our Common Stock outstanding.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following summary describes all material provisions of our capital stock. </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Our Common Stock</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Voting rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. Each share of our Common Stock is entitled to one vote per share on all matters (including the election of directors) submitted to a vote of stockholders, unless otherwise required by law or our certificate of incorporation. Our Certificate of Incorporation and our Bylaws do not provide for cumulative voting rights. Our directors are elected by plurality vote of the shares of our Common Stock present at an annual meeting and entitled to vote. With respect to matters other than the election of directors, at any meeting of the stockholders at which a quorum is present or represented, the affirmative vote of a majority of the voting power of the shares present in person or represented by proxy at such meeting and entitled to vote on the subject matter shall be the act of the stockholders, except as otherwise required by law. The holders of a majority of the stock issued and outstanding and entitled to vote, present in person or represented by proxy, shall constitute a quorum for the transaction of business at all meetings of the stockholders.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Dividend rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. Subject to preferences that may be applicable to any then-outstanding preferred stock, holders of our Common Stock are entitled to receive dividends, if any, as may be declared from time to time by our board of directors out of legally available funds. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Rights upon liquidation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. Upon a liquidation event, holders of our Common Stock are entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then-outstanding shares of preferred stock.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Other rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. Holders of our Common Stock have no preemptive, conversion, subscription or other rights, and there are no redemption or sinking fund provisions applicable to our Common Stock. The rights, preferences and privileges of the holders of our Common Stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that we may designate in the future.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Preferred Stock</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our board of directors has the authority, without further action by the stockholders, to issue shares of preferred stock in one or more series and to fix the designations, powers, preferences and rights, and the qualifications, limitations or restrictions thereof. These designations, powers, preferences and rights could include dividend rights, conversion rights, voting rights, redemption rights, liquidation preferences, sinking fund terms and the number of shares constituting any series or the designation of such series, any or all of which may be greater than the rights of our Common Stock. The issuance of preferred stock could adversely affect the voting power of holders of our Common Stock and the likelihood that such holders will receive dividend payments and payments upon liquidation. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a change in control of our company or other corporate action. As of June 30, 2022, there are no shares of preferred stock outstanding, and we have no present plan to issue any shares of preferred stock.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Election of Directors and Vacancies&#59; Board of Directors</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Subject to the rights of the holders of any series of Preferred Stock to elect additional directors under specified circumstances, the number of directors of our board of directors shall be fixed solely and exclusively by resolution duly adopted from time to time by our board of directors, but currently consists of nine (9) directors, which are divided into three (3) classes, designated Class I, II and III, with each class consisting of three (3) directors. Under our Bylaws, at all meetings of stockholders called for the election of directors, directors shall be elected by a plurality of the voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the election of directors. All directors are elected to hold office until the expiration of the term for which they are elected and until their successors have been duly elected and qualified or until their earlier resignation or removal. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Except as the DGCL may otherwise require and subject to the rights, if any, of the holders of any series of our Preferred Stock, newly created directorships resulting from any increase in the number of directors and any vacancies on our board of directors resulting from death, resignation, disqualification, removal or other cause shall be filled only by the affirmative vote of a majority of the remaining directors then in office, although less than a quorum, or by a sole remaining director. A director elected or appointed to fill a vacancy resulting from the death, resignation, disqualification or removal of a director or a newly created directorship will hold office until the next election of the class for which such director shall have been chosen until his or her successor shall have been duly elected and qualified, or until such director&#8217;s death, resignation or removal.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Subject to the rights, if any, of any series our Preferred Stock, any director or our entire board of directors may be removed from office at any time, but only for cause and only by the affirmative vote of the holders of at least 66 2&#47;3% of the voting power of our issued and outstanding capital stock entitled to vote in the election of directors.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition to the powers and authority expressly conferred upon them by statute or by our Certificate of Incorporation or our Bylaws, the directors are empowered to exercise all such powers and do all such acts and things as may be exercised or done by us, subject, nevertheless, to the provisions of the DGCL, our Certificate of Incorporation and our Bylaws adopted and in effect from time to time&#59; provided, however, that no Bylaw adopted, amended, altered or repealed after the date of our Bylaws will invalidate any prior act of our directors or officers which would have been valid if such Bylaw had not been adopted, amended, altered or repealed.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Quorum</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The holders of a majority of the voting power of the capital stock issued and outstanding and entitled to vote thereat, present in person or represented by proxy, will constitute a quorum at all meetings of the stockholders for the transaction of business. Where a separate vote by a class or series or classes or series is required, a majority of the voting power of the outstanding shares of such class or series or classes or series, present in person or represented by proxy, shall constitute a quorum entitled to take action with respect to that vote on that matter, except as otherwise provided by law, our Certificate of Incorporation or our Bylaws, each as amended from time to time. If, however, such quorum will not be present or represented at any meeting of the stockholders, the holders of a majority of the voting power present in person or represented by proxy, will have power to adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum will be present or represented. At such adjourned meeting at which a quorum will be present or represented, any business may be transacted which might have been transacted at the meeting as originally noticed. If the adjournment is for more than thirty (30) days, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting will be given to each stockholder entitled to vote at such adjourned meeting as of the record date fixed for notice of such adjourned meeting.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Anti-takeover Effects of Our Certificate of Incorporation and Our Bylaws</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our Certificate of Incorporation and Bylaws contain provisions that may delay, defer or discourage another party from acquiring control of us. We expect that these provisions, which are summarized below, may discourage coercive takeover practices or inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors, which we believe may result in an improvement of the terms of any such acquisition in favor of our stockholders. However, they also give our board of directors the power to discourage acquisitions that some stockholders may favor.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Authorized but Unissued Capital Stock</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Delaware law does not require stockholder approval for any issuance of authorized shares. However, the listing requirements of Nasdaq, which would apply if and so long as our Common Stock remains listed on Nasdaq, require stockholder approval of certain issuances equal to or exceeding 20% of the then outstanding voting power or then outstanding number of shares of our Common Stock. Additional shares that may be issued in the future may be used for a variety of corporate purposes, including future public offerings, to raise additional capital or to facilitate acquisitions.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">One of the effects of the existence of unissued and unreserved common stock may be to enable our board of directors to issue shares to persons friendly to our management, which issuance could render more difficult or discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise and thereby protect the continuity of our management and possibly deprive stockholders of opportunities to sell their shares of our Common Stock at prices higher than prevailing market prices.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Special Meeting, Action by Written Consent and Advance Notice Requirements for Stockholder Proposals</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Unless otherwise required by law, and subject to the rights, if any, of the holders of any series of our Preferred Stock, special meetings of our stockholders may be called only by the Chairperson of our board of directors, our Chief Executive Officer, our President, or our board of directors acting pursuant to a resolution adopted by a majority of our board of directors. Unless otherwise required by law, written notice of a special meeting of stockholders, stating the time, place and purpose or purposes thereof, shall be given to each stockholder entitled to vote at such meeting, not less than ten (10) or more than sixty (60) days before the date fixed for the meeting. Business transacted at any special meeting of stockholders will be limited to the purposes stated in the notice.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our Bylaws also provide that unless otherwise restricted by our Certificate of Incorporation or our Bylaws, any action required or permitted to be taken at any meeting of our board of directors or of any committee thereof may be taken without a meeting, if all members of our board of directors or of such committee, as the case may be, consent thereto in writing or by electronic transmission.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition, our Bylaws require advance notice procedures for stockholder proposals to be brought before an annual meeting of the stockholders, including the nomination of directors. Stockholders at an annual meeting may only consider the proposals specified in the notice of meeting or brought before the meeting by or at the direction of our board of directors, or by a stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has delivered a timely written notice in proper form to our secretary, of the stockholder&#8217;s intention to bring such business before the meeting.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">These provisions could have the effect of delaying until the next stockholder meeting any stockholder actions, even if they are favored by the holders of a majority of our outstanding voting securities.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Amendment to Certificate of Incorporation and Bylaws</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The DGCL provides generally that the affirmative vote of a majority of the outstanding stock entitled to vote on amendments to a corporation&#8217;s certificate of incorporation or bylaws is required to approve such amendment, unless a corporation&#8217;s certificate of incorporation or bylaws, as the case may be, requires a greater percentage.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our Certificate of Incorporation will provide that the following provisions therein may be amended, altered, repealed or rescinded only by the affirmative vote of the holders of at least 66 2&#47;3% in voting power of all the then outstanding shares of our stock entitled to vote thereon and the affirmative vote of at least 66 2&#47;3% of the then outstanding voting securities of the Company, voting together as a single class&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the provisions authorizing our board of directors to issues shares of our Preferred Stock, with any rights, preferences or privileges as they may designate&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the provisions dividing our board of directors into three classes, each of which stands for election once every three years&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the provisions providing that a director may only be removed from our board of directors for cause only by the affirmative vote of the holders of at least 66 2&#47;3% of the voting power of our issued and outstanding capital stock entitled to vote in the election of directors&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the provisions providing that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the provisions prohibiting cumulative voting&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the provisions requiring that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and not be taken by written consent&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the provisions regarding calling special meetings of stockholders&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the provisions regarding notice of stockholder nominations for the election of directors and of business to be brought by stockholders before any meeting of our stockholders&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the provision regarding the approval requirements for such amendments&#59;</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our Bylaws may be amended or repealed (A) by the affirmative vote of a majority of our entire board of directors then in office (subject to any bylaw requiring the affirmative vote of a larger percentage of the members of our board of directors) or (B) by our stockholders, provided that the affirmative vote of the holders of at least 66 2&#47;3% of the total voting power of outstanding voting securities, voting together as a single class, shall be required for our stockholders to alter, amend or repeal, or adopt certain provisions of our Bylaws.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Delaware Anti-Takeover Statute</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are subject to Section 203 of the DGCL. In general, Section 203 of the DGCL prevents a public company incorporated in Delaware from engaging in a &#8220;business combination&#8221; with any &#8220;interested stockholder&#8221; for three years following the time that the person became an interested stockholder, unless, among other exceptions, the interested stockholder attained such status with the approval of our board of directors or holders of 66 2&#47;3% of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">voting power of the outstanding capital stock held by stockholders unaffiliated with the interested stockholder approve the business combination. A business combination includes, among other things, a merger or consolidation involving the interested stockholder and the sale of more than 10% of the company&#8217;s assets. In general, an interested stockholder is any stockholder that, together with its affiliates, beneficially owns 15% or more of the company&#8217;s stock. A public company incorporated in Delaware is automatically subject to Section 203 unless it opts out in its original corporate charter or pursuant to a subsequent charter or bylaw amendment approved by stockholders.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Limitations on Liability and Indemnification of Officers and Directors</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our Certificate of Incorporation limits the liability of our directors to the fullest extent permitted by the DGCL, and our Bylaws provide that we will indemnify them to the fullest extent permitted by such law. We have entered into indemnification agreements with our directors and officers and we expect to continue to enter into agreements to indemnify our directors, executive officers and other employees as determined by our board of directors. Under the terms of such indemnification agreements, we will be required to indemnify each of its directors and officers, to the fullest extent permitted by the laws of the state of Delaware, if the basis of the indemnitee&#8217;s involvement was by reason of the fact that the indemnitee is or was a director or officer of us or any of our subsidiaries or was serving at our request in an official capacity for another entity. Any claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against it and may reduce the amount of money available to it.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exclusive Jurisdiction of Certain Actions</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our Bylaws provide that, unless we consent in writing to the selection of an alternative forum (an &#8220;Alternative Forum Consent&#8221;), the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another state court in Delaware or the federal district court for the District of Delaware) will, to the fullest extent permitted by law, be the sole and exclusive forum for (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers, stockholders or other employees to us or our stockholders, (iii) any action arising pursuant to any provision of the Delaware General Corporation Law or our Certificate of Incorporation or our Bylaws (each, as may be amended from time to time), or (iv) any action asserting a claim governed by the internal affairs doctrine of the State of Delaware, except for any claim as to which the court does not have jurisdiction over an indispensable party to that claim. The foregoing shall not apply to any claims under the Exchange Act or the Securities Act of 1933, as amended. In addition, unless we give an Alternative Forum Consent, the federal district courts of the United States shall be the sole and exclusive forum for resolving any action asserting a claim arising under the Securities Act of 1933.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Transfer Agent</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The transfer agent for our Common Stock is Continental Stock Transfer &#38; Trust Company.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exchange Listing </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our Common Stock is listed on Nasdaq under the symbol &#8220;NAUT.&#8221; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">20</font></div></div></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_83"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">PLAN OF DISTRIBUTION</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are registering the Securities covered by this prospectus to permit the selling securityholders to conduct public secondary trading of these Securities from time to time after the date of this prospectus. We will not receive any of the proceeds of the sale of the Securities offered by this prospectus. The aggregate proceeds to the selling securityholders from the sale of the Securities will be the purchase price of the Securities less any discounts and commissions. We will not pay any brokers&#8217; or underwriters&#8217; discounts and commissions in connection with the registration and sale of the Securities covered by this prospectus. The selling securityholders reserve the right to accept and, together with their respective agents, to reject, any proposed purchases of Securities to be made directly or through agents. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Securities offered by this prospectus may be sold from time to time to purchasers&#58; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">directly by the selling securityholders&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">through underwriters, broker-dealers or agents, who may receive compensation in the form of discounts, commissions or agent&#8217;s commissions from the selling securityholders or the purchasers of the Securities&#59; or </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">through a combination of any of these methods of sale.  </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Any underwriters, broker-dealers or agents who participate in the sale or distribution of the Securities may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act. As a result, any discounts, commissions or concessions received by any such broker-dealer or agents who are deemed to be underwriters will be deemed to be underwriting discounts and commissions under the Securities Act. Underwriters are subject to the prospectus delivery requirements of the Securities Act and may be subject to certain statutory liabilities under the Securities Act and the Exchange Act. We will make copies of this prospectus available to the selling securityholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. To our knowledge, there are currently no plans, arrangements or understandings between the selling securityholders and any underwriter, broker-dealer or agent regarding the sale of the Securities by the selling securityholders. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The term &#8220;selling securityholders&#8221; includes donees, pledgees, transferees or other&#160;successors-in-interest&#160;selling securities received after the date of this prospectus from a selling securityholder as a gift, pledge, partnership distribution or other transfer. The selling securityholders will act independently of us in making decisions with respect to the timing, manner and size of each sale.&#160;The Securities may be sold in one or more transactions at&#58; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">fixed prices&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">prevailing market prices at the time of sale&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">prices related to such prevailing market prices&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">varying prices determined at the time of sale&#59; or </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">negotiated prices. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">These sales may be effected in one or more transactions&#58; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">on any national securities exchange or quotation service on which the Securities may be listed or quoted at the time of sale, including Nasdaq&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">in the over-the-counter market&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">in transactions otherwise than on such exchanges or services or in the over-the-counter market&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">through trading plans entered into by the selling securityholder pursuant to Rule 10b5-1 under the Exchange Act that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of their securities on the basis of parameters described in such trading plans&#59;</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">through one or more underwritten offerings on a firm commitment or best efforts basis&#59; </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">settlement of short sales entered into after the date of this prospectus&#59; </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">agreements with broker-dealers to sell a specified number of the securities at a stipulated price per share&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">in &#8220;at the market&#8221; offerings, as defined in Rule 415 under the Securities Act, at negotiated prices, at prices prevailing at the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities exchange or sales made through a market maker other than on an exchange or other similar offerings through sales agents </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">in privately negotiated transactions&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">in options or other hedging transactions, whether through an options exchange or otherwise&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">in distributions to members, limited partners or stockholders of selling securityholders&#59;  </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">any other method permitted by applicable law&#59; or </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">through any combination of the foregoing. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">These transactions may include block transactions or crosses. Crosses are transactions in which the same broker acts as an agent on both sides of the trade.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In connection with distributions of the Securities or otherwise, the selling securityholders may enter into hedging transactions with broker-dealers or other financial institutions. In connection with such transactions, broker-dealers or other financial institutions may engage in short sales of the Securities in the course of hedging transactions, broker-dealers or other financial institutions may engage in short sales of the Securities in the course of hedging the positions they assume with selling securityholders. The selling securityholders may also sell the Securities short and redeliver the Securities to close out such short positions. The selling securityholders may also enter into option or other transactions with broker-dealers or other financial institutions which require the delivery to such broker-dealer or other financial institution of the Securities offered by this prospectus, which Securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). The selling securityholders may also pledge the Securities to a broker-dealer or other financial institution, and, upon a default, such broker-dealer or other financial institution, may effect sales of the pledged Securities pursuant to this prospectus (as supplemented or amended to reflect such transaction).</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">A selling securityholder may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell the Securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities pledged by any selling securityholder or borrowed from any selling securityholder or others to settle those sales or to close out any related open borrowings of stock, and may use securities received from any selling securityholder in settlement of those derivatives to close out any related open borrowings of stock. The third party in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">such sale transactions will be an underwriter and will be identified in the applicable prospectus supplement (or a post-effective amendment). In addition, any selling securityholder may otherwise loan or pledge the Securities to a financial institution or other third party that in turn may sell the Securities short using this prospectus. Such financial institution or other third party may transfer its economic short position to investors in our securities or in connection with a concurrent offering of other securities.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">At the time a particular offering of the Securities is made, a prospectus supplement, if required, will be distributed, which will set forth the name of the selling securityholders, the aggregate amount of Securities being offered and the terms of the offering, including, to the extent required, (1)&#160;the name or names of any underwriters, broker-dealers or agents, (2)&#160;any discounts, commissions and other terms constituting compensation from the selling securityholders and (3)&#160;any discounts, commissions or concessions allowed or reallowed to be paid to broker-dealers. We may suspend the sale of Securities by the selling securityholders pursuant to this prospectus for certain periods of time for certain reasons, including if the prospectus is required to be supplemented or amended to include additional material information. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The selling securityholders will act independently of us in making decisions with respect to the timing, manner, and size of each resale or other transfer. There can be no assurance that the selling securityholders will sell any or all of the Securities under this prospectus. Further, we cannot assure you that the selling securityholders will not transfer, distribute, devise or gift the Securities by other means not described in this prospectus. In addition, any Securities covered by this prospectus that qualify for sale under Rule 144 of the Securities Act may be sold under Rule 144 rather than under this prospectus. The Securities may be sold in some states only through registered or licensed brokers or dealers. In addition, in some states the Securities may not be sold unless they have been registered or qualified for sale or an exemption from registration or qualification is available and complied with. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The selling securityholders and any other person participating in the sale of the Securities will be subject to the Exchange Act. The Exchange Act rules include, without limitation, Regulation M, which may limit the timing of purchases and sales of any of the Securities by the selling securityholders and any other person. In addition, Regulation M may restrict the ability of any person engaged in the distribution of the Securities to engage in market-making activities with respect to the particular securities being distributed. This may affect the marketability of the Securities and the ability of any person or entity to engage in market-making activities with respect to the Securities. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The selling securityholders may, from time to time, pledge or grant a security interest in some shares of the Securities owned by them and, if a selling securityholder defaults in the performance of its secured obligations, the pledgees or secured parties may offer and sell such shares of the Securities, from time to time, under this prospectus, or under an amendment or supplement to this prospectus amending the list of the selling securityholders to include the pledgee, transferee or other successors in interest as the selling securityholders under this prospectus. The selling securityholders also may transfer shares of the Securities in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">A selling securityholder that is an entity may elect to make an&#160;in-kind&#160;distribution of the Securities to its members, partners or shareholders pursuant to the registration statement of which this prospectus is a part by delivering a prospectus. To the extent that such members, partners or shareholders are not affiliates of ours, such members, partners or stockholders would thereby receive freely tradable shares of the Securities pursuant to the distribution through a registration statement.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">With respect to those Securities being registered pursuant to the Registration Rights Agreement, we have agreed to indemnify or provide contribution to the selling securityholders and all of their officers, directors and control persons, as applicable, and certain underwriters effecting sales of the Securities against certain liabilities, including certain liabilities under the Securities Act. The selling securityholders have agreed to indemnify us in certain </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">circumstances against certain liabilities, including certain liabilities under the Securities Act. The selling securityholders may indemnify any broker or underwriter that participates in transactions involving the sale of the Securities against certain liabilities, including liabilities arising under the Securities Act.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For additional information regarding expenses of registration, see the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; appearing elsewhere in this prospectus.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">24</font></div></div></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_86"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">LEGAL MATTERS </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The validity of the Securities offered hereby has been passed upon for us by Wilson Sonsini Goodrich&#160;&#38; Rosati, Professional Corporation, Palo Alto, California. Certain members of, and investment partnerships comprised of members of, and persons associated with, Wilson Sonsini Goodrich &#38; Rosati, Professional Corporation, directly or indirectly own less than 0.3% of the outstanding shares of our common stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">25</font></div></div></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_89"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">EXPERTS </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The financial statements incorporated in this Prospectus by reference to the Annual Report on Form 10-K for the year ended December 31, 2021 have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">II- 1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">WHERE YOU CAN FIND ADDITIONAL INFORMATION </font></div><div style="margin-bottom:9pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We file reports, proxy statements and other information with the SEC. The SEC maintains a web site that contains reports, proxy and information statements and other information about issuers, such as us, who file electronically with the SEC. The address of that website is</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;http&#58;&#47;&#47;www.sec.gov</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:9pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our website address is www.nautilus.bio. The information on our web site, however, is not, and should not be deemed to be, a part of this prospectus.</font></div><div style="margin-bottom:9pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This prospectus and any applicable prospectus supplement are part of a registration statement that we filed with the SEC and do not contain all of the information in the registration statement. The full registration statement may be obtained from the SEC or us, as provided below. Statements in this prospectus or any prospectus supplement about these documents are summaries and each statement is qualified in all respects by reference to the document to which it refers. You should refer to the actual documents for a more complete description of the relevant matters. You may inspect a copy of the registration statement through the SEC&#8217;s website, as provided above.</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">INCORPORATION BY REFERENCE </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The SEC&#8217;s rules allow us to &#8220;incorporate by reference&#8221; information into this prospectus, which means that we can disclose important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus, and subsequent information that we file with the SEC will automatically update and supersede that information. Any statement contained in this prospectus or a previously filed document incorporated by reference will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus or a subsequently filed document incorporated by reference modifies or replaces that statement. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">This prospectus and any accompanying prospectus supplement incorporate by reference the documents set forth below that have previously been filed with the SEC&#58; </font></div><div style="padding-left:81pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Annual Report on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001808805/000180880522000010/naut-20211231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form&#160;10-K</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December&#160;31, 2021, filed with the SEC on February&#160;24, 2022 (our &#8220;Annual Report&#8221;), including the information specifically incorporated by reference into our Annual Report from our Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 28, 2022&#59;</font></div><div style="padding-left:81pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Quarterly Reports on Form&#160;10-Q for the quarter ended </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001808805/000180880522000046/naut-20220331.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">March 31, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001808805/000180880522000046/naut-20220331.htm" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">May&#160;3, 2022</a> and for the quarter ended </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001808805/000180880522000081/naut-20220630.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">June 30, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed with the SEC on August 2, 2022&#59;</font></div><div style="padding-left:81pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Current Reports on Form 8-K filed with the SEC on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001808805/000180880522000030/naut-20220330.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">March 31, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001808805/000180880522000059/naut-20220614.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">June 16, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (excluding any information furnished but not filed in such reports under Item&#160;2.02, Item 7.01, or Item&#160;9.01)&#59; and</font></div><div style="padding-left:81pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the description of securities set forth in the section titled &#8220;Form 10 Information&#8212;Description of Company&#8217;s Securities&#8221; in our Current Report on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0001808805/000162828021011892/nautilus-form8xkclosing.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 8-K</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed with the SEC on June 10, 2021, and any amendment or report filed with the SEC for the purpose of updating such description.</font></div><div><font><br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">All reports and other documents we subsequently file pursuant to Section&#160;13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, which we refer to as the &#8220;Exchange Act&#8221; in this prospectus, prior to the termination of this offering, including all such documents we may file with the SEC after the date of the initial registration statement and prior to the effectiveness of the registration statement, but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated by reference into this prospectus and deemed to be part of this prospectus from the date of the filing of such reports and documents.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"> </font></div><div><font><br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">You may request a free copy of any of the documents incorporated by reference in this prospectus by writing or telephoning us at the following address&#58; </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Nautilus Biotechnology, Inc. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2701 Eastlake Avenue East</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">II- 2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Seattle, Washington 98102</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(206) 333-2001&#160;</font></div><div style="margin-top:12pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus or any accompanying prospectus supplement. </font></div><div style="margin-top:12pt"><font><br></font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">PART II</font></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">INFORMATION NOT REQUIRED IN PROSPECTUS</font></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_92"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">ITEM 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following table sets forth all expenses to be paid by the Registrant, other than underwriting discounts and commissions, in connection with this offering. All amounts shown are estimates.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.407%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SEC registration fee</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;96,732</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FINRA filing fee</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange listing fee</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Printing and engraving</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal fees and expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting fees and expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blue sky fees and expenses (including legal fees)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer agent and registrar fees</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,732&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">______________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Previously paid. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">*These fees and expenses are calculated based on the amount of securities offered and accordingly cannot be estimated at this time.</font></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_95"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">ITEM 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As permitted by Section 102 of the Delaware General Corporation Law, our certificate of incorporation provides that our officers and directors will be indemnified by us to the fullest extent authorized by Delaware law, as it now exists or may in the future be amended. In addition, our certificate of incorporation provides that our directors will not be personally liable for monetary damages to us or our stockholders for breaches of their fiduciary duty as directors, to the fullest extent permitted by Delaware law as it now exists or may in the future be amended. Our certificate of incorporation also authorizes us to indemnify our officers, directors and other agents to the fullest extent permitted under Delaware law.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As permitted by Section 145 of the Delaware General Corporation Law, our bylaws provide that&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">we may indemnify our directors, officers and employees to the fullest extent permitted by the Delaware General Corporation Law, subject to limited exceptions&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">we may advance expenses to our directors, officers and employees in connection with a legal proceeding to the fullest extent permitted by the Delaware General Corporation Law, subject to limited exceptions&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">II- 3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">the rights provided in our bylaws are not exclusive.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our certificate of incorporation and our bylaws provide for the indemnification provisions described above and elsewhere herein. We have entered into separate indemnification agreements with our directors and officers that may be broader than the specific indemnification provisions contained in the Delaware General Corporation Law. We have entered into agreements with our officers and directors to provide contractual indemnification in addition to the indemnification provided for in our certificate of incorporation. Our bylaws also permit us to maintain insurance on behalf of any officer, director or employee for any liability arising out of his or her actions, regardless of whether Delaware law would permit such indemnification. We have obtained a policy of director&#8217;s and officer&#8217;s liability insurance that insures our officers and directors against the cost of defense, settlement or payment of a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors. These indemnification provisions and the indemnification agreements may be sufficiently broad to permit indemnification of directors and officers for liabilities, including reimbursement of expenses incurred, arising under the Securities Act of 1933, as amended, or the Securities Act.</font></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_101"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">ITEM 16. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%;padding-left:6.34pt">Exhibits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. We have filed the exhibits listed on the accompanying Exhibit Index of this Registration Statement.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#8224;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1808805/000114036121003650/brhc10019858_ex2-1.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Business Combination Agreement, dated as of February 7, 2021, by and among ARYA Sciences Acquisition Corp III, Mako Merger Sub, Inc., and Nautilus Biotechnology, Inc. (incorporated by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on February 8, 2021).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1808805/000162828021011892/exhibit31-form8xkclosing.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Certificate of Incorporation of Nautilus Biotechnology, Inc. (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 10, 2021).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1808805/000162828021011892/exhibit32-form8xkclosing.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Bylaws of Nautilus Biotechnology, Inc. (incorporated by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 10, 2021).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1808805/000162828021011892/exhibit41-super8xkclosing.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 10, 2021).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1808805/000162828021014270/exhibit51-sx1.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Opinion of Wilson Sonsini Goodrich &#38; Rosati, P.C. (incorporated by reference to Exhibit 5.1 to the Company&#8217;s Registration Statement on Form S-1 (File No. 333-258100) filed with the SEC on July 22, 2021). </a> </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1808805/000114036121003650/brhc10019858_ex10-3.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Form of Subscription Agreement (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on February 8, 2021).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1808805/000114036121003650/brhc10019858_ex10-2.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Form of Amended and Restated Registration Rights and Lock-Up Agreement (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on February 8, 2021).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1808805/000114036121003650/brhc10019858_ex2-1.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Form of Nautilus Shareholder Transaction Support Agreement (incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on February 8, 2021).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="exhibit231consentofpwcllp.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consent of PricewaterhouseCoopers LLP</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1808805/000162828021014270/exhibit51-sx1.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consent of Wilson Sonsini Goodrich &#38; Rosati, P.C. (included in Exhibit 5.1).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i1e81c8a398e14e3b82517ba4446b0b26_107" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Power of Attorney (</a><a href="#i1e81c8a398e14e3b82517ba4446b0b26_107" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">included on signature page </a><a href="https://www.sec.gov/Archives/edgar/data/1808805/000162828021014270/exhibit51-sx1.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">to the Company&#8217;s Registration Statement on Form S-1 (File No. 333-258100) filed with the SEC on July 22, 2021</a><a href="#i1e81c8a398e14e3b82517ba4446b0b26_107" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="exhibit242powerofattorney.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Power of Attorney for Karen Akinsanya.</a></font></div></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">__________________</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">+ Indicates management contract or compensatory plan.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">&#8224; Schedules and exhibits to this Exhibit omitted pursuant to Regulation S-K Item 601(b)(2). The Registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">II- 4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%;padding-left:6.34pt">Financial Statement Schedules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. All financial statement schedules are omitted because the information called for is not required or is shown either in the consolidated financial statements or in the notes thereto.</font></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_104"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">ITEM 17. UNDERTAKINGS.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The undersigned registrant hereby undertakes&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.34pt">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8.57pt">To include any prospectus required by section 10(a)(3) of the Securities Act&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:5.8pt">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.03pt">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement&#59;</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> that paragraphs (a)(1)(i), (ii) and (iii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to section 13 or section 15(d) of the Exchange Act that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.34pt">That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.34pt">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.34pt">That, for the purpose of determining liability under the Securities Act to any purchaser&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:4.12pt">Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:4.68pt">Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii) or (x)&#160;for the purpose of providing the information required by section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">II- 5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.34pt">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8.57pt">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:5.8pt">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.03pt">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.57pt">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.34pt">The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">II- 6</font></div></div></div><div id="i1e81c8a398e14e3b82517ba4446b0b26_107"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">SIGNATURES</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Post-Effective Amendment No. 2 to this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Seattle, State of Washington, on August 2, 2022.</font></div><div style="padding-left:274.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.346%"><tr><td style="width:1.0%"></td><td style="width:9.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NAUTILUS BIOTECHNOLOGY, INC.</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sujal Patel</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sujal Patel</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">II-7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font><br></font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Pursuant to the requirements of the Securities Act of 1933, as amended, this Post-Effective Amendment No. 2 to this Registration Statement has been signed by the following persons in the capacities and on the dates indicated&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Signature</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sujal Patel</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer, President and Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2022</font></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sujal Patel</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Anna Mowry</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2022</font></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anna Mowry</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2022</font></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Altman</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2022</font></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Melissa Epperly</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2022</font></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parag Mallick</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2022</font></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew McIlwain</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2022</font></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Farzad Nazem</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2022</font></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vijay Pande</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2022</font></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Karen Akinsanya</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2022</font></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Karen Akinsanya</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.506%"><tr><td style="width:1.0%"></td><td style="width:14.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*By&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sujal Patel</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sujal Patel</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As Attorney-in-Fact</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">II-8</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>exhibit231consentofpwcllp.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8921fe965f6a4bc0be939319bf7e2a7f_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit 23.1</font></div></div><div style="margin-bottom:24pt;margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:100%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:100%">We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of Nautilus Biotechnology, Inc.</font><font style="color:#ff0000;font-family:'Georgia',serif;font-size:10pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:100%">of our report dated February 24, 2022</font><font style="color:#ff0000;font-family:'Georgia',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:100%">relating to the financial statements, which appears in Nautilus Biotechnology Inc.'s Annual Report on Form 10-K for the year ended December 31, 2021.  We also consent to the reference to us under the heading</font><font style="color:#ff0000;font-family:'Georgia',serif;font-size:10pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Experts&#8221;</font><font style="color:#ff0000;font-family:'Georgia',serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:100%">in such Registration Statement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; PricewaterhouseCoopers LLP</font></div><div><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:100%"><br>Seattle, Washington <br>August 2, 2022</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.2
<SEQUENCE>3
<FILENAME>exhibit242powerofattorney.htm
<DESCRIPTION>EX-24.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i36ff278309a941f5b4aab23f9a33d280_38"></div><div style="min-height:119.52pt;width:100%"><div style="margin-top:12pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 24.2</font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">POWER OF ATTORNEY</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">KNOW ALL PERSONS BY THESE PRESENTS, that the person whose signature appears below hereby constitutes and appoints Sujal Patel and Anna Mowry, and each of them, as her true and lawful attorney-in-fact and agent with full power of substitution, for her in any and all capacities, to sign any and all amendments to this registration statement (including post-effective amendments or any abbreviated registration statement and any amendments thereto filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, increasing the number of securities for which registration is sought), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact, proxy and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact, proxy and agent, or her substitute, may lawfully do or cause to be done by virtue hereof.</font></div><div style="margin-top:12pt;text-indent:36pt"><font><br></font></div><div style="padding-left:0.07pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.669%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.746%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.670%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Karen Akinsanya</font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Karen Akinsanya</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">August 2, 2022</font></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>nautilus_primarylogoxblue.jpg
<TEXT>
begin 644 nautilus_primarylogoxblue.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^(,6$E#0U]04D]&24Q%  $!   ,2$QI
M;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E0     245#
M('-21T(                  /;6  $     TRU(4" @
M                                               18W!R=    5
M   S9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4<EA96@
M A@    49UA96@   BP    48EA96@   D     49&UN9    E0   !P9&UD
M9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0   _@    4
M;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U120P  !#P
M  @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W
M;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@245#-C$Y
M-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M                                                     %A96B
M      #S40 !     1;,6%E:(                     !865H@
M;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(        "2@   /
MA   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M     !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                    9&5S8P         N245#(#8Q
M.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M       N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@
M+2!S4D="                             &1E<V,         +%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M     "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M
M,BXQ                                  !V:65W       3I/X %%\N
M !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4    %<?YVUE87,
M         0                        */     G-I9R      0U)4(&-U
M<G8        $      4 "@ / !0 &0 > ", *  M #( -P [ $  10!* $\
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M[D(P0G)"M4+W0SI#?4/ 1 -$1T2*1,Y%$D5519I%WD8B1F=&JT;P1S5'>T?
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M @(" @+_P  1" ,K"?8# 1$  A$! Q$!_\0 'P !  (# 0$! 0$!
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MI*71TM5&5X.5H\/$)41D\,'"A>$F96;D\?_:  P# 0 "$0,1 #\ O\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                      U#V[SG
MXQZ&W=@G'O;>QFL(V1L:RVC(,::N]GO3>-.6V_WO(,=L[UTR]J"JW63S[WC5
MTCTK+D,I;4EM;RFVW$N'36K!N(;U9JR^VNA6LH*![V2:'LXS4QC)'Z8LT>_2
MR1KN0U<]^G-6D:XEVMX!PABNU8,Q'?$M5\OD44T"2Q2\1HFEF@B62I1BP0ZY
MH)&>FO9I72KLFJCC;PYDDH
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MK5='JWK"]CLW9YFU1SI(8
M
M
M
M
M
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M:?CITJ5HYMR\YHJBHJ9IS'^@_H
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M!;C]*.]7S9S73?2]Z:ZOH4<NY*JG:UM5$UO?34R,E[B-HW[U5R(6U2LIHZ
M
M
M
M
M
M
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M8YF)(S/N/1'9.3G:Y%:N]#W1\A[
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M[>/5W_==F_TX??I/$O\ C*?J<T#^ZL>A+L^]3_\ :ZW]Y'T4^WCU=_W79O\
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MZL>A+L^]3_\ :ZW]Y'T4^WCU=_W79O\ 3A]^D\2_XRGZG- _NK'H2[/O4_\
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M;-<CW.T,8QC<]+&HW)#/QXQV0
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MH.@I]-0RMM\+)-=+202+E'/*W0YZL77J5N;6JVS25\+Y@
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MB^9UJCXR"HKH(9F:XZ!DC-<;W-UL>Q[<]3'(N2EUXJ0:J
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MJ99&D37-D:U['(YCDS14WHJ+S*B]S])_<_A_L
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M-JKL)R\=3-7+-U!5O<]6MRY3N(J^-UJNYC*B%C=S<DL)$'ET0
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M<GP*>8/T6^0/V39:=%@_JNPIY2H?.8R/MK76JVF_>]>OU;4G.#+[&'
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M4\/OHM\?OLFQ(H3C#JNQ7Y2KO.9#<?9+UJMF7WO67]6TQM(<Z2"
M                              5E_22/R+XG?*C;OU3@!838']<XG]SI
M/E)BA?#G^Q6SGQBY?)T95'+*&=8       )[/1VOAK;0^BWFOVLZ2(6VZ]2-
MN\I0^:UA<3@3]=;$/WOU?ZRM)<T*H&H@                          !I
MCXBOP$N6OS"['_9V8=9@3JSPQX[3_*(1=MMZT.TCR-7_ "#SG6E[#$@
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MK?(KOI&F7H:B1J]JM/%I;-IS5K7U*S2Z5RUJ:6G6$4@
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M:S^FC_5S_OV*Y[?_ /9+^?\ _A&@O 4YMJ/L6/\ 3>"T@5S- P
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M2M#B%IHI"T+37HM-4UI6E:>RM/\ UHRJ*BY+N5#:E%1R-<U4<UR;E/ZG\/\
M0                               *//CR_G \B^:W6?U9-+@;%^HB#QF
MH^,TR;X7W7FK_)]!\D\AE)8*M@       N:>CM? IVA]*3-?LFTD50VZ]5UN
M\FP^=5AJ+P)>M5B#[X:O]6VDGL(6+A@                          %>K
MTC'X+VC_ )^VOL\S4G+8/U17CQ+_ +\12SAO=;_"?EE/,JLIZ%IC,H
M $]GH[7PUMH?1;S7[6=)$+;=>I&W>4H?-:PN)P)^NMB'[WZO]96DN:%4#40
M        U;YR? IY@_1;Y _9-EIT6#^J["GE*A\YC(^VM=:K:;][UZ_5M2<X
M,OL8<                                          %F?T;C\MN6/R6
MU)];9Z5\V^_6>&?=:KXL)?3@,?97:-XO;?E*PM<E:C10          $,OCR_
MF_,B^=+6?UG-)8V+]6\'BU1\5I5WA?\ 69K?*%#\=Y1Y+@&3(       -S/#
ML^'9Q)^?S6O[2P3D\=]1F)_$JCY-24MB/7=V<>6*#SAAT5"B9ML
M      >6SG\B<P^2V0?5,L^FB^O*3W6/XR'GW;[%7/Q>;Y-QS"#0\P'
M    .CYP;^!3P^^BWQ^^R;$BA.,.J[%?E*N\YD-Q]DO6JV9?>]9?U;3&TASI
M((                                      !67])(_(OB=\J-N_5. %
MA-@?USB?W.D^4F*%\.?[%;.?&+E\G1E4<LH9U@       GL]':^&MM#Z+>:_
M:SI(A;;KU(V[RE#YK6%Q.!/UUL0_>_5_K*TES0J@:B
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M?J@MM,KF4<.72.<S/5/,WLS3*]^;G<5Q;%2--&CLB(
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M/:N'[U'VS:Q'>\L+$3XJF:/#>A>W'.$*A?J<MI<Q/;,K*ASOZ)&E=\G4I*
M     "TAZ-9_31_JY_W[%<]O_P#LE_/_ /PC07@*<VU'V+'^F\%I KF:!@
M                                JG>D/<GES[_JOB3CMP56'88[>W-E
MML.4JV[>;DU/LV V60MM=%4>BVA=_GO,K35I:;_;7J=5M4[+)["L.:(+EB>>
M/ES*M)!GWB:7S/3V7Z&([UDC>R9X<-7'RS5N']G%#,O%4;4N5>B99+*]'Q4<
M*Y;]3(N.F>Q>2J30/WJW=60+"E!@    7T_!]Y05Y,<,,%3>[EZ]L'3%4:@S
M:KSBUS92<9@Q:8=?9%7??R5S<-?L]'I*JKK(GP9ZJKJM*Z)I;M3PZF'\6UG$
M1Z*&[_3</<3C%=QS$[FB;7DWM6.9X#87@SX_^?S9;:$JYN-O6%\K95Y].[B&
M-Z%F55Y3N,I5BUO7/7,R;?J1Q*:1R6#
M  !1Y\>7\X'D7S6ZS^K)I<#8OU$0>,U'QFF3?"^Z\U?Y/H/DGD,I+!5L
M   %S3T=KX%.T/I29K]DVDBJ&W7JNMWDV'SJL-1>!+UJL0??#5_JVTD]A"Q<
M,                           KU>D8_!>T?\ /VU]GF:DY;!^J*\>)?\
M?B*6<-[K?X3\LIYE5E/0M,9E        GL]':^&MM#Z+>:_:SI(A;;KU(V[R
ME#YK6%Q.!/UUL0_>_5_K*TES0J@:B         &K?.3X%/,'Z+?('[)LM.BP
M?U784\I4/G,9'VUKK5;3?O>O7ZMJ3G!E]C#@
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MORE7><R&X^R7K5;,OO>LOZMIC:0YTD$
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M[K=;E?;A67>\5TMSNEP>LDU1,]9)9'KVSWNW\V34;S(U$:U$:U&GF#Z#RP
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M/V&_6O$UFMN(++4=&6F[1,FIY=#X]<;^E=HD:Q[?8<U%/>GRGL
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M(U',>U4<US7(BM<UR+DYKDWHJ;E0_8#]0
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MU<_%VC'#$HUS=DQM:S4^A?EWSWNEI6[M[JEO80N\%0C5T
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M+?('[)LM.BP?U784\I4/G,9'VUKK5;3?O>O7ZMJ3G!E]C#@
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MWV38D4)QAU78K\I5WG,AN/LEZU6S+[WK+^K:8VD.=)!
M                      *R_I)'Y%\3OE1MWZIP L)L#^N<3^YTGRDQ0OAS
M_8K9SXQ<ODZ,JCEE#.L       $]GH[7PUMH?1;S7[6=)$+;=>I&W>4H?-:P
MN)P)^NMB'[WZO]96DN:%4#40                           TQ\17X"7+
M7YA=C_L[,.LP)U9X8\=I_E$(NVV]:':1Y&K_ )!YSK2]AB0       #:3@W\
M-;A]]*3C]]K.)'.XPZD<5^3:[S:0D+9)UU=FGWP67]94IT?"A)N,
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M8]CVJK7L>U6N:YKE1R*BHI] _A^P
M!4=](\_GKXW_ #6Y7^UC19[8+]A[_P",Q_)&;/#AZJ\#>3ZGSHK@D]%'0
M    6D/1K/Z:/]7/^_8KGM__ -DOY_\ ^$:"\!3FVH^Q8_TW@M(%<S0,
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MH6!,-XN@TMDNE.WCV,YHJJ-5BJXLMZHUE0Q^C5O='H?S.139H\ [T
M                       H\^/+^<#R+YK=9_5DTN!L7ZB(/&:CXS3)OA?=
M>:O\GT'R3R&4E@JV       "YIZ.U\"G:'TI,U^R;215#;KU76[R;#YU6&HO
M EZU6(/OAJ_U;:2>PA8N&                           5ZO2,?@O:/\
MG[:^SS-2<M@_5%>/$O\ OQ%+.&]UO\)^64\RJRGH6F,R@       3V>CM?#6
MVA]%O-?M9TD0MMUZD;=Y2A\UK"XG GZZV(?O?J_UE:2YH50-1         #5
MOG)\"GF#]%OD#]DV6G18/ZKL*>4J'SF,C[:UUJMIOWO7K]6U)S@R^QAP
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MX%/#[Z+?'[[)L2*$XPZKL5^4J[SF0W'V2]:K9E][UE_5M,;2'.D@@
M                               %9?TDC\B^)WRHV[]4X 6$V!_7.)_<
MZ3Y28H7PY_L5LY\8N7R=&51RRAG6       ">ST=KX:VT/HMYK]K.DB%MNO4
MC;O*4/FM87$X$_76Q#][]7^LK27-"J!J(
M:8^(K\!+EK\PNQ_V=F'68$ZL\,>.T_RB$7;;>M#M(\C5_P @\YUI>PQ(
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M-_G?PE68_N,&FZXP]+I=34U16V%^Y4[9O1=0UTKFKN?%#32-Z8L"D)%RP
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MC6?TT?ZN?]^Q7/;_ /[)?S__ ,(T%X"G-M1]BQ_IO!:0*YF@8
M                     !SZ/%"Y/4Y5\R=GYQ:;E6X8'B4Q.L=9J1*5)AKP
M_"WY,.MWMZ_93U.[9$[?KNWT32J6[\A"NZJ.M;P;.<._.UA.VT<L?%UM4G1-
M1NTNXV;2NAWAB9HC=GWFHQBV_8^3:)M/Q!=J>?CK/;7= 4&2YLZ&I55G&L]9
M4S+-4IX)D:O2YD>QW!"@       +-?H\/)WW-R+:G$S([BI,3)&%[<UFR^XT
MEE%]MC$*S9_9HRUJ\QR3*LK6/SV64T\M#>-7%[WJW*U77K;KAU9(+;BBGCY5
M.O0E1EWCE5\+W>!K];'+TVJ1C>P7WX%6/D@KL1;.*Z;TNN3YI4#79(G'1HR*
MLB;OS<Z2%(9FL;R6I3SOZ9SM5K4K8:(@
M %'GQY?S@>1?-;K/ZLFEP-B_41!XS4?&:9-\+[KS5_D^@^2>0RDL%6P
M  7-/1VO@4[0^E)FOV3:2*H;=>JZW>38?.JPU%X$O6JQ!]\-7^K;23V$+%PP
M                          "O5Z1C\%[1_P _;7V>9J3EL'ZHKQXE_P!^
M(I9PWNM_A/RRGF564]"TQF4       ">ST=KX:VT/HMYK]K.DB%MNO4C;O*4
M/FM87$X$_76Q#][]7^LK27-"J!J(         :M\Y/@4\P?HM\@?LFRTZ+!_
M5=A3RE0^<QD?;6NM5M-^]Z]?JVI.<&7V,.
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M*5=YS(;C[)>M5LR^]ZR_JVF-I#G200
M        "LOZ21^1?$[Y4;=^J< +"; _KG$_N=)\I,4+X<_V*V<^,7+Y.C*H
MY90SK       !/9Z.U\-;:'T6\U^UG21"VW7J1MWE*'S6L+B<"?KK8A^]^K_
M %E:2YH50-1                           #3'Q%?@)<M?F%V/^SLPZS
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M=RX_R#T?K@K>*.4MEXWSBBE4;[*V+8&.2J-J;HKNK1.3X'<:JHNM:572M?\
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M4,K*2L8R6*6)[7QR1O:CF/8]JJUS'-5'-<U51R+FF>9]<_R?2
M                   5'?2//YZ^-_S6Y7^UC19[8+]A[_XS'\D9L\.'JKP-
MY/J?.BN"3T4=       !:0]&L_IH_P!7/^_8KGM__P!DOY__ .$:"\!3FVH^
MQ8_TW@M(%<S0,                               $;'BO\G4\7N%^R[_
M &JX>HY[LB.K4>NZM.N-S&;_ )G!FL72]1'&>JH\BV8G&O\ /9>K3RTS(,1I
M:NYU%%=]LSPZN(\6VZ&6/516]>BY\^E6.%R:6.[Y))58Q4[Q7+V""^$5CY,
M;+;]64\_$WB^)\S:+)51[9JICTEE;IWM6GIDFF8_F25D2+TZ% 8NT8U@
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M2*H;=>JZW>38?.JPU%X$O6JQ!]\-7^K;23V$+%PP
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MTX:P[873/L=@HK*ZJ1J2+24D%,Z1&9Z6O6%C-:-U+IU9Z=3LN<R*?$>V
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MCM?#6VA]%O-?M9TD0MMUZD;=Y2A\UK"XG GZZV(?O?J_UE:2YH50-1
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MRIT;=,59P4>I-\=NA?RGM[*=%U+-2Y[G1T\#VKD\L+D'%TP
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M+$]KXY(WM1S'L>U5:YCFJCFN:JHY%S3/,^N?Y/I
M       !4=](\_GKXW_-;E?[6-%GM@OV'O\ XS'\D9L\.'JKP-Y/J?.BN"3T
M4=       !:0]&L_IH_U<_[]BN>W_P#V2_G_ /X1H+P%.;:C[%C_ $W@M(%<
MS0,                               %*SQY^3B]O<J+?I*PW)4C#..UG
M799C3*^L69LO*FH-TS"3W-JI1^L.VLX[;.BT]T>3;)Z45[7E];:[%L._,O#<
MEWE9IK+\_6G=2GBU,B;^&NN3PM5G>F6'"_Q\N)=H<&%*2?C+7@F+BGHWI75]
M2C):EWKN+8D$&2]))',B=,[.#(F,J,          "Y?X!/*!6TN-V0\>\BN/
MK&6<?;O16/(?=6J5,UAF<J;=+11#CM.Z5[G9*G(8BNU2DQH<FV1^U"/*36J&
MVW#B6Z_T]]@CTTM];R\N9*F%$:_V-<>A_KGI*O=-1>!UC_YOX&KL%ULW&7+!
MDOI.?3/H*MSY(N?IN)GXZ/UD;J=FY-*$^)"Q<,
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M/WV38D4)QAU78K\I5WG,AN/LEZU6S+[WK+^K:8VD.=)!
M                       *R_I)'Y%\3OE1MWZIP L)L#^N<3^YTGRDQ0OA
MS_8K9SXQ<ODZ,JCEE#.L       $]GH[7PUMH?1;S7[6=)$+;=>I&W>4H?-:
MPN)P)^NMB'[WZO\ 65I+FA5 U$                           -,?$5^
MERU^878_[.S#K,"=6>&/':?Y1"+MMO6AVD>1J_Y!YSK2]AB0       #:3@W
M\-;A]]*3C]]K.)'.XPZD<5^3:[S:0D+9)UU=FGWP67]94IT?"A)N,
M      "IUZ1AO%ZXY[H?CG;I;B8.+XW=-NY3&:=[V)-XRB=+Q;$D2&Z*K1$V
M%;,?R9Q-*T[O)RI-?Y*T];+[!K.D=%>[](SEU,C:6->9S61HDLNGP/<^-/;1
MF='#<Q8Z>\80P1!(O$V^"2Y5#47DNEJ'NIJ;5Z^*.&H5.SIJ/"5I"P)0X
M      N!>#9X7UGU1B>.<K=^8W#N>V<OMUOOVJ,3OMN3(IJO'9:6YULRB5$F
M)K1G84]A<5YE56TO6>+5#:%HG2)2&*M;5]HTUSJ:C#-DJ%CM=*Y65,K'?7+V
M[EB:Y/M#-[5Y6F5W=8UJNTRX,&P&EP[;J+:+C&A;48CN3&36ZFF9G\SX'<ME
M0K'IR:V9,GLY.NECTHBI*^5K+#Q!A=8                'SKC;K==X$NU7
M:!#NELGQW(EPMUQB,3H$V*\E3;T:7#DMJ;DQUIJJBD+2I*J5Z5I4_P!1R21/
M;)#(Z.6-<VN:NE6KW45-Z+^(_">GIZJ&2GJ865%/,US7L>U'L>U=RM>QV;7-
M7F5JHJ9$/'*3P0N(&_$W&^ZXM<CCCG\M:GT737,)E[!),E=5=U+IK*2^S"CQ
M>U5>B+,]9JT6BBUJ<I1:%RIAO;!BJR+'#7R)?Z%O)TSKZ>C?6U"(KU7W9)O>
M*S;0."ALSQBE15V.G=@>]2[^,HF-6C5W\I0.<V%&Y=K2OI-^2JKMZ+6BY9>%
M#R]XF-W7(K[A--E:PMRY#O\ M.U@F5D5GAV]I/F5FY18TL)N>(-(94W1Y^9%
MI;T.J4TW/?\ >K58+#&TO"V)UC@@K/F?<9/_ &U3DQ[E[V)^?%R]QK6+KRWN
M8A1':+P=MI>SEM375EI^;N'X%5>CZ#5-$QC=^NHAR2HID1.G?+'Q+7<ELS^=
M=7^)7';).5G(?6&B<:K(CN9MD++607AAJCGW-X;;6UW/,,D7WI\OOAX]"N#K
M"'*I3(E)CQ4J[Y"$UZ/$]]I\,V*X7FH1')1Q\ACOMDCMT<??<MZHCLNE;J=T
MJ' ;.,$UVT/&F'\)4*NC6ZSM2:5$SXBF9Z94S]STN%KW,:[<^71'TST.C;AF
M'X[K[$,5P/$+8Q9L4PK';)B>-6B-6M6+7C^.VV-:;/ 9JNM5*;:@0X[=*JK5
M5:-]5*K4H75U4]=5U%=52+-4UDCY9'NYW/>Y7O7WW*JFWMKME#9K9;[/;8$I
M;=:X(J:")O2QPPL2.)B>U8UK?>/4'X'H
M IE^D2_#6U?]%O"OM9W:6OV%=2-Q\I3>:T9EWPV.NMA[[WZ3]978@3)I*=@
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MW_\ V2_G_P#X1H+P%.;:C[%C_3>"T@5S- P
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M0^E)FOV3:2*H;=>JZW>38?.JPU%X$O6JQ!]\-7^K;23V$+%PP
M               "O5Z1C\%[1_S]M?9YFI.6P?JBO'B7_?B*6<-[K?X3\LIY
ME5E/0M,9E        GL]':^&MM#Z+>:_:SI(A;;KU(V[RE#YK6%Q.!/UUL0_
M>_5_K*TES0J@:B                           '+?-&#_ )]P
M#I2<4_@N\;?F#T[]GF.E <2=45_\=JOEY#=?9WUO\"^1K9YE 9\/%.Q
M                      (9?'E_-^9%\Z6L_K.:2QL7ZMX/%JCXK2KO"_ZS
M-;Y0H?CO*/)< R9       !N9X=GP[.)/S^:U_:6"<GCOJ,Q/XE4?)J2EL1Z
M[NSCRQ0><,.BH43-M@              #RV<_D3F'R6R#ZIEGTT7UY2>ZQ_&
M0\^[?8JY^+S?)N.80:'F X        !T?.#?P*>'WT6^/WV38D4)QAU78K\I
M5WG,AN/LEZU6S+[WK+^K:8VD.=)!
M       *R_I)'Y%\3OE1MWZIP L)L#^N<3^YTGRDQ0OAS_8K9SXQ<ODZ,JCE
ME#.L       $]GH[7PUMH?1;S7[6=)$+;=>I&W>4H?-:PN)P)^NMB'[WZO\
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MFA5M<W4R3BGM2F@?VN4T[F*]B_5((YDRRS<E]HI8;"
M     UZPKBKQVUQMW(][:^U'AN%;4RW'Y&+Y'E&+VWW%K=K3+ND*\3:/V: Z
MBWMW"1<K=$=ES6HK<R6J.CUI]ZB$43[59B6^W"UT]EKKK+66RD>DD<4BZ]#T
M:YB9/7EZ6M<J-8KE8S/DHTXRU;/,$V+$E?B^S8;I;7B&Y0K3SU$#.*XR-SV2
MNSB8J0M>][&.DE;&V656IQCWY(;"GBG9@
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MTAZ-9_31_JY_W[%<]O\ _LE_/_\ PC07@*<VU'V+'^F\%I KF:!@
M                     %6_TA[E#[W5G$?&KCU4KR]O[0:C.IK1*:5GV37E
MCE+;ZUHNM:9'<9$5RM*THFU2>VM%,K+&;"L.?9+%%1'_ /$IM7O/J'M_Z;$7
MW1.Z9^\-;'R*F']FU#.FK=<J]&K[>*BA=E[$\SV._P#C/RY352K>6,,^0
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MFTD50VZ]5UN\FP^=5AJ+P)>M5B#[X:O]6VDGL(6+A@
M        %>KTC'X+VC_G[:^SS-2<M@_5%>/$O^_$4LX;W6_PGY93S*K*>A:8
MS*       !/9Z.U\-;:'T6\U^UG21"VW7J1MWE*'S6L+B<"?KK8A^]^K_65I
M+FA5 U$                           .6^:,'_/N         =*3BG\%W
MC;\P>G?L\QTH#B3JBO\ X[5?+R&Z^SOK?X%\C6SS* SX>*=B
M               0R^/+^;\R+YTM9_6<TEC8OU;P>+5'Q6E7>%_UF:WRA0_'
M>4>2X!DR       #<SP[/AV<2?G\UK^TL$Y/'?49B?Q*H^34E+8CUW=G'EB@
M\X8=%0HF;;               'ELY_(G,/DMD'U3+/IHOKRD]UC^,AY]V^Q5
MS\7F^3<<P@T/,!P        #H^<&_@4\/OHM\?OLFQ(H3C#JNQ7Y2KO.9#<?
M9+UJMF7WO67]6TQM(<Z2"
M5E_22/R+XG?*C;OU3@!838']<XG]SI/E)BA?#G^Q6SGQBY?)T95'+*&=8
M    )[/1VOAK;0^BWFOVLZ2(6VZ]2-N\I0^:UA<3@3]=;$/WOU?ZRM)<T*H&
MH@                          !ICXBOP$N6OS"['_ &=F'68$ZL\,>.T_
MRB$7;;>M#M(\C5_R#SG6E[#$@       &TG!OX:W#[Z4G'[[6<2.=QAU(XK\
MFUWFTA(6R3KJ[-/O@LOZRI3H^%"3<8             ',4V9EKF?;(V!G3W5
M3N:9OE>6N*4GL4IS([]<+RNM4=*=E:JF*]G2G0T-M]*E%04-&G-1PQ1_D,:S
M^G(P0OUR=>;Y>KN[<ZZ5=34N]FHF?(OQ_P#^1XH^L\8       %PGT=K5<;'
M^-NXMN/Q*M7;96UVL78?<9JE;^,ZXQR$[ <:>72GF-UR',<H;51/5/=!]JJJ
MIT15C;O<G3X@M5K:[TJWTW&N;WLE0]=7]2&)?PC37@3X>918%Q-B1\>FIOUQ
M2G1<NFIZ&%BL5J]SCJNH:N6[-G=YK"Y!Q=,
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M(>C6?TT?ZN?]^Q7/;_\ [)?S_P#\(T%X"G-M1]BQ_IO!:0*YF@8
M                   /@91DEDPS&<AS#)KBQ9\;Q2QW;),@N\M7EQ+79+#
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M385K)^*M>-XDA3/+)M?3ZY*5RY]+QK'3TR(U,WRS0H[I6Y76"I!JD
M                    4>?'E_.!Y%\UNL_JR:7 V+]1$'C-1\9IDWPONO-7
M^3Z#Y)Y#*2P5;       !<T]':^!3M#Z4F:_9-I(JAMUZKK=Y-A\ZK#47@2]
M:K$'WPU?ZMM)/80L7#                           *]7I&/P7M'_ #]M
M?9YFI.6P?JBO'B7_ 'XBEG#>ZW^$_+*>9593T+3&90       )[/1VOAK;0^
MBWFOVLZ2(6VZ]2-N\I0^:UA<3@3]=;$/WOU?ZRM)<T*H&H@
M             !RWS1@_Y]P        #I2<4_@N\;?F#T[]GF.E <2=45_\
M':KY>0W7V=];_ OD:V>90&?#Q3L0                          "&7QY?
MS?F1?.EK/ZSFDL;%^K>#Q:H^*TJ[PO\ K,UOE"A^.\H\EP#)D       &YGA
MV?#LXD_/YK7]I8)R>.^HS$_B51\FI*6Q'KN[./+%!YPPZ*A1,VV
M      /+9S^1.8?);(/JF6?31?7E)[K'\9#S[M]BKGXO-\FXYA!H>8#@
M    '1\X-_ IX??1;X_?9-B10G&'5=BORE7><R&X^R7K5;,OO>LOZMIC:0YT
MD$                                       K+^DD?D7Q.^5&W?JG "
MPFP/ZYQ/[G2?*3%"^'/]BMG/C%R^3HRJ.64,ZP       3V>CM?#6VA]%O-?
MM9TD0MMUZD;=Y2A\UK"XG GZZV(?O?J_UE:2YH50-1
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MMRSS]*T>U;+>1D61
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MB;W6E^+,9U\.?[*[.?%[E\I1E9@L&4+       !:0]&L_IH_U<_[]BN>W_\
MV2_G_P#X1H+P%.;:C[%C_3>"T@5S- P                            0
M:>/'R>IIWBE#TK8;C5C->1MW<L$A##CC<N'K;%GH%WS671;?_=IF3'\=M*FW
M.B9$2^3TH[JLK[9@V+8=^:N)77::/51V%NMO<=42YLA;^ FN7=TJL9W2I7"^
MQ]\[&SN+"M'-HNN.)5A<B+DYE!3JR2K=N^ZO=!3*U>GCFFT](I2J+<&5@
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M.U\"G:'TI,U^R;215#;KU76[R;#YU6&HO EZU6(/OAJ_U;:2>PA8N&
M                     5ZO2,?@O:/^?MK[/,U)RV#]45X\2_[\12SAO=;_
M  GY93S*K*>A:8S*       !/9Z.U\-;:'T6\U^UG21"VW7J1MWE*'S6L+B<
M"?KK8A^]^K_65I+FA5 U$                           .6^:,'_/N
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M#JNQ7Y2KO.9#<?9+UJMF7WO67]6TQM(<Z2"
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MK*=S>SE+Q58UWL.Z)<U%[K')OR)MR(BU@
M                            *9?I$OPUM7_1;PK[6=VEK]A74C<?*4WF
MM&9=\-CKK8>^]^D_65V($R:2G8                   );?#,\4C.^$N30L
M S=RXYIQJR&[J>R'%J55*O&!2Y[B:2\NP"KSB:-KHY5+TZUU52-/HEQ;?J\Y
M:I*HQVA;.*'&%.^MHD;1X@IV\B3I63-3I8YOZ49)SLS3/-B:2R>P?A W?95<
M([/=GR73 E=+JFINFEHWO7E5-'J7D\KE34^?%S<I6Z)G:UO X#GV&[2PW'-A
MZ\R.UY?A.7VN->L=R*RR:2K=<[=*I7L=:7THIIY+B'&GF74H>CO,N1Y#;3K2
MT)I[7457;ZN>AKH'4M72/5DD;TR<UR?_ '-JIFUR*CFJK5136&SWBUX@M=#>
MK+71W*U7*-LL$\3M3)&.YE3N*F]KV.1KV/1S'M1[7-;[(^<]0
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M-/1VO@4[0^E)FOV3:2*H;=>JZW>38?.JPU%X$O6JQ!]\-7^K;23V$+%PP
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MQAU78K\I5WG,AN/LEZU6S+[WK+^K:8VD.=)!
M               *R_I)'Y%\3OE1MWZIP L)L#^N<3^YTGRDQ0OAS_8K9SXQ
M<ODZ,JCEE#.L       $]GH[7PUMH?1;S7[6=)$+;=>I&W>4H?-:PN)P)^NM
MB'[WZO\ 65I+FA5 U$                           -,?$5^ ERU^878_
M[.S#K,"=6>&/':?Y1"+MMO6AVD>1J_Y!YSK2]AB0       #:3@W\-;A]]*3
MC]]K.)'.XPZD<5^3:[S:0D+9)UU=FGWP67]94IT?"A)N,            ? R
MBS)R+&L@QYRD=3=]LEVLSB9;5)$53=TM\B$M,EA5*T?CU2]6BT5I6BDUJG\5
M3]:>58*BGG3/.!['[MR\ER+N7NGQW"E;74%=1.TZ:R&6)=3=3?3&*Q=3>RG*
MWIV4.8'(CR(LAZ+*9=8E,.N,2&'VULOLOLN*;=9>:<3133J7$J2I*J4JFJ.U
M1HHUR.1KFN1R.3-')VQ@2^-\;W1R-6.2-5145N3D5-RM<B\RMYE13^1_#\0
M      3Z> %R:AZPY&YAH#)KBB'CW("R17,96^M"6$;,P9$^=:8%%NII2-[H
MXS/R1FBJ+I5Z7;[?&2AQ;K79"FVW#S[C8:6]T\6J>QO7C<OX/-DCW>NT2-C=
MX&.>[DHUR%R.!QCR+#^-[E@VOFXJBQE"WB-72MKZ36^)F:]+QT#ZAG/RY60L
MTJYR97+"J1J
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MY_W[%<]O_P#LE_/_ /PC07@*<VU'V+'^F\%I KF:!@
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MNE!,E50W*&*>&1O2R0S,;)&].ZCV.1R>!3T)^1]H
M   !1Y\>7\X'D7S6ZS^K)I<#8OU$0>,U'QFF3?"^Z\U?Y/H/DGD,I+!5L
M    %S3T=KX%.T/I29K]DVDBJ&W7JNMWDV'SJL-1>!+UJL0??#5_JVTD]A"Q
M<,                           KU>D8_!>T?\_;7V>9J3EL'ZHKQXE_WX
MBEG#>ZW^$_+*>9593T+3&90       )[/1VOAK;0^BWFOVLZ2(6VZ]2-N\I0
M^:UA<3@3]=;$/WOU?ZRM)<T*H&H@                          !RWS1@
M_P"?<         Z4G%/X+O&WY@]._9YCI0'$G5%?_':KY>0W7V=];_ OD:V>
M90&?#Q3L0                          "&7QY?S?F1?.EK/ZSFDL;%^K>
M#Q:H^*TJ[PO^LS6^4*'X[RCR7 ,F0       ;F>'9\.SB3\_FM?VE@G)X[ZC
M,3^)5'R:DI;$>N[LX\L4'G##HJ%$S;8               \MG/Y$YA\EL@^J
M99]-%]>4GNL?QD//NWV*N?B\WR;CF$&AY@.         ='S@W\"GA]]%OC]]
MDV)%"<8=5V*_*5=YS(;C[)>M5LR^]ZR_JVF-I#G200
M                    "LOZ21^1?$[Y4;=^J< +"; _KG$_N=)\I,4+X<_V
M*V<^,7+Y.C*HY90SK       !/9Z.U\-;:'T6\U^UG21"VW7J1MWE*'S6L+B
M<"?KK8A^]^K_ %E:2YH50-1                           #3'Q%?@)<M
M?F%V/^SLPZS G5GACQVG^40B[;;UH=I'D:O^0><ZTO88D        VDX-_#6
MX??2DX_?:SB1SN,.I'%?DVN\VD)"V2==79I]\%E_65*='PH2;C
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M%<J5'(F4G,VJA9GJZ&J>F9]RDUP*KN+1[Y&3A";P
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MNH:RV5E5;KC2R4-=0R/BFBE8YDD4C%5KV/8Y$<CT<F2HJ>R?%/V/A
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MQ-[K2_%F,Z^'/]E=G/B]R^4HRLP6#*%@       M(>C6?TT?ZN?]^Q7/;_\
M[)?S_P#\(T%X"G-M1]BQ_IO!:0*YF@8                          !3,
M\?;E#3:7)+'N/F.W'UC$N/UHJO(41W$JB3=GYE$@7.\44MJG;*I;L:1C\1/5
M55QIDBZ,=J%^8E5K]B6'/F=8)KY/'IJKZ[D:NF2FA<K6>QKDUO\ "Q(U[AEY
MPQ<?_/!CFBP90S:[=@R+T[)>2^OJFL?)O3<[B8.)B]9(ZH9N740)$TE.@
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M"E9-G=,$2\4S/IGT%2KY*5V_IN*>E13\E,F1QPZM[]\YY#I;<
M             H\^/+^<#R+YK=9_5DTN!L7ZB(/&:CXS3)OA?=>:O\GT'R3R
M&4E@JV       "YIZ.U\"G:'TI,U^R;215#;KU76[R;#YU6&HO EZU6(/OAJ
M_P!6VDGL(6+A@                          %>KTC'X+VC_G[:^SS-2<M
M@_5%>/$O^_$4LX;W6_PGY93S*K*>A:8S*       !/9Z.U\-;:'T6\U^UG21
M"VW7J1MWE*'S6L+B<"?KK8A^]^K_ %E:2YH50-1
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MOX%/#[Z+?'[[)L2*$XPZKL5^4J[SF0W'V2]:K9E][UE_5M,;2'.D@@
M                                %9?TDC\B^)WRHV[]4X 6$V!_7.)_
M<Z3Y28H7PY_L5LY\8N7R=&51RRAG6       ">ST=KX:VT/HMYK]K.DB%MNO
M4C;O*4/FM87$X$_76Q#][]7^LK27-"J!J(
M :8^(K\!+EK\PNQ_V=F'68$ZL\,>.T_RB$7;;>M#M(\C5_R#SG6E[#$@
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M:$;*^3LCTGP
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M^Q7/;_\ [)?S_P#\(T%X"G-M1]BQ_IO!:0*YF@8
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M/I29K]DVDBJ&W7JNMWDV'SJL-1>!+UJL0??#5_JVTD]A"Q<,
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M:&II6/F=7VV1L35J(X\WJR-[VHG:L?W%+8Q6@T8
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M_J))-BF+V/"<7QK"\8@^Y>-8A8+/B^.VWUF9,]SK'8;=&M-I@^N7&0[(E^3
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M4)QAU78K\I5WG,AN/LEZU6S+[WK+^K:8VD.=)!
M                 *R_I)'Y%\3OE1MWZIP L)L#^N<3^YTGRDQ0OAS_ &*V
M<^,7+Y.C*HY90SK       !/9Z.U\-;:'T6\U^UG21"VW7J1MWE*'S6L+B<"
M?KK8A^]^K_65I+FA5 U$                           -,?$5^ ERU^87
M8_[.S#K,"=6>&/':?Y1"+MMO6AVD>1J_Y!YSK2]AB0       #:3@W\-;A]]
M*3C]]K.)'.XPZD<5^3:[S:0D+9)UU=FGWP67]94IT?"A)N,
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M'L76R&\X9O$%ZME1S2P/1Z(O99(W<Z*5O;Q2-9(SF>Q%,G'P'O@
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M?ZN?]^Q7/;__ +)?S_\ \(T%X"G-M1]BQ_IO!:0*YF@8
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M?)M#V7X?NU3/QUXMK>@*_E:G]$TJ(SC7[NGJ85AJ7)ETTRM3/+,D,.()J
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MW=U>?<>S##%!&V&")L,;.9K$1K4S7-<D;N3E;_9WG[C^'Z@
M
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MTDC\B^)WRHV[]4X 6$V!_7.)_<Z3Y28H7PY_L5LY\8N7R=&51RRAG6
M ">ST=KX:VT/HMYK]K.DB%MNO4C;O*4/FM87$X$_76Q#][]7^LK27-"J!J(
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M(K#BBW0W;#MWI[U;INEFII62LS[UVA5T/3MF/TO8NYS6KN,A'QGM@
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M6&[X8NUPL5]H)+9=[7(L4T,J:7-<WL]Q['ID]DC%5DC'->QSF.15\.?8>*
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MK3-0I"D)75,;[5L0_,'"%8V"3BZV\?2D673-25J\<_\ !A:]$=VKWL+$\&+
MB8XVJ6B2JAXZT853YIU.:<ASH'MZ$C=VJZZMT3W,=GKABF;IRS+Y92\U_
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M7,<U%S:I."1 6Q
M
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M56/1LC'(CFJJ.YVKD9Y/(.P
M  *R_I)'Y%\3OE1MWZIP L)L#^N<3^YTGRDQ0OAS_8K9SXQ<ODZ,JCEE#.L
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MTB7X:VK_ *+>%?:SNTM?L*ZD;CY2F\UHS+OAL==;#WWOTGZRNQ F324[
M   !<+]'.^"]O#Y^W?L\PHJSMXZHK/XE_P!^4TUX$/6_Q9Y97S*D+"I!I=,
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M:9^<.OFV7>Q?/TV<JWEC#/H       %I#T:S^FC_ %<_[]BN>W__ &2_G_\
MX1H+P%.;:C[%C_3>"T@5S- P                       "%3QSN3ZM'\0W
M]6V*:F-F_)&X2L#CI:=HB5%UY:FHEQV1<&DU5_&,OPI5GLKR:IK3R<R<4E25
MH14EK8YASYL8H;<IF:J+#[4F7N+.[-*=N7K5:^9OAA0JOPML??.GLU=AZCFX
MN[8Y>ZC;DO*;0QZ7UST[Y)&.BI7IETE4Y=RHA2*+?&3X       +MG@4<9UZ
M6XA4VI?;=ZGF?(V]-9JXMYCRIK&N[$F7:-=0GE=:U=COMO9!>8ZZ*Z*CY@SU
M2E:5%0]LV(4N^*?F;#)JI; SB? L[\GSK[+>1"[UT2FKG!%P&["VS7YXJR#B
M[ICB7HO>W2]M%#JBHF.[Y'HLU6Q>\J6[LT4FT(C+6   $'7CR<:O]K_$J)N&
MR0_/R_CG?ZY*[5#?F2).N\L7 L6;PVDT;ZUJQ,9Q:Z+4I5$M1<=EU[5572M)
M@V+XA^9>)W6F9VFEOS.+\"3Q:GPK^$WC(_"Y[$*F<+_ OSR[.(L3TD7&7/!$
MW'KETSJ*IT0U34]H]*>H5<\FQPR[E<I2D+<&50       /2X5F.0Z\S'%,^Q
M&XNVC*L*R2R99C5T8I_&VV_8[<HUWM$YO_XK:GQ(ZZ4_%7R^T_"KI8*ZDJJ*
MJB22FK8WQ2-=V6/16/3\)%4].UW.MLMTMUXMTRTUQM,\-3!(G3,F@>V2-Z>U
M>Q%_IYCI%\<=V8[R/T3JS>.,40W:=E8?:LB5"0Y5Y5FNZVU1<DQU]VE.CLJV
MY'%NL!Y2>J:NVU=4U4GMK6@=_L\]@O-RLU1RI;?*K-7?LZ:-_L2,5KV^M<;D
MX&Q918YP?AW%EOR2FOM+'-HS1>*ERT3PJJ<[J>=LD+^QJ8N1G \HZP
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M\_<?P_4
M
M
M                   K+^DD?D7Q.^5&W?JG "PFP/ZYQ/[G2?*3%"^'/]BM
MG/C%R^3HRJ.64,ZP       3V>CM?#6VA]%O-?M9TD0MMUZD;=Y2A\UK"XG
MGZZV(?O?J_UE:2YH50-1                           #3'Q%?@)<M?F%
MV/\ L[,.LP)U9X8\=I_E$(NVV]:':1Y&K_D'G.M+V&)        -I.#?PUN'
MWTI./WVLXD<[C#J1Q7Y-KO-I"0MDG75V:??!9?UE2G1\*$FXP
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M<]O_ /LE_/\ _P (T%X"G-M1]BQ_IO!:0*YF@8
M !0I\8/D\KDKS2SUNS7"LS -,5=T]A7EK2J+(<Q>=*3F5[8JW3LD4F9F[>J,
MR4U5Y\"# 51=4(0E-T=E>'/G>PE1++'E6W;Z;F[Y.,1O$L\&B'1J3L/<\Q]X
M2^/OG[VI7A*6;C;-A?.V4NGI7=#O=T7*F2Y.XVJ670_?KA9#OR1I%J2.5Y
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M6Y]X_B9F,3-5XVH?R6L+/)7DOR
M
M
M
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MYNC<[>C)HG92P29;^*G8R7+?I,P'F'3
M       %,OTB7X:VK_HMX5]K.[2U^PKJ1N/E*;S6C,N^&QUUL/?>_2?K*[$"
M9-)3L       %NOT<>=)<T-R&MJUTK$B;>L,YAKL1129-QPR)'E+4Y2G<NBF
MK9#I1-:UHGRZ]OXZUK5_;TQJ7NQ/3IG4KV_@MF<K?C*:4\!^:1V#\;4ZN]*B
MN4+V^V?2M:[^B-GXO"6-2!R[X     !'MX@7AZ:LYX:\9ME]6SA^VL5C2?\
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M?ZN?]^Q7/;__ +)?S_\ \(T%X"G-M1]BQ_IO!:0*YF@8
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M<CV,>W/)Z(O*:K7;^ZUR(YJ]U%1%;O140_2?T_V
M
M
M
M                      "LOZ21^1?$[Y4;=^J< +"; _KG$_N=)\I,4+X<
M_P!BMG/C%R^3HRJ.64,ZP       3V>CM?#6VA]%O-?M9TD0MMUZD;=Y2A\U
MK"XG GZZV(?O?J_UE:2YH50-1                           #3'Q%?@)
M<M?F%V/^SLPZS G5GACQVG^40B[;;UH=I'D:O^0><ZTO88D        VDX-_
M#6X??2DX_?:SB1SN,.I'%?DVN\VD)"V2==79I]\%E_65*='PH2;C
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ME-*)2FE*)32E*42FE.E*4I3\5.E#P^?>O.=JB(B9)S'^@_H
M
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M%T$-XI*:K8QRHYS&U$+)FL54Y+G-:_2JINSWISH>Y/D/7
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MDC'IFCFKFU4[J*FY3](/T
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MD0MMUZD;=Y2A\UK"XG GZZV(?O?J_P!96DN:%4#40
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MT<YKOP2F=PMUPM59/;[K0S6VX4SM$L%1&^&:)W91\<B(]B^M<B>P?!/V//
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MZGJ8LW:)&Y\Z.?&]O+B>]BHXV//#.Y
M !3+](E^&MJ_Z+>%?:SNTM?L*ZD;CY2F\UHS+OAL==;#WWOTGZRNQ F324[
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M:/$V&:SHNWUB:7-=DDU/,B)QE/41YKQ4\>I-3<U:YJMDC<^-['NSP>0=>
M   5;_24_P"A=_6,_N)+&; /]K?YA_YIGYPZ^;9=[%\_39RK>6,,^@
M 6D/1K/Z:/\ 5S_OV*Y[?_\ 9+^?_P#A&@O 4YMJ/L6/]-X+2!7,T#
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MC+3@IG1\BJG)6JU*R@B5>U?QVJJ9WS:1Z%Y<IX:U
M
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MN)\65]]H8;)4SLAJZF2:-LK:^VL;(UKW*B/:R61B+SY/<G,I:V*V&B(
M                     !RWS1@_Y]P        #I2<4_@N\;?F#T[]GF.E
M<2=45_\ ':KY>0W7V=];_ OD:V>90&?#Q3L0
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MR04:\9#)(UCV.?T-KU.:N6MKVO1=Z/:[E%V(J.:J
M                                                    'YY$=B4P
M]&DLM2(TAIQB1'?;;=8?8=15MUA]I=*I<94A54J2JE:*HJM*TZ!KG(YJHY45
M%S14W99<V_\ 0I^;VLD8Z.1J2,>BM5')J14=N5%1>=J]EO-D:O["X/<.]J)D
M?=WQFTI>Y<GM\Z[MZ\QNSY$JB*]:)3DMC@1;@A'7_<F32E3HZ'&.*[;ET%B"
MKA8WM>/D>S\V]7,_JG 7G9-LRQ CUN^ [5522<\G04$4_P"?A8R;_J&B^P?
MH\/S-U/.6+$=C:K>?><><=UYLB[/I2M=*]]&HNQ8^01X[55U[J-MM)0CV(0E
M+=*(IV-#MFQS1HU)ZJ"YHU/_ '%.S^E8%@<O/SJO])$MZX(NQB[:G4EMKL//
M<N>=#72KTW<;7)6L:G9TM:B-YD1&[C1/8GHWUC=H](U/RAN\"J4N>KV?8>NH
MEW\]=54JS1[),;R*%ZK1*:=%5I:GN^JNZE$=O:KLZ';Y,FEMTPZU_KZ>H<S_
M *<K'Y_G6D0WO@.4CE=)AW'\D.6>F*MH62Y][JGIYX=/ARIG:N?=TIHAL7P"
M.=F'TD/8C74.V&$(<=C,8GGCEBN;R4J4E$=V/L2SV:-'F*I3KTI-<9I15.Y_
MKU33M+?MMP;4Z4JNBK8J],LL.M/;9T[YE<GX#5\!$-ZX'6UVV:G6U;;B*-$5
M6I35G$R+ES(J5T5*Q'K[HYB=^;G>"EPVY0\9>9>QKGO72F:Z\LDWCEE]AA9)
M<X<6X8K,ODG9VHI\:T1,KL<N7;95R<@VFYO-L(E*=6S >=2BJ$54GDMKN*\.
MXAPG;X[-=X:Z9M?$]T;7*DJ,2FJFJ]T3VM>UJ.>UJN5NG-S4[)*/!6V88_P%
MM/OD^+L*U5EI9K'4PLG>U'TSYEK[:]L25,+I('2.9%(]K$DU*UCW-32CBTZ5
MQ-"                           #3'Q%?@)<M?F%V/^SLPZS G5GACQVG
M^40B[;;UH=I'D:O^0><ZTO88D        VDX-_#6X??2DX_?:SB1SN,.I'%?
MDVN\VD)"V2==79I]\%E_65*='PH2;C                        &M?(GB
M'QRY56!=BWGJK&<T<;C+B6K)78E;;F^/(4I;B?N>S2U*:N5J:I(4EU4=N1ZH
M^I":28[R.J*^]8<4W_#4Z36>YR4;47-T>>J%_8Y<+LXW;MVK3K1.94.#QMLT
MP/M$H^A,78=I[HYK<HZC3Q=7#V?2:N+1/&FKE.8U_%O7IV/3<5NN5'H]FPL9
M]T<FXD[ 8V-9D44^WK794NW8_G+:$T56L:SYC&8CV;(7JKJWVTF,V1*$=U*O
M/+33OGS#6W*BJ>+I\44*T,O-T13M5\/MGQJYTK/P%F]A"CFT/@77J@2:OV;W
MI+W2MWI05[F0U:)WL=2UK*:9W<25E)DWMGKTT >UM,;8T9E#^%[AUYEVN,GC
M+>32U9;9)MH<EM,+HA4RUR)#5&;S;556FK<J(X]&=2[1;3JT*2JLW6V[6R\T
MS:NU5T5PIW=O&]K]/@5K>4Q>^1Z-<WLM*<8APMB/"5PDM>);+4V.O8J^E5,+
MXU<B=O&YR:)&=[)$Y[%3)S7*BF-#T#G0                 #9CB=RQVYPX
MVY9]LZFO'D2F/+@91B\]Q]>,YUC+CZ'IN-9+":6GSXKG9W,O)Z2(<A"),9:'
MD)4<_B;#-KQ7:Y+9<X]37;XY$^J0R=K+$[L*G93F>FIKFJCB0=G.T;$FS#$E
M/B3#=3ID;R*BG?GT/60:LWP3L1=Z+SL>WEQ/TO8YJM+[G#SE[JKFEIVU[:UA
M*=CJ\Y-IS/#KDXA5_P $RUJ,Q(GX]=J-I2F4UY;[;L.8TFC,V*\AU%&W?.89
MI3BK"URPE=I+9<6HY,E?#,WI)HM637L[U>P]B\ICMV]-+EV$V9;2L/;4\,4^
M)+!(L>](JNFD7TZCJ4:U7PR\R*F]'12MY$K%1R:7:F,VL.=)#
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M%:B;UG'DN@
M  _'%G0IWK/J4R+-]4ENP97JTEF1ZI-CT3Y\.1Y*E>3*1WI[VU=%I[J=R:=3
M^N9(S3K8K-2:DS3+-J\SD];V,S\HYHI>,XJ5LG%N5CM+D=I>WG8[)=SF]LU=
MZ'[#^'Z@                          %>KTC'X+VC_G[:^SS-2<M@_5%>
M/$O^_$4LX;W6_P )^64\RJRGH6F,R@       3V>CM?#6VA]%O-?M9TD0MMU
MZD;=Y2A\UK"XG GZZV(?O?J_UE:2YH50-1
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M)[H
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MB&TXKL=JQ'8ZE*ZTWB%LT,B=EJ\[7M[22-Z.CD8O*CE8]CLG-4R,?$>X
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M26P8@AU1NS?2U;$=Q%9!JR26)5YG)N;-"Y=<+^2[-JL>_5(Z0C<
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M011PP1-AAC32UC&M:Q$[B-3<B>!-Q^T_A^P
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M=KX%.T/I29K]DVDBK>W7JNMWDV'SJL-+>!+UJL0??#5_JVTD]A"Q<,
M                     KU>D8_!>T?\_;7V>9J3EL'ZHKQXE_WXBEG#>ZW^
M$_+*>9593T+3&90       )[/1VOAK;0^BWFOVLZ2(6VZ]2-N\I0^:UA<3@3
M]=;$/WOU?ZRM)<T*H&H@                          !RWS1@_P"?<
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M5V*_*5=YS(;C[)>M5LR^]ZR_JVF-I#G200
M                                                     :8^(K\!
M+EK\PNQ_V=F'68$ZL\,>.T_RB$7;;>M#M(\C5_R#SG6E[#$@       &TG!O
MX:W#[Z4G'[[6<2.=QAU(XK\FUWFTA(6R3KJ[-/O@LOZRI3H^%"3<8
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M]>K%>\.7":TW^U5%GN5.O+AJ8GPR(G=TO:W-CN=KTU,>W>CE;O/$GUGC
M          L"^!;SO?U#M1/$_8][<1K'<5VHO6\F?(JJ+AVV)78S&M$>KBO^
MRVK(TH;BU;3W)3>&H%4-M^O3GJPAMDP8VZ6WYYJ&'_U&UM^F$1O*EIF\[W=U
MT'3:ON6O?R&(7/X)&UZ3#6(?0ZOM4OS Q-)G0N>[DTUR=DUL29KR8ZWDQ:4W
M=$I"J(WC9GEQLJL:<@                            IE^D2_#6U?]%O"
MOM9W:6OV%=2-Q\I3>:T9EWPV.NMA[[WZ3]978@3)I*=@       M<>C;_D7R
MQ^5&HOJG/RM>WSZYPQ[G5_*0FBG 8^Q6T;QBV_)UA9H*]E]
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M?S__ ,(T%X"G-M1]BQ_IO!:0*YF@8
M                                             *//CR_G \B^:W6?
MU9-+@;%^HB#QFH^,TR;X7W7FK_)]!\D\AE)8*M@       N:>CM? IVA]*3-
M?LFTD50VZ]5UN\FP^=5AJ+P)>M5B#[X:O]6VDGL(6+A@
M          %>KTC'X+VC_G[:^SS-2<M@_5%>/$O^_$4LX;W6_P )^64\RJRG
MH6F,R@       3V>CM?#6VA]%O-?M9TD0MMUZD;=Y2A\UK"XG GZZV(?O?J_
MUE:2YH50-1                           #EOFC!_S[@        '2DXI
M_!=XV_,'IW[/,=* XDZHK_X[5?+R&Z^SOK?X%\C6SS* SX>*=B
M                 0R^/+^;\R+YTM9_6<TEC8OU;P>+5'Q6E7>%_P!9FM\H
M4/QWE'DN 9,@       W,\.SX=G$GY_-:_M+!.3QWU&8G\2J/DU)2V(]=W9Q
MY8H/.&'14*)FVP              !Y;.?R)S#Y+9!]4RSZ:+Z\I/=8_C(>?=
MOL5<_%YODW',(-#S <         Z/G!OX%/#[Z+?'[[)L2*$XPZKL5^4J[SF
M0W'V2]:K9E][UE_5M,;2'.D@@
M                                            TQ\17X"7+7YA=C_L
M[,.LP)U9X8\=I_E$(NVV]:':1Y&K_D'G.M+V&)        -I.#?PUN'WTI./
MWVLXD<[C#J1Q7Y-KO-I"0MDG75V:??!9?UE2G1\*$FXP
M                  ,*;OX[Z2Y(XFO"=X:UQC8N/UH[6*U?8/6YV9YY-&W9
MN.7^&XU<,:N-4)2GUB!)CO533LJNJ:U2>K9[]=[!4]%V>X24,_9T+R7HG8>Q
MV;)$]:]KD.5Q9@G"F.;<ZU8LL5/?*/?I29GID2NYWP3,TS4[^QKA>Q^6[/25
MEN9W@!YGB:;QG7#G(Y&?6%OSIKNG<TE0H>;VYA#2GG6L4RYQ3,+*T4<HJC,2
M:W EH;0A%)=RDU]]87"6VZCJ>(HL54R4,W-T7"U5A<O8XV+E/B\+V.>S/M8V
ME#-J' WNEN2JN^S&N=>:-N;W6RJ<QE4QN6;FTU3R(JGUD4K89&MR;QD[^>NG
ME6)Y1@N17?$<UQV]XEE5@FN0+WCN26N;9+W:9K24+5%N-KN#+;T61V+;51*T
M)K5+B:I]BDU)XIJFFK((ZJDJ&55-,FICV*CV/;WR*W-%*1W&W7&T5M1;+K0R
MVVX4;E9+!41OBFB>G.U\;T:]CO;-YES//G['P           _M#ERH$J-.@R
M7X<V'(9EPYD1YR/*B2H[B7H\F-(94E;$AMUM*D+36BDJ2FJ5)4D_CFM>US'M
M1S')I5'<I'([IFN;WI^[))(98Y8I'12Q.:YCVN5'-<U<T<U4Y2.1V]%;O1=Y
MT(/#6Y8)YA\3< V7=933^P+"ES7VUFVZ-(53/<6C0T3;JMEE-$LHNMIEV>[I
M0E*4->[M6$_]R4=V@X9^=7$]=;HVJVAG]/IO<9'+DW_AO:^+PZ-7;&S^PO:*
MFTW9Q9K]42HZ]4:+17!-WUY3M9KD5&\W1,3HJE&IR6\=H3I3?HXHF(
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MTD50VZ]5UN\FP^=5AJ+P)>M5B#[X:O\ 5MI)["%BX8
M        !7J](Q^"]H_Y^VOL\S4G+8/U17CQ+_OQ%+.&]UO\)^64\RJRGH6F
M,R@       3V>CM?#6VA]%O-?M9TD0MMUZD;=Y2A\UK"XG GZZV(?O?J_P!9
M6DN:%4#40                           Y;YHP?\ /N         =*3BG
M\%WC;\P>G?L\QTH#B3JBO_CM5\O(;K[.^M_@7R-;/,H#/AXIV(
M                !#+X\OYOS(OG2UG]9S26-B_5O!XM4?%:5=X7_69K?*%#
M\=Y1Y+@&3(       -S/#L^'9Q)^?S6O[2P3D\=]1F)_$JCY-24MB/7=V<>6
M*#SAAT5"B9ML               >6SG\B<P^2V0?5,L^FB^O*3W6/XR'GW;[
M%7/Q>;Y-QS"#0\P'         .CYP;^!3P^^BWQ^^R;$BA.,.J[%?E*N\YD-
MQ]DO6JV9?>]9?U;3&TASI((
M !^-V9#8D18CTN,S*G><F'&>>;1(FJC-*>DIBM.+HI]3;-*K71%*]J:=RNE/
M:$:YS7.1JN8W+4N6Y,^;5W/!F?D^6)CXHW2-;+/GH:KD1S]*9NTISNR3>N7,
MF\_8#]0                                     :8^(K\!+EK\PNQ_V
M=F'68$ZL\,>.T_RB$7;;>M#M(\C5_P @\YUI>PQ(       !M)P;^&MP^^E)
MQ^^UG$CG<8=2.*_)M=YM(2%LDZZNS3[X++^LJ4Z/A0DW&
M                      !I3S X#\=.:V-5MFVL23%S&!!5$Q7:>,HC6O8.
M+J[UK::8NRF%HO5EH\Z]55NN+4J%6LEQQIIF35$E'685QM?\(5"26RJU4LBY
MRTTF;H)/99FFA_KV*U^Y$<KF\E8KVF;'L$[5:%:;$EMT7*%NFGN%/ICK*?LH
MB2Z526+-5S@F;)%O5S6L?I>VE]SH\-O??!C(5/9;"^[;4=TGN1,2W'C<&0C'
MK@IQ2U1;5D\!3CKF%Y2J.E*JPY+CC#ZDN^YTZ>EAY;5L\&X_LN,H%2D=T'=(
MVZI:25R:V]\^->2DT>?;M1KF[M;&9IJRWVM[#<8;):[5<H?FMANI?E37.!B\
M2_O8YV9JZEJ,M_%/<YC^5Q,TR,>Y(]CN2$P          3]^C[\B'L!Y+9EH
M"[SU-X]O3$7[E8HCKJJMM[#UU'F7N+2.VKWK%9.&.Y=1Y5.BG5VF&BO?V(HF
M$MN%B2NP_2WN&/T^SRM1[NST/.K6+G[$W%:4[&MZERN!GC5UFQY=,&U$V5%B
MVF<^%JKNZ-H6OF;I[":Z5:G6O3.6.)N_)$+DI50T^
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M'^KG_?L5SV__ .R7\_\ _"-!> IS;4?8L?Z;P6D"N9H&
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MRHO<5%\)MW!/#4P15-/(V:GJ&->Q[79M>QZ:F/14Z9KFJBHO-D?1/\G[@
M           %'GQY?S@>1?-;K/ZLFEP-B_41!XS4?&:9-\+[KS5_D^@^2>0R
MDL%6P       7*_1V9#"^&.U8B7D*DL\GLNDO1Z*I5UIB5JK3C49U:/;VMK<
MARDIK^*M8ZNGMI4JEMW8Y,66UVGDNMT:9]US:FKS_2B^^:A\"9S%V78ABU)Q
MC+_4N5O91'6^V(U?8<K'9>U4GU(4+B@                          %>K
MTC'X+VC_ )^VOL\S4G+8/U17CQ+_ +\12SAO=;_"?EE/,JLIZ%IC,H
M $]GH[7PUMH?1;S7[6=)$+;=>I&W>4H?-:PN)P)^NMB'[WZO]96DN:%4#40
M                          Y;YHP?\^X        !TI.*?P7>-OS!Z=^S
MS'2@.).J*_\ CM5\O(;K[.^M_@7R-;/,H#/AXIV(
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M6%&I9L;76VQM[2&OJV1]+EDZ-LO%.W(WDJU6\E.X;F8)XS_B)X-Y3*MYM9G
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MA(6R3KJ[-/O@LOZRI3H^%"3<8
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ME0W7CDCF9'+$])(I&M<UR;T<U4S:Y%[U4R5/>WG[#^'Z@
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M>(,/S:96U%Q95TCW)T11S\31JL4J)TS7;UAF:FB9F],G->QE?<F\I<
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M<=)%T'T=QG'.1B0IJZ*9HXJ23/2_5IY.J;HB(M<
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M=,28AOKE?>[[6WAW?5=7/4KW?MSWKSHCOP3'Q]IX(
M+QO@@\GE;[X<VC ;[<%3,XXZ38NLKE1Y=%R9&$KC.3-9W&M*+KV146)B79V^
MO;55<,77M]]U53S;!AY+)BN2NAC1E'?T6H;ETJ3(N50WV5?E*ONR&M7!1Q\N
M,=F--9JR99+O@=S:"3/G=2:5?0/Y]S6PHZF;V?I55\),F146>
M    *07CV1),;G]=GGVE-M7#4FMID-=5)K1^.AB[V];J:)5U32DN#*1T5TKU
M9[NG;6E:V_V+/8[!$:([ZG55#7>!<V.^*YID]PP8Y&;9*A[FZ6S6V@>SPMRD
M9G^6Q6^\0N$LE6        6X?1Q,D9E:3Y'X>GR_6+'M/%,C=I2E?-\G*\27
M;(]7*]_3RJN8;*[?>TKW=_MK3I1-8=O=.K;O8*KM9J:2/\U+J7Y9#2;@/5S)
M<*8XMC<N,HKA3U"]]E4TW%M_!^E'9>_X2Q^0*7B
M      *W?I'F3-1-,\;,.4MM+]^V=F&2MMJHGS5M8IBL2UON(5YM%>6ES-(]
M%4HA5*U<1U6CV)7/FP2#5=L05?W"GBB_.RN=_P!DHUPX*]D6%\"VM7)KJZ^I
MG1.VRIJ9(W9;^;Z;;GFB\Z;V]M4C+.&;@       )^/1UK>^[S$VW=DU;]6A
M<:LEM[M*JK1VK]TVCJ63&JA';T4WY=JE=U>M*TKV>]KW>]A+;N]J85M<7;.N
M$;O>;35*+\=I<O@30O=M-Q'4)EQ<5AG8O=U/N%M5/Z(W9^\7*"JAIZ
M                     <M\T8/^?<         Z4G%/X+O&WY@]._9YCI0'
M$G5%?_':KY>0W7V=];_ OD:V>90&?#Q3L0
M"&7QY?S?F1?.EK/ZSFDL;%^K>#Q:H^*TJ[PO^LS6^4*'X[RCR7 ,F0
M ;F>'9\.SB3\_FM?VE@G)X[ZC,3^)5'R:DI;$>N[LX\L4'G##HJ%$S;8
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M7CJY8<>KIK5-E4V^=^]9J.5SN+UN1&IQL3D?!-R6YR1N>C48]BKI&=>1*
M      =%GP^=AN[5X2\8,UDO.2ITS3N'V6ZRGJJ4[,O>'6].&WR8XI=.JENW
M;'YCBJ_BK5RM:>PHCCF@2VXOQ%2,;HC;52O:WO63+QS&^\QZ(;<[%[V[$.RG
M %TD<LDTELIHI'+SNEIF="RN7PNDA>[WS<<Y4D\
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ML\N=V6:<REM4K*:.@                          '+?-&#_GW
M .E)Q3^"[QM^8/3OV>8Z4!Q)U17_ ,=JOEY#=?9WUO\  OD:V>90&?#Q3L0
M                         "&7QY?S?F1?.EK/ZSFDL;%^K>#Q:H^*TJ[P
MO^LS6^4*'X[RCR7 ,F0       ;F>'9\.SB3\_FM?VE@G)X[ZC,3^)5'R:DI
M;$>N[LX\L4'G##HJ%$S;8               \MG/Y$YA\EL@^J99]-%]>4GN
ML?QD//NWV*N?B\WR;CF$&AY@.         ='S@W\"GA]]%OC]]DV)%"<8=5V
M*_*5=YS(;C[)>M5LR^]ZR_JVF-I#G200
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MV&L<M',]WK6Q3O5WK<_ =%,HD;:
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M_IH_U<_[]BN>W_\ V2_G_P#X1H+P%.;:C[%C_3>"T@5S- P
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MQ4U=;:C%E9'DNNXSJZ/5V<J:G2G@<SUDS)N3SJ[G)4,(U[@6M+&QC.N<)Q/
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M99<^[]*&WS',D8V2-R2,>B.16KJ14=O145.=J]AW-D?H!^@
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ML^P:5\""T+!A#&E]6/3\TKC#2ZMV]**F27V<FK7+EVN:NRWZBQJ0.7=
M                      .6^:,'_/N         =*3BG\%WC;\P>G?L\QTH
M#B3JBO\ X[5?+R&Z^SOK?X%\C6SS* SX>*=B
M   0R^/+^;\R+YTM9_6<TEC8OU;P>+5'Q6E7>%_UF:WRA0_'>4>2X!DR
M   #<SP[/AV<2?G\UK^TL$Y/'?49B?Q*H^34E+8CUW=G'EB@\X8=%0HF;;
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M;,,7QX\P!A7%3'HZ:[4D;I]/,VJB])JV=CI*F.5K=R;D1<DS-G#GSO0
M
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MZN?]^Q7/;_\ [)?S_P#\(T%X"G-M1]BQ_IO!:0*YF@8
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M0JZLU5<\R9FM;&UK&-1K&IDB)N1$3F1$[GZ#^Y_#_8
M        !_!UYMAMU]]UMEEEM;KKSBTH:::0FJW'''%UHEM"6TUJI5>E*43U
MK7H?U$U9(B9YG^'.;&USWN1K&IFJKN1$3G55[GZ#G=^(9R8?Y9<MMM;:CS')
M.(UO;F'ZU0M5*ML:[Q%;EIQQ]A%*?Q%9Z6Y5V?;[E]DK('TI75"4U+U8&P\F
M&<,6NV/;HJM'&5'AGDY<OY')B:[O6-,4=M..W[1MI&),1LD62V++T-0)V&T-
M-JC@<WN<<B.J7MWY23/:BJAI4=:10
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MBLP%LRN5-2520X@Q<C[=1HCN6UDB95M0W>CFI#3.<QLK?J51-3KV4*'1<\R
M         +Z_@V:N5J_P^-)(E1/5;ML).3;1NG\51I4E&89!-<QR56M:=7._
M"H6,5HJOMJFE.GO:)*6;5KC\T<=7C2[5'0\73-\'%,:CT_/.E-A^#!A]</[%
M\)I)'Q=3>^/N$F[+5T3,]8'>'.D93[R4DCHL"
M    <M\T8/\ GW         .E)Q3^"[QM^8/3OV>8Z4!Q)U17_QVJ^7D-U]G
M?6_P+Y&MGF4!GP\4[$                           AE\>7\WYD7SI:S^
MLYI+&Q?JW@\6J/BM*N\+_K,UOE"A^.\H\EP#)D       &YGAV?#LXD_/YK7
M]I8)R>.^HS$_B51\FI*6Q'KN[./+%!YPPZ*A1,VV               /+9S^
M1.8?);(/JF6?31?7E)[K'\9#S[M]BKGXO-\FXYA!H>8#@        '1\X-_
MIX??1;X_?9-B10G&'5=BORE7><R&X^R7K5;,OO>LOZMIC:0YTD$
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MIY*65O:2,<QWXGHUQ^U!<K==:=M7:[A!<J1W-+3RLFC7V'QN<U?QGI#\3[0
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M(>C6?TT?ZN?]^Q7/;_\ [)?S_P#\(T%X"G-M1]BQ_IO!:0*YF@8
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M^RVZ04D_$WG%B_,RFR=D]K)F.Z,F;VR(RF1[$>W)8YIH79HNG.A\7/,@0
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MV\CUD=_2Y3=^S6NEL5HM5EHFZ**STT%)"G<BIXF0QI^0QIZ\^8],
M                   Y;YHP?\^X        !TI.*?P7>-OS!Z=^SS'2@.).
MJ*_^.U7R\ANOL[ZW^!?(UL\R@,^'BG8@                          $,
MOCR_F_,B^=+6?UG-)8V+]6\'BU1\5I5WA?\ 69K?*%#\=Y1Y+@&3(
M-S/#L^'9Q)^?S6O[2P3D\=]1F)_$JCY-24MB/7=V<>6*#SAAT5"B9ML
M          >6SG\B<P^2V0?5,L^FB^O*3W6/XR'GW;[%7/Q>;Y-QS"#0\P'
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MBJIT=J=25C$3CX']G)'*CXW*C>,A?%*C41^2;3'.D@@
M     J$>/#SJB[-SN#Q!UG>FYF%ZNNR;QMRYVZ15V+?=G,)?9A8BEYA79(A8
M_$?>K+IW*36\7!R.ZVV_:$J7:'8O@U]OHI,4W"'15W-NBE:Y.4RF7II? Z9S
M>1N^IM:Y%5LIFKPOMKL=_N\.S6PU226K#\G&W*1CN3-7MS:RFS3<YE&CEXW>
MOTR]T;FM?39K7\Q+-\UP&ZMW[!,ORC"KXU3M:O.)7^Z8Y=6DTK6M*-7&SRV7
MFZ=U>OL63?54=)61<364D=9"[M)&,D9^2]%0IG;;M<[-4MK+1<JBUU;.:6FF
ME@E;^'$YCOZQ(1JCQ?O$&U+6-'A[\N^>VAA:5NV?:UILVPO6^RM>U,G(KY"5
M?$HZ55UHS=6N[N]]UK1-4\-<]EF!KGJ<ZRMH97=O3/?!I]B)CN)_'&I-.'.$
MKMFPVL3(L92W>F:N^*Y1Q5NOP.GF8M7EV.34-_029:G](YSN'6)#WCQSQ;(D
M5[43;]JW*KIB;[2$].LAK&,JCW=$UVM**ZH]U8J>JNY-4TIV$>W/8)1/U.L]
M_DIU[5E3$V7WN,B6++V>+4GC#G#@N\7%1XLP13UR=O-;ZF2F5/"D%0VJ1Z^M
MZ(C3?TR<Q)IJ;QT. NR4Q8^1Y=F^FKK)4AGU#9>$W!<2LE72CE$WW!7;W"8A
M]U%]KTMZ)2J>VKB&EJ[*1[<]CF-;?J=3TL-VC;VU/,W4J>TGXEZKZUB/\&9/
M.'>%ML<OJ1QUURJ\+U$G)T5](_1J]VHUJHFL[CY71;NF1J[B2_66^]'[HC>M
M:CV_K39;5&://-X/FV/9+)BH4A*JTGP[3<77K>ZE*D][;S;:VZU[5I34CZXV
M6\6AVFZ6NHMZY_;H7Q(OM5>U$=[RJ3O8<8X3Q3'QF&\2T%^;EFO0E7!.YOMV
M1O<]B]UKVHJ=E#+IYITH
M      ,&<F\V8UMQRWYL"0]Y*<,TWLO)4+HXAM:W[/AUXFQ&6EN-KI20Y*99
M;;I5"Z5<<33L5U[:^OAVC6OO]EH6MU+5U=/'EX'RL:[WD3>OL*<CCVZLL6!\
M87E[M*6NUU\_X45-*]J)R5Y3G(B-W+O5.2O,<U(T!,)0        "ZYZ/YCZ
MK-P2NMQJW5-,KWUL'($*JXIRCB(V/8'BWF)3T_BJ=^,J3V^WK5NJ_P#B*C[;
MIN-QG''_  :B@9^-\TO_ '#5;@:T2TNR&HGT:?FE>*V;V=,-'3>]O@T_@Y]D
MG$(?+9                          IE^D2_#6U?\ 1;PK[6=VEK]A74C<
M?*4WFM&9=\-CKK8>^]^D_65V($R:2G8       +2'HUG]-'^KG_?L5SV_P#^
MR7\__P#"-!> IS;4?8L?Z;P6D"N9H&
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M]J,HIY7:EIIGN<C6TM0]RNC?]IG<K7>E2JZ&WH5?-*0
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MB]ZY,YJF->PZE+NI4(U<                            !RWS1@_Y]P
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MG&'5=BORE7><R&X^R7K5;,OO>LOZMIC:0YTD$
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MR4:C>E:UO>F3KY))I9)99'2RRN<Y[W.57.<Y<U<Y5Y2N5V]5=O5=Y_$_I^
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M(E^&MJ_Z+>%?:SNTM?L*ZD;CY2F\UHS+OAL==;#WWOTGZRNQ F324[
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M8[\)%,,;K;:RSW.X6BXP+3U]KGEIIV+TS)H7NCE9^"]JIX<CS9]!YH
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M0T1CDCFCCEBD;)%(U',>U4<US7(BM<UR+DYKDWHJ;E0_8#]0
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MOLFQ(H3C#JNQ7Y2KO.9#<?9+UJMF7WO67]6TQM(<Z2"
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MMN6/R6U)];9Z5\V^_6>&?=:KXL)?3@,?97:-XO;?E*PM<E:C10
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MYI7/%&V;:AC%)&7_ !M75%--TU/#)T)3*G<=34B0P/R[&MCG>',T\.I(N
M      +2'HUG]-'^KG_?L5SV_P#^R7\__P#"-!> IS;4?8L?Z;P6D"N9H&
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M2E":)32B4II2B4TI2E$II3I2E*4_%3I0I1S[UYS8M$1$R3F/]!_0
M                    <M\T8/\ GW         .E)Q3^"[QM^8/3OV>8Z4!
MQ)U17_QVJ^7D-U]G?6_P+Y&MGF4!GP\4[$
M AE\>7\WYD7SI:S^LYI+&Q?JW@\6J/BM*N\+_K,UOE"A^.\H\EP#)D
M &YGAV?#LXD_/YK7]I8)R>.^HS$_B51\FI*6Q'KN[./+%!YPPZ*A1,VV
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MXNAQ];*?39,8.TU.A.3#=&,Y>KDY-Z,B;Q[.4KGS1U;G:>3G 4384V
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MGHW=QD\JOFERW<:]V1E\\PZ8
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M4%9@# %4Y; YVBON+%5O1[4Z:FIN9R4>K-)I';ZK+0SZ6U+45T"=RD
M   !+_X(G'I>[>;V*9?<H-9.(:!M4S:]X<>;76,YDD1:;1K^$EVGL:N",IGQ
M[HS2O\MO$GT_[O9%NU^^I:,'U5+&[357IS:9G=XI>7.[VO%(Z)WKI4+-\%'!
M3L5[5[=<IX>,MN#HW7"153D\>WTNB9J[#TG>VH;W4IGEZ$IR:V@
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MVP]#VZST\-- S/I(8(TBC3PJC&MS7LKO/8'S'I@
M  $4?C*<;?X0W"3/9]KA*EYII%Q.Y<6\MM2GWXF,0IC6<6Q-6J][C;N$S+X^
MAE-%^=,M,-/;524J3).RB_K8<7T+)7Z:2\?2DG<19%3B7>],C$S[5CWE=N$_
M@;Y]-E%YFIX>,NN%%^:=/ETSF0,<E6SNJCJ1\KT;OU2Q1;N;*AV7/,@
M    "8/P2^3M- <RK#A=]N-8F!<AXC&KKVAZ2IJ#&S!V365K2\.,].V1,^Z-
MQRT-555-&FLTDN=?9VJBS:]AWYMX3FJX8\ZVQJM2SD\I8\LJAGL:/3%[KH6I
MV"SG!3Q]\YNU"CM57-Q=GQJUMOFS7)B5*NU4$BIV7\?G3)JYFU;W%YTIT:V
M             B9\77@K7F-QX>OF$6E4O>NF$73*M=(BLI5/RVTO,-JRO75:
M]?XUR?%AQY-OITJJETM,9A"V69DM2I+V78R^=6^I#62:;-=LHJC/I8G_ &J?
M+L:%<K7_ ,F]SM[F,*Y\)/9)Z)V"G5=II^,Q=AA):BB1B<NIB<B+4T/KG3-8
MU\*<_'Q,8BM9)(JT2'6G6'G&'VW&7F7'&7F7FU-NM.MJJAU"VG*44VXE:54K
M2M*5I5/:HN8UR/3--Z*9$/8K%<U[58]BY.:NY45.=%3_ !\.X_X/Z?D
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M8/3OV>8Z4!Q)U17_ ,=JOEY#=?9WUO\  OD:V>90&?#Q3L0
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MY?YT>@OC?[A3?"&_Y1]%_L9_AMP^ O\ \X^_R^'Y_P!1;2_1G<O\Z/07QO\
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MG&.*L:W!UTQ7?:F^5KE72Z>159'JZ9L,*:88&;OJ<+&,3O3$!ZARH
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MIL\=@G9I3W:NI^)O>-G,KYM3<GLI-*MH(E[.7$N=4HCN4QU6]'<Q,6166;
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M-OH[:M=6YS66O'WVT+0O-<HB,3,PNL)SMZM3+?AKL.%6O=1*F<\=IVJJGN1
M6W3$70]!;L-P2>F5[N/GR^XQ+E$U? ^7-_LPISEZ>!9@)*Z]W[:)6PZZ>R,6
M@HE=_"ZAC7U,C.X^&F5D?<<E8[N;K;)60T?
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M_P#0[M)G=88V[J2KD=]=HB=+!6/7TU<O2ZMRJKM-2QD5=$G@I
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M<,C<G7![5YGSL<K*7/[2YU0W4DT+VV9"OI?$
M       '+?-&#_GW         .E)Q3^"[QM^8/3OV>8Z4!Q)U17_ ,=JOEY#
M=?9WUO\  OD:V>90&?#Q3L0                          "&7QY?S?F1?
M.EK/ZSFDL;%^K>#Q:H^*TJ[PO^LS6^4*'X[RCR7 ,F0       ;F>'9\.SB3
M\_FM?VE@G)X[ZC,3^)5'R:DI;$>N[LX\L4'G##HJ%$S;8
M\MG/Y$YA\EL@^J99]-%]>4GNL?QD//NWV*N?B\WR;CF$&AY@.
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M.(ZI6A:%4ZI71=.E:5]M*END5%3--Z*95.:K55KDR<FY4W]T']/Q
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M]SG.=DFE,U7>N[=[!^8_I\X              !,AX1/ASR^8.TV]I;-L[O\
M!QU7>([N0M2FUH9V9ET=#4ZWZ_A*73^-LZ*+BR;ZZGNJF&XU 1Y;UP1)C15M
M1QXW"UM^9UOF_P#7KFQ=&G_V\;N2M0[U_3-A3O\ -_*:S)UH>#9L1DVF8A;B
M"_4J_.1AV5KID=TM?4MR>RB9W8DY+ZMR?:M,*:7S(]EXEIEMAMIAAIMEEEM#
M33+:$H:::0FB&VVVT4HEM"6TTHE-.E*43TI3H4]5=6:JN>9K(UK8VM8QJ-8U
M,D1-R(B<R(G<_0?W/X?[             !&YXI',R-PRXO9)D5CN3,?;FQJ2
M\!U!#HZW69&O]QA+I=<R3&K6JE0[#9W')M'%(6PJX+MD-_M3-3U[W9SA-V+,
M1T\$T:NM=!E-5+V%8U>1#GW9G\C+IM'&O;TA!G"!VHLV7[/Z^MI)TCQ)?-5'
M;6]NV9[/3:K+N4<2K+JTJSCNAXG_ %5"@/(D2)4AZ5*>=?E/NN/R'WW%O/O/
MO.*<=>>=<553KJG%*4I2JUJJJ^Y1=QK4:C6M:C4:F2-3M3'!\CY'NDD<LDDB
MJJJKLW*J[U<Y5YU=SJJG\C^'XG[;9<[E99\2Z6:?.M-T@/MR8-RMDN1!GPI#
M=?XN1$F174.1GTU_$M"DJIU]BC_,D<<S'12QI)'(FES51'-5O>N1W)4^F"HG
MI9XZBFG?3U$*ZF/8Y6/8Y.RU[516KX47,D>TEXNO/?1RHD:W;NNFQ[!%HTFN
M-;CBM[%AOMLU;HVVJ_W-U-]BL4;1V41&NS"*)=K[WNHA2.!N^R[!5XU.DLS;
M?.[[92.Z'<W\!OI*_A1J3CA3A)[8<)+''!BR2]T<?VBZ-Z-8N66E..DRJVIE
MR<F5+$R\.64P^CO2,L4G>HVWD9H*\6!ZM4-R\NU!>8U_@+<=<HFKZL)RUV'(
MML-M%4J75%ZN#RJ)5V,U51*%Q9>-@M2S5)8KTR9.UCJF*Q? G'1:T<J^XL3U
MQ9G"?#=MTO%PXWP;+1OW(ZIMDK9F;UY^A*E8GL:G;95<ZJG2MSR19BM'>)!P
MHY"TBQM=\@,(;O\ *2RA&(YK-=U[E:Y+JNRD*'9LT:@KO<A*ZUHJMNK,;_$I
M+E4JHJL4WG .+K%J=7V.986_;86\?'I[JOAUZ$]OH7P%F\)[<ME>-=$=DQG2
M-K),OI:K<M%4ZE[1D56V%97)_(\:WPY&\AR!+0           !Y[*8617#'K
MU!Q&^0,8R:7 D,63(;G8EY/;[/<'$=D>?+Q]%V@5N[3:J]WD>N1Z+K3VN43^
M/]:5\$<\,E7"ZIIVN36QK^+<]O91'Z'Z,^[H7V#XKA%73T55#;:QEOKY&.2&
M:2'CV1O[#W0\9#QK6]YQC,^^*I_B+\5O&6O;=_E9-M7(^2>G:MR5.V31+_W'
MQ?<ABM5LM9-H['V(4B]3:)2XJB6$Y+5%$)JN=WUHDLI@/$FR>!86T]LCP_=>
M3RZSTU=?\G6/UM8GMNA_:&>.V[9[PGJMM9)7XAGQSAE4=G%:%Z&9Q;5S:E1:
M84B?*_P,;7Y=M,JE;NXVVXV>?+M=V@3;7<[?(=AS[?<HK\*?"E,JJAZ-+AR6
MDN1I"%T512%I2I-4]*T)]CDBE8V2*1)&2)J:Y'9M<WOFN;N<THW/!/3324]3
M"ZGJ(7*CV/:K'L<G.US79.:J<RM<FKV#\A_H^8          $DGA:\+)?,[D
M[8+'?+<Z_I_6CEOSK;\M='$1)ECB2ZJLV%>:FE.LR_72+ZHI"5MNIMS%RELU
M[XG17 [2,6MPGAV::&33=KAG#2IVR/<WES>UA:[7V6Z^+8O3DZ\'[9;)M2Q[
M1T=7"KL,V%65ES?VKH6O]*I-7?UDC>*RU(Y(6U$K%U1E_2/'8BL,QHS+4>-'
M:0Q'CL-MM,,,-(HVTPPTBE$MLI0FB4I32E$T32E*="DKG.5SE5RJJKFJKOSS
MY]_Z5-CV-9&QL<;4C8Q$:B-32B(W<B(B<S4[#>;(_0#]
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MQ*Y*29<WOI9':G]!5+N?6B:NAY7+Z?$W-5XUDC4B=)+*X
M                     $\GA!^%M*Y)Y!:.1^]K(MGC_BUW4[BV*76)*:5N
M7(;8M5$5['*(2YKR#<4)I->I5QNY282[6E"V4SZLPOM3VC-L$$E@L\VJ]U3?
M3)&JGTHQ?^^]O2)N5B+QG/HU7#X-/!^EQS608YQ?2Z<&V^7.GII&N;\U)H_Q
M9T4+_JB[VSR,6GR5J3:;FK3+;#;3##3;+++:&FF6T)0TTTA-$-MMMHI1+:$M
MII1*:=*4HGI2G0J@JZLU5<\S4)K6QM:QC4:QJ9(B;D1$YD1.Y^@_N?P_V
M                            #EOFC!_S[@        '2DXI_!=XV_,'I
MW[/,=* XDZHK_P".U7R\ANOL[ZW^!?(UL\R@,^'BG8@
M         $,OCR_F_,B^=+6?UG-)8V+]6\'BU1\5I5WA?]9FM\H4/QWE'DN
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ML?UU=23.?AJS:J.ULWZ5A8[TVJT\VNLESE15:U_$\1$_?"A'"=Z06
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M#:/#U)IGN<^4]QJT3?4U3VHCM.?*2&%/2H&;D:QNM4XV25SMV3DB5@
M                      4R_2)?AK:O^BWA7VL[M+7["NI&X^4IO-:,R[X;
M'76P]][])^LKL0)DTE.P       69?1NJ*3FO*RM6W:)=Q75/ENT9=\A2H]V
MS;S6O/HWV4=I22S7LJJBJT<[J)JE*NE>]OOUIAO>F;9*GV>4R'L?@E]> UFE
MVVAYM7)U/;]^2Y;I*O/E=+GO3D\Y:[*UFB8
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MV.?"]J4D7>ZGU3HGJQW3PPS;MRE\8IB:^
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M9''&QJ-8QC&HC6L:U$:UK41&HF299'US_)](
M        !RWS1@_Y]P        #I2<4_@N\;?F#T[]GF.E <2=45_P#':KY>
M0W7V=];_  +Y&MGF4!GP\4[$                           AE\>7\WYD
M7SI:S^LYI+&Q?JW@\6J/BM*N\+_K,UOE"A^.\H\EP#)D       &YGAV?#LX
MD_/YK7]I8)R>.^HS$_B51\FI*6Q'KN[./+%!YPPZ*A1,VV
M /+9S^1.8?);(/JF6?31?7E)[K'\9#S[M]BKGXO-\FXYA!H>8#@
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M"SE0KO=)4T$;>FA7II:1B*Z-<W4Z+#Z5#63+"%!P
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MBZFQ%;UDM<K\J:XP(Y]'4IOTHDN7I,VE%5T$VB5,E<UKX],CM+3K2*0
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M(8XZK'=VCRD<WELM\#]+EI(7YJQ\KE1%J9V<ER^DQ*L3%?-,@166=
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M9[)9\/T$-KL=KI[/;J?I(*:%D,3=R)GHC:UNI<DU.7>[+>JGM3YSU0
M                               5;/%C\'A5*Y;RBXE8]2J.V3D.TM(6
M*!7NHKN>DWC,]:P(E/:FM.Y^=8VFZ=.UZ1:^O6EO38S9EM4WTN',3U&_DLIJ
MQZ_@LAJ%7\EDRN[C9._,^^$9P9-]RQ_LXH=V^:X6F%GLNEJJ!C?RYJ1J=^^#
M[B5<BQAGV    "TAZ-9_31_JY_W[%<]O_P#LE_/_ /PC07@*<VU'V+'^F\%I
M KF:!@          I->.YR=KN?EFUI^PW&DO">.5I?Q52&%KK'D[(R#U.Y9[
M*]JJ)4[%1%L-I4FJ.K<C'9?:NJ'"W.QC#OS)PPZZSQZ:R_.XSPI3LS;"GX6;
MY?7->G<,J>%WC[YZ=H[<,T4W&6K \:TZZ<\G5LVA]8[L?4],-,N[DOADR54<
M0B$OE30       7<? KXSITIQ!;VK>H"HN:\C[LUFTA;[%&)3& 6/UVTZ[@J
MK5/5V,]'?OEX97UZ*9RYOI3WO550MLN(?FOBGYFQ2:Z.PLXE-^Y:A^3ZA?91
M49$[UT2FK_!&P&F%=FK<0U4/%W3'$C:MV;<G-HH=<=$SPM>CIJECL][*E.X3
M7D2%J0                             "C7XX'&ZNC>:%]SJSV[U3"^0U
MMIL^UN,LK;AMYE1U%LV3 HZJO\?<',A;;O,CI[$_=HVDN'L>O_S8PE#1RR:J
MNQNZ&7ON*Z:G=X$1GI+?<5,EN%A@7YTMJ=9=Z:#B[7C6/H^-43D)5:M%>S/+
M>]TV52_N=%M(<R52L         !<,]'XY0TS_1.8\9<BN7FY+I"ZN9'A;,AQ
M%'Y>L\UGR)DJ+%I2E5R$6O-'+GYRUUZ-M99;V$>\12B:L;<,.= WJEQ#!'II
M[PW1-EVM1"C417=SC8=.2=E8GN7G--N!GC]+SA&Z8"KY]5?A.3CZ5%YUH*M[
MG.:WLNXBK5^MR]*VIA8FY-UA0@XND               ?%OV/V+*[)=L;R>R
MVK(L=OT"7:[W8;Y B76SWBV36E,2[==+;.:<9G0G67%H<:<0I"TJJE5*TJ?[
M@GFIIHZBGF=!40N1['L<K7L<BYHK5:N:.3L*B]P^2MHJ.Y4E105])'7458QT
M<T,S&R1R1O32^.1CT<Q[')N<UR*CD*GWB+>!UDF$/W_<G#&TW'+<+4J3=;_H
MMI<JYYABR.M77W-=./*6_F-C32KE4VQ:G+LQ1"41E7+O[&+,8#VQ4]8V&U8K
MD;2U?):RLW)%+W.B.9L3_P"43TMW9XOLYU;;N";76I]9BC9=3/N5JY4DUH35
M)4T_.YW06>;ZF%.Q YSJEG2Q]$9Y,K?R8TF')?B2V'HLN*\[&E19+2V)$:0P
MM33[#[#J:*9>0XE25)52BDJ2JE4]2?&N:]K51R.:Y-37-Z5S>;4W,HZ]CXGO
MBE8L<D:JU45,G-<FY6N1<E1R*F3FKS'\C^GX@
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MGTT7UY2>ZQ_&0\^[?8JY^+S?)N.80:'F X
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MW7/<JN7WRWUNMENM%%3VZU4$-MM]*W1%!3Q,AAC;WK(HT:QB9]A$/1GXGW
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M@:U&M0P[KJVKN5;67"NF=55M?+)--*_IY)97J^1[O7/>KG.]<[=D?(/T/B
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M::*0M"TUZ+35-:5I6GLK3_UHPJ*BY+N5#:A%1R-<U4<UR;E/ZG\/]
M          BWYR^%!QSYHTN&7*B_[)=W/QU48VGB%LC+3?)*&ZMQ:;!QBCK#
M&8LIIY::R?-B75+;#32;C2.VE@D7!NTR_826.EU_-2SM7ZVE<O(3MN(DY2Q>
MUR='GF[1F[45]VM<'7!&U))KFL?SMXL<FZXTS&^G.RR;T;3YL94HFY->J.HT
MM:Q)M#485#.7'AW<H.&5T?5M+!G[I@59-6;3MG"T2K_KRYI6Y1N,B7=&XR'<
M8N+CE>U$.[,0I#BFEJCH?92EZMH\+X[P[BR-J6VM2.MRY=--DRH;W<FZM,C4
M[^-SVM[;)=QFOM(V*8_V7U#UQ#:5J+0KLH[E2ZIJ*3?DU'2HU'4[W=*D=2R%
M[EST->SEKHT=@1"                        2B<,O"5Y2<OI%IR)=AD:>
MTY,7&D/[1S^U38B;I:WJ=ZI6!XJZMB7FJU-T5Y3R%1;6I2:H7<FEI[*QSBS:
M=AO"[98./2Z75N:)30*U=*]R:3E,A]<F^3^3<6#V7\'':!M+?3UJT:X9PQ+D
MY;C61/;QC%[-'3+HEJ_6O18X%YEJ$=N+>7#;P\N.'"6Q^5J_&EWG/I\-,7)=
MLY=2+=,ZO25H:5*APY:&$-8W8%O(36EO@-LM*HTVJ4J7(1YZJNXKQUB#%\V=
MQJ.)HHUSBIHLTA9W%<W/.1_KWJJ\^G0G)32G9AL6P/LIH\K!0K57B9B-GN53
MI?62\VIC7HUK:>%53ZC"C&KDU9%E>W6;U''DN
M               Y;YHP?\^X        !TI.*?P7>-OS!Z=^SS'2@.).J*_^
M.U7R\ANOL[ZW^!?(UL\R@,^'BG8@                          $,OCR_
MF_,B^=+6?UG-)8V+]6\'BU1\5I5WA?\ 69K?*%#\=Y1Y+@&3(       -S/#
ML^'9Q)^?S6O[2P3D\=]1F)_$JCY-24MB/7=V<>6*#SAAT5"B9ML
M      >6SG\B<P^2V0?5,L^FB^O*3W6/XR'GW;[%7/Q>;Y-QS"#0\P'
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MU%QLD+\989;F[CZ6-RU4#.?Z;HVZWY-3IIH>-BTMUOXG/0D/!*96(
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MWE$:CWQ1OTU,2+]VI9-%1#W/3(F[^8V&/$.V
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M#;;?2MT104\3(88V]ZR*-&L8F?81#T9^)]P
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M (/Z?D6D/1K/Z:/]7/\ OV*Y[?\ _9+^?_\ A&@O 4YMJ/L6/]-X+2!7,T#
M        *L'I#_)ZKT_5?$C')R:M06V]P;+2PZE5*S)*;C8]?V*0IM75IUJ)
M]T=QD,.=>]-RM4BE*=J%*L=L*PYDRY8GG;O=]*P9]Q,GSO3FZ9W%,:J=[*TS
MWX:V/M<V'MF]%-R842YU^E>W=KAHH79;VZ6\?.]CN='T[^U0J_%BC/\
M   !:"]'<XR^=*VWRTR*WU[(5*Z=UJZ^VJB%2'D6_(-AWF.TZCVU;CKQ6#'D
MMU52OKEUC=R:H=25UV[8AR;:\,PR;W_351EW$U,IV.]_C7JB][$[+I30'@4X
M#URXDVCUL.:1?^ET"N3MG(R:MD3/N-Z&A8]O?5#.=%0M/%<30<
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MXJ=*$:<^]><L8B(B9)S'^@_H
M  !RWS1@_P"?<         Z4G%/X+O&WY@]._9YCI0'$G5%?_':KY>0W7V=]
M;_ OD:V>90&?#Q3L0                          "&7QY?S?F1?.EK/ZS
MFDL;%^K>#Q:H^*TJ[PO^LS6^4*'X[RCR7 ,F0       ;F>'9\.SB3\_FM?V
ME@G)X[ZC,3^)5'R:DI;$>N[LX\L4'G##HJ%$S;8               \MG/Y$
MYA\EL@^J99]-%]>4GNL?QD//NWV*N?B\WR;CF$&AY@.
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MU6N<BM]@K'6T%;;JF:AN-'+;ZVG=IDAFC?%*QW>OC>U'L=X'-1?8/C'ZGQ
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M3F3L;B9+19K1A^WT]IL=M@M-MI4RC@IXV0QL]JQB-;FO9=TSEWN55/9GSGJ
M                                                  %>#Q7O""B;
ML^Z7DOQAL\>W;@0Q*O.PM66V*VS!VNZWT?EY%C*&UI1;]BU9H\J1'HBK5]7T
M<3Y-UJZNYSGLSVI.L_0^'L13+):U5K*>I5>53=QDO?4_>KTT/-RHLN+I3PB>
M#3'BOYH8[P!2M@Q,UKI:VWL:B,N2IO?-!S(RMRS5[,M-8[E<FIU+45!)D25
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MSW!&'L(4CFS)9Z=K)96IDDU2]72U,VE<U1LM0^1[6JJJUBM9V#8T\([@
M                             @[\3#PB[ISAV_B6X]>[%Q76]_AX6C#L
MU9R"QW*X-9!2SW*3,QR[,.6BM%>Z+<.Z3XDA;W6JH]O@-H]C-27]GVU&/!UJ
MJK57T,MP@=-QL.A[4T:VHDC.7VKG-1Z:>V<]5YRINWC@VU&UG$MMQ/9;W3V.
MLCI4I:M)HGO2;BWN?!*G%=NUDCXGJ_M&0M3F(X?P</=?QD-6_P!E,L_Q3O\
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M_ 8TLKA; 6"\$P<1A3#-'8DTZ5?#"Q)GHGW6H=JGF]M+(]?"9X/'.P
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MCEE;42V:AI:1[VHJ(]U-!'"Y[6N74B.5FI$7?DID@^$]T
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MYSU+-P+,46R[VFY28UH)([?4T\[FMIZG-6PR,D<B9[D<NG)"UL5K-$0
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M=F&!EAEP[@^DIZVG7-M5,Q:NK1W?,J:E9IHU7/FB>QO8:U$1#<PY4E$
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M\)9C!VP[9;@5T4UAPC3+7PJUS:NJ1U95(]O;LFJ5D6%WBZ1-\!O"<B2R
M
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M:K'L>Q;PU['L=DYCVN16N:Y&N1R9*6A2NQ?X
M
M                'Q[I8K+>O(K>+/:;OZM1SU?W3M\2?ZOYWE^=5CUII7E=
MU6FN[MZ=W8GKU[:'^XYIH4=Q,KHU=TVERMSR3P'S3TE)5:5JJ:.HXO/3K8U^
MG/GRU(N6>29\W,?.^X;"?^C\6_L_:?\ *'[=&UG\+E_.._Q/P^9-J_BRG_,Q
M_P"4^U MENM,=,2UP(5MBI4IRD6!$8B1Z+77JM=&H[:4T6JO3K7IUKT/P?))
M*[5+(LC^ZY<W?TGU104],Q(Z>%E/'WK&HQ/Q-R0_>?Y/V
M
M
M
M   /PS[?!ND5<.Z08EPAKJE3L2=&9F1W%-JHMM2F9"%)55*TIK3K3V5IU/ZQ
M\D;M4;EC=W47)?Z/\3\IH(:ACHYXFSQNYVO:CD_$N:'Q/N&PG_H_%O[/VG_*
M'T=&UG\+E_.._P 3Y/F3:OXLI_S,?^4_?;<?L-F6X[:+):;4X\FC;SEMML*"
MXXA'6J4.KB,IJXBBO;2E>M*5J?E)/--NEE=(B=\YSOTG[0T5'2JKJ:EBIW.3
M>K&,9G[;2B?_ '^G[1^9]0
M               !\RXVFU7>.W&NUMM]TC(=2^B/<84>:RV^E"T)>;9DMJ2E
MRC;KB:*I3K1+BJ=>E:G^F221.UQ2.C?EIS:JI^@_">GIZEG%U,#*AB+GI>Q'
MMSYL]+D7?DJ[_"?)^X;"?^C\6_L_:?\ *'[]&UG\+E_.._Q/F^9-J_BRG_,Q
M_P"4_?;<?L-F6X[:+):;4X\FC;SEMML*"XXA'6J4.KB,IJXBBO;2E>M*5J?E
M)/--NEE=(B=\YSOTG[0T5'2JKJ:EBIW.3>K&,9G[;2B?_?Z?M'YGU
M
M                                      'BL?UY@&*Y%E^7XQ@N'8WE
MFP)%KE9[E%@QFR6?(<WE61F6Q9Y.87NWPFY.2R(D>=-1&7-=>4PB8ZEI2$N+
MHKZ)ZZNJH*6EJJV6HIJ%')#&^5[XX4?DKTB8Y5;&CU:W5H1,\D5>9#RZ*RV>
MW5MSN5OM-+07&\NC=65$,$44U4Z)'-B=4RL8V2=T37O;&LKGJQ'.1N6I3VI\
MYZ@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M[7L=[#V*K5]Y3ZI_@^@
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M2-9QM/)I58*A&,;*B*CF1RLDB9NV<D2N
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M=NTQ3.=GO3=EV4[IG8\<Z\
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MCW\_;M:=I;+]8[TQ7V:\TEVC3MJ:IAG3<[2N^)[^9V[V=Q[D^0]<
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M125#*J"1.2^-[7L=[5S55J^\I](_R?0
M
M
M                                                        #5OG
M)\"GF#]%OD#]DV6G18/ZKL*>4J'SF,C[:UUJMIOWO7K]6U)S@R^QAP    #T
M=BS3,,64VO&LKR7'5-.N.MKL5]NEH6VZ^U5E]QM=ODM^6XN/7L6JG2JD>]5[
MT_":DI:G)*BECJ$?W[$?S>V1QZ5'=;E;U:MON,]#I5SF\3-)'DYR(U7<AR;W
M)R5[J;M_,;;ZQ\2'G3J%]A[#N3^V7F(M:>3:LSR-W9-C;;ZTJIAJQ[#:ND2.
MS7WW6C32.E5JJGM77K7F+C@#!ET:]*K#E,CG=O"SH=_MM=/Q;G>^I)%@VX[6
M\-/C?;-H%Q<QFY(ZJ=:^%&]ZV&M2HC:B^M:WN\Y,OQ@](=R.-<+7C?+;5UKN
MEI=<CPWMG:E:?MMWMS=>UJMQOV W::\Q>J56OS)#ENG0*M-M*]6MLEQ26B)\
M1;"J=T<E1ABY.CE3-S:>IY3%]:R9B(YO<:DC'YKSR-3E%G\ \-6NCFIZ':/A
M]E13.5&NK[:BLE9V-<U'*]S)>^>L$L.E$713O=DA9=U!N75V_<#M&S-.YM8\
M]PB^=Z85\LDA3J&I;5&ZRK9<X;Z$2+->&/,;I(ARVF93%7$T=91UH5\NEIN-
MEK9K;=:-]%60],QZ=KV'-7F>QW:O8KFN[#B]^&<4X?QA:*6_89NL5XM-5TDT
M*YY.3IF/:J(^*1F::XI&LD9VS4,I'P'0        Y_OBY_G&.3_RJQ?[.,,+
MM[,.H/#ON4GG$IC3PE.OAC_QBF\QI2.$[T@TL?>CA_SU\D/FMQ3]K'2!=O7V
M'L'C,GR1>+@/=5>.?)]-YT6XBL)I,         ?XI24)JI5:)2FE:J4JM*42
MFE.M:UK7\5.E!S[DYS^*J(F:\Q"QS&\;KC-QRD7;"]5)KR'VE;ZOQ'XF*7-B
M'KC'[BA2FW6;]GM&7T7.2TNM%*C6>/.2I32XTB9 >I[V6,*;'\0W]L59<O\
MT.VOY6J5,YWIZR'-%:B]]*K,MRHQ[2K.T[A6X#P1)56K#W_]:X@@S8K::1&4
M$+TW935F3T>Y%YV4S)N9S'RPO*X&_P#Q?N=>_9$V.]MV;J3%Y2U^1B.E$2,
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M'_+;B=\EMM_6V!%E=@7UGB;W6E^+,9U\.?[*[.?%[E\I1E9@L&4+
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M9MFN;FZV*WQ*-6SKW)I:9S<\G97*RJ9I\
M
M
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M+:/-5V##,DN'<$9N8K&NT55P9GEKK'M7D0O;S4;%T9.7CWS<G1#"2P59
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MVQX1M:(Z*UPHDLN62U%2_EU-0_LYRS.>YJ.ST,T1IR&-0V+/$.W
M
M
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M7]]1(U%<EON2LS?V=,-;&QC$7L,9/"UJ[M=2F]Q6UV;JW8NF,UO6NMJX;?\
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MK\Z4#ZLN9Q>T7J(Q+XL[XS28N#]UYMGOE"/XCSH5%&S:8
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M@7 TV6H]U=M4N]/N9QM':4>G;;V5E8SV.51QN3NU;5;N12TT5R-!@
M
M
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M:4MH3UZ(0E*$4ZUK6O1*:=*>VO7_ /B?U55=ZKFI_$:UJ9-1&G]#^']
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M4X]^?(>R
M
M
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M"ETXJQ?''5U2N;D^"G<W724>_E-T1NXZ9,FNZ(E>Q^KB8\I>2,"RH
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M(ES0
M
M
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M*%Z.!/@YE;B#%6-ZJ'4VQPQT-*Y4W<?5:GU#V+V'Q01,C=ZRJ5/8MME9#2
M                 IE^D2_#6U?]%O"OM9W:6OV%=2-Q\I3>:T9EWPV.NMA[
M[WZ3]978@3)I*=DM_@>?G&=1?)C:WV;Y(1CM@Z@[K[I3><1EDN"9U\,-^+W'
MS&<O8E-378       $1OCB_FY]L_*K5'VCXZ2=L?ZO+5[G4^;R%;>%GUC\2>
M,6[SZ HHERC(D '3.T;_ #*:>^:W7W[)V@SYO/V8NOC,_P J\WGPCU*88\G4
M7FT1E(\TZ$    &+=Y?S*;A^:W8/[)W<]*S?9BU>,P?*L.>Q=U*8G\G5OFTI
MS,308P8 !;PTMX>FM.=_A.<8+=</4L3W)B>$YJK6&ST1?,?MCZ]DYN_7&,HI
M';J[=L*ER:_QK7OGH3SM9L*GF>>Q+J[=L=7#!FTS$4D>=5:JJ:'HFFSY_I>%
M.,BSW,F8G,[<U[4T/W:7,TLPML6L6U[@YX!@J-%MQ/;:2KZ KT;RHUZ/JUZ'
MGT[Y:21W3-Y3HG.XV+E:V2U8MUZ4V7QYV7D^I-MXQ-Q/.,3FUAW&W3*=[$IA
M?OX-WM$Y'\7=K'+C>6]$ELJ4R^RXE:%?RDILC:+O;[];Z>YVNH2JHZI-37)V
M.^8]O.Q[%Y+V.WM4SXQ5A6^X+OMPPWB2WOMMVMK\GL7F5.TEB?TLD,C>7'(S
M-KVKFABP]$YHRGI3=>R^/.R\8VWJ3)YN)YQB<VDRW7&'7O8E,+]Y.M%W@K_B
M[M8Y<;S&9<1Y*F7V7%(6G^2I/G7>T6^_6^HMETITJJ.J32YJ]CO7L=SL>Q>4
MQ[=[5.EPKBJ^X+OMOQ)ANX/MMVMK\V/3F5.WBE9TLD,C>1)&_-KVKDI>B\.7
MQ&M><[]>5;<I;L0WMB%NC*V3K9,E5$N)HIJ)]VF%^MNJ=N6&R92VZ*353DBU
MR)*(4U:Z+AS+A3;'N J[!E=FB.JK+5.7H>HR]_B9M.YLS4]A)&IK9NUL9K;L
M0VWV7:[94:Y66W%]M8WH^@U<_,WHNDU+J?2O=SIRGT[W)%*KM44LTE9P).P
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MH31*:42E-*42FE*4HE-*=*4I2GXJ=*%#N?>O.;=HB(F2<Q_H/Z
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M,8QJ,8QC4W(UK41&HFY$0^F?P^@
M
M
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MK,)2V*5TEOVN[-ZB//5)>:"#=WM341TS_>T3+GEV#HL%$#;8    %4;TD?\
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M)E_K2N-=N"=;64&Q+#M0UN3[Q47&I?X7)6S4K?QQTS,O!D2YD8ED@
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MW*7LC LJ
M
M
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MG!%J6U&Q:TQ-RSH:VX1.R=FN:U"S<I.T7*9N35WZ<G=L3&D6%G
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M.!/5,CVE8DI'9(ZILDSD7/+-8ZZ@Y"-[95:]7;NE:Q>QS7)BJAIX
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MG ^*OSI0/JRYG%[1>HC$OBSOC-)BX/W7FV>^4(_B/.A44;-I@
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M?2E(O87CI6+)(U=SZ>&9G)544O@%,S7H
M
M
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M4:L7WS=+9SB:/&6!,)8GC?K?=Z"GDEWYY5",1E2S/NLJ&2L7PM7,V(/#.V
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MHM;0?5!_9*+]V'T+&P?U"?WI>?\ 42.CQ4_#2X3<;^%FQ-LZ6TK]QFP;%?\
M7L*U9!_M&VWD7JL6^9M9;1=&_<K*\\G07_-MTN0WW.1EJ1YG>W5"TI73NMFV
MT'&%_P 6T-LNUVZ*H9F3N<SH>E9J<R%[V\N*%DFYS4=N=[)"7"&V$;*<#;++
MYB/"V%?F5>J.:B;'-T;<I]+9:N&*1.*J:R:%=3'N;RHU5N>;<ER4J?%F#.8
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M&;G8EH6A_P!XMNJ)U:5HNG96GL5[#[[36+;KI;K@G/0U$,W9^UR-?V-_:_\
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M37Q*BWO7UU3"[H=N79UU;*=GOZNU+Z12XV!    !5O\ 24_Z%W]8S^XDL9L
M_P!K?YA_YIGYPZ^;9=[%\_39RK>6,,^@    69_1N/RVY8_);4GUMGI7S;[]
M9X9]UJOBPE]. Q]E=HWB]M^4K"UR5J-%         "LYZ0!PRK?L:QOF;@EH
M4N[XHBW8+NAF"PXIR7BTF15G"LTE(:I1-*VZZR56J6\JBG7&+Y;$U52/ KTL
M#L0Q9Q%1483K9$XJJSFI,UYI$3TZ%/;M3C6)TJ.9+VSRAW#*V7]&4-!M1M%-
MJJ+:C*.ZHQ%S=3N=E253D3)/297=#ROR5RLF@[2'DU0BRYG0 #]=NM\^[3X5
MKMD.3<+E<I<:!;H$1ER3+FSI;S<>)#B1VDJ5(DNR5MH;0FE5*4ZE*4]RC_#W
MLB8^21R1QQHY7.=R41J;W.<[L(UO.?1#%+4314]/&Z:>=R,8QB*KWO>NEK&M
M;RG.<JHUK6[U7)#H0>'#Q!@<+^+V%ZVEQXE=C7]",VVY=(]&7%3,[O<2.N7:
M6YK77URV6B$W"M<5=*]CJ+8N71"%RG4E',?8I?BS$=5<&.5:"'TFE8O:PL5=
M+\NU65=4BIV-6C?I0V@V'[-(=EN +78I(V_-NK3HNY2MTKJK)FMUQH]O31TS
M4;3QKTJI&LJ(BR.-]3C28
M
M
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MGX"L^)62-2YM:E-<8DR3B:^%C./32G2LEU-J(6]B&9G9S-TSDR5
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MFI, MIIHX5YW5U4LZ4DN7-HITIYINZDR0.3<CBZ65*-3
M
M
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M8'H]G6!\/X1I-+WVR%.B)4^W5<OIM5-OY63YG/XM';V1(QG,Q#9PY\[X
M%4;TD?\ +;B=\EMM_6V!%E=@7UGB;W6E^+,9U\.?[*[.?%[E\I1E9@L&4+-]
MO"[_ #@?%7YTH'U9<SB]HO41B7Q9WQFDQ<'[KS;/?*$?Q'G0J*-FTP
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M[F\B5;]?X'&FHC7_ &#E:(_F1[+:Z>2ZJ+!0I;3D^>II;$".KS'$K>7'CO\
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MD"N9H&
M
M
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MTE-0T4#*2CHXV0PQ,1&LBCC:C&1L:FY&,8U&M:FY$1$YC[!_D^D
MY_OBY_G&.3_RJQ?[.,,+M[,.H/#ON4GG$IC3PE.OAC_QBF\QI2.$[T@TLS^C
M<?EMRQ^2VI/K;/2OFWWZSPS[K5?%A+Z<!C[*[1O%[;\I6%KDK4:*
M   JC>DC_EMQ.^2VV_K; BRNP+ZSQ-[K2_%F,Z^'/]E=G/B]R^4HRLP6#*%F
M^WA=_G ^*OSI0/JRYG%[1>HC$OBSOC-)BX/W7FV>^4(_B/.A44;-I@
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M['@M_FT.-?\ ^F/[?MJ%+=K77!Q!_-/,J8V&X+'6'P)__%/US<24@CDL$
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MKX7Y;WQOBEET[.J(O !84]'/^%%N_P"8-[[0\)(-V\=3MG\=_P"Q*73X$/7
MQ9Y&7SVD+AA5DTU      *^?C=>'=+WCAU.56G[$Y-VOK6Q>I[&QRU15NW#/
M]=VRCC[-WB1XZ:JG918VW)"NE$U?F6I2V*.+7;X,=<W['\=-L]4N&KK,C;9<
M'ZJ=[UY,,[NT55Z6.9<O R7E9<M[BF/"NV*28LMB;1,,T:RXBL4.BMAB3-]9
M11YJDC6IT]11IJ7FURP9LS<L,+%IUEJ3,4 $@G!;Q'M[\%LD<3ATQ&9ZHO<]
MN;F.GLDER48]<GZT;9D7K')B$N+P[+%1&D-^NQFUM2*,LTN4.>W&C(9XC&6
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M;:C[%C_3>"T@5S- P
M
M
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MXB@HXJ&'O(8V1L_)8U&D<76^7F^U*UM\NU5>*Q4^K5=1+4R+^',][_ZW])Y
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MRZ8TNL;4K*O2BL@;TRTE&JM1[84=EQKW*CZE[&O<C&-CBCE-([+!
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M]^Q7/;__ +)?S_\ \(T%X"G-M1]BQ_IO!:0*YF@8
M
M
M                                            -6^<GP*>8/T6^0/V
M39:=%@_JNPIY2H?.8R/MK76JVF_>]>OU;4G.#+[&'        /9X%KG/MJ9+
M!PW6F%93GN57)=$0<=Q"Q7+(;S(IUZ+<1!M<5QQ,='7JXZI-&VT]RUKHE*E'
MRUM?0VVGDJZ^LCH::/G?*]&,;^$YS6ZNXG3+VI[%GL=YQ!7PVNQ6RHO%QJ.D
MAIH7S2.[JZ(VN7).R[I6IO<J-+$'!KP$,OR.?9=B\U)5<1Q9IQF?&TAC=U9?
MR^_)0M#S,?.,HM+[D?%K4XBB:/0[<\_<W&WE-KEVF2UU()QEMKI8&3T&$F]%
M5+N2M9(S*)F79AB?OE<WM7O1L:.Y6B5%+K;)>!Y<JV:EO>U.3YF6]N3VVF"1
M'5,V7*1*NHC564\:]M%"]\ZM5S5DIGH6J<2Q+%\"QJR87A6/VG%<3QFVQK/C
M^.6&!'MEHL]LAMT:C0;? B(2W%CH12G2B4T]M:JKU4JM2MM555-;435E9,ZI
MJ:ARO>][E<][EYW.5=ZJIH9;;;;[/04=KM5%%;K=01MCA@A8V.**-FYK&,;D
MUJ)X#TA^)]P     !S_?%S_.,<G_ )58O]G&&%V]F'4'AWW*3SB4QIX2G7PQ
M_P",4WF-*1PG>D&EC[T</^>ODA\UN*?M8Z0+MZ^P]@\9D^2+Q<![JKQSY/IO
M.BW$5A-)@        #4[EAPLT!S.PM.(;KQ%$Z9;TN_<MG5C5&M6?X9)?I_&
MNXYD:HKM6XCB^U3\&4U*MTE3;:Y$-UUIE;?289Q;>\)U?15GJ=+)-TL+\UAF
M3U[$<G*[U[7->F_2]$5<XYVC;*\&;4;7\S<4VWC9847H>LARCK*1R\[H)M+N
M2[MX9&RP/<C7/C<YC%;4AYA^"GRFXXR[EDFK[3.Y%:J:6Z^S>L$M+SN>V2)5
MQRK;62Z[CN/3'UH93U<EVGW0BT0VIZ3ZE15&TV>PIM<PW?FQT]QD2P7)W)T3
M/])>O\E.[)B9]JR70[M6Z^F,W]IO!7VA8'DGKK!3/QMAYJJYLM'$JUD+<]S:
MBA:KY79)TTE-QT:(W6_BNE(<Y,:3#DOQ);#T67%>=C2HLEI;$B-(86II]A]A
MU-%,O(<2I*DJI125)52J>I*K7->UJHY'-<FIKF]*YO-J;F5C>Q\3WQ2L6.2-
M5:J*F3FN3<K7(N2HY%3)S5YC^1_3\0    >WUWK38FV\H@85J_"<IV!EMS51
M,/'<1L=POMT=;[T(7(<BVYA:HT)OO35U]SL9912JW5H0E2D_)77&@M5-)5W*
MLCH:6/G?*]K$]C4YS<U=VK6[U[5I[5EL-[Q)<(K58+547FY5"\B&FA?-(OAT
ML:N3$YW/=I8Q.4Y40L5\)O %R2^/6?8'-2\*QFQ]6)K&C\-NK4C)KDBBE+I%
MSO,[:XN/CT9?8WYD2SNRY;C,JJ?=.V26ZHI ^+MMM/"V2APC#T1-TJUDS,HV
M^NAA7E/=W'R(QB*GU.5JYEVME7 XKZMU+>=J=3\SZ1,GMM-)(UU0_P!;653%
M5D+5[:.F=)*YCOKB!Z:2T3K_ %W@VJ,/L> :VQ.Q83A>-Q$P;)C>-6Z/;+5;
MV*54XY5N-&2GS)3KZW'7WW*K>D//+??<<><6XJN=;75MRJYJZXU3ZRKJ%U/D
MD<KGJOME["<S6IR6MR:U$:F1?^S62T8=M=)9;%;8;5:J%NB&"!B1QL3L\EO.
MYRYN>]VI[WJY[U5SE4]J?,>J            <_WQ<_SC')_Y58O]G&&%V]F'
M4'AWW*3SB4QIX2G7PQ_XQ3>8TI'"=Z0:69_1N/RVY8_);4GUMGI7S;[]9X9]
MUJOBPE]. Q]E=HWB]M^4K"UR5J-%           51O21_P MN)WR6VW];8$6
M5V!?6>)O=:7XLQG7PY_LKLY\7N7RE&5F"P90L            O7>!U^;GU-\
MJMK_ &CY$4UVP=7EU]SIO-XS7;@F=8_#?C%Q\^G)<B,2R0       ,+[UX_Z
M?Y*X#<=9;KP>T9SB=QI5U,2Y-K:GVFX>4XTQ>,?O,1QN58+RTEY=&Y41UIVB
M7%-J4IM:T*]2S7VZX?K8KA:*QU'51]E.9[>RR1BYM>QW,K7HK??WG+8NP9AK
M'=EFL.*[5%=K;-RD:_<^)^2HDL,K=,D,K47DR1N:[G1>2KFK4\YE> WO34LN
M\9EQ@F/[VURVIZ8UASZHD';^/Q$U4M4:EOHEF'GC;:*)HEVW5CSWU*[$6=7;
MYJ[,84VT6:Z-AI,1-2R5_-QJ9K2/=W=6]\.?>OS8WGXSM3.K:?P0<78<DJKI
M@&5<6V-NIZ4SM++E"WO=&Z.LT]AT.B9Z\E*;=FZ"/(<<R'$;S<,<RNPWK&,A
MM,A<2ZV'(;7.LMYMDIJO1R-<+7<F&GX<BE?QH<0E5/\ B23/!40544<]-,R>
M"1,T>Q4>QR=\U6N<BM]@J%6T%;;JF:AN-'+;ZVG=IDAFC?%*QW>OC>U'L=X'
M-1?8/C'ZGQ     (0MY;;32%N..+2AMM">]:W%]$H0A":=5+JNO2E*>VM3^*
MJ(F:[D0_9K5<J-:F;EW(F_NDJO%'P>>8?)V3:KQ<\/?T;K.;5E]_/=J0)EGG
M2K<Y5*JR,8P-SR[KD"UQE4<C..M0;;)2JG2YH35-2.,3;5,*X<:^*.J2\7!O
MVFF<UZ([O9)N5$S?R7(CGRM^YEA-G?!FVFX]?3U-1;EPG89LE6LN+'QO5B]F
M"C734S*YO*C<K8:=Z?;VEQ+A?P\UYPCTVQI[75ZRO(H<B]3,JR*_Y9<E2I=X
MRBYQ+?!N,Z':H]$Q,=MU8]KAH:B1&Z42B.E4EZ5)4[)=JIBS%==B^[+=:^&*
MF<UC8V,B;DC(VN5R-5R\M[LW.S>]>SR4:W)J::[+=F-EV487;AFR55171R3/
MJ9IJE^I9:A[&,>]D;=,4#-,;$;'&WF3-[Y)%=([;DYHDD    %,OTB7X:VK_
M *+>%?:SNTM?L*ZD;CY2F\UHS+OAL==;#WWOTGZRNQ F324[);_ \_.,ZB^3
M&UOLWR0C';!U!W7W2F\XC+)<$SKX8;\7N/F,Y>Q*:FNP       (C?'%_-S[
M9^56J/M'QTD[8_U>6KW.I\WD*V\+/K'XD\8MWGT!11+E&1( .F=HW^933WS6
MZ^_9.T&?-Y^S%U\9G^5>;SX1ZE,,>3J+S:(RD>:="    #%N\OYE-P_-;L']
MD[N>E9OLQ:O&8/E6'/8NZE,3^3JWS:4YF)H,8,  O7>!U^;GU-\JMK_:/D13
M7;!U>77W.F\WC-=N"9UC\-^,7'SZ<ER(Q+)         &&-^:#U=R8U=DFG]
MP8W'R7#<EC]'&Z]K-SLUS92Y6VY'CERHVI5GR*&ZXI<:2BE>G<IEY+T=YYES
MU+)>[CAVXT]VM50M/5TZ_@O;VT<C<^6Q_9;[[<G(CDY;&&#[!CRP5V&<34+:
M^UU[=[>EDBD;]3G@DWNBFB5<V/3PM<BL<]BT.>?/ 3:?!/:#F.9*U(R76.1R
M9;^L=I18+C%JRBVMJJY6UW2C=5(LV8Q&5HI-@*77K[V3&4]%=;<K=#!6-K9C
M2W=$T^5/<:=&I4TRNY<3N^;W\+^T?[SD:]KD,A-L.QW$.R+$"T->CJ^P5SG.
MH+@C,HZAB;UCDYTCJHTW2PJO\I'JB<CB2'T<_P"%%N_Y@WOM#PDX';QU.V?Q
MW_L2DW\"'K@8L\C+Y[2%PPJR::@        $.'//P;]%<N)5[V3KZ1'TGO:X
M^L39N1VBW)?PG.KDJBW?,SK%HZF_*NK\G_O;Q;ZM3*JDN/S6+JM+;:94P7M7
MO.&&PV^N:MXLT>E$C>[TZ%O\C(NKDM3FB?FS<B,=%O4K%M?X,>$MI,E5?;*]
MN$\7SZGOGB9JI*Q_/G5T[=.F5Z]-4PY2<ISYF5*HUI4UY0\!N4W$*Y2&=Q:P
MNL?%VY:XMOV7C"'\EUM>*5=HW&<CY3"8HFU.O*KU:B71JWW!2:54J'3MJ6:P
M[C7#6*(FNM5Q:ZIRU.@D]+G9W=4:NWZ>R^-SV>O,YL?['MH&S2=[<3V&2.WM
M=I97T^<]!)V$5*AJ:8W/[6.H;#,OW)#3@ZHBT      VNXU<(>3W+6[1X.D]
M59!?K,N2J-/SRYQUV#75EJTM*)5;EFET0W#5):36JE0X[DBX.):5ZO#>73L.
M9Q!B_#N&(G27>Y,AERS;"UVNH?WNF%-3\E[]6M8WMGH23@791CW:-4LAPIAV
M:LI7.TOK'MXFBBT\_&54FF+-O3+$QSYEYF1/7<6O>!_@K:1XP2K'LK<TFW[S
MW;;:M3H*YT#IJ_"+HBB%M2<6QRXL>9?[Q'=HJK-TNB>J5MLRH=MMLII+I6G&
M>UN[XC;-;K0QUGM,FYV2_3,S>]DD;N8Q=^<47A1[WH[(T3V0\%C"N )*6^XI
MD9B[%4.3V:V?2%))V'4\#TU32,7I*BHYETOB@@D;J)M2(RU@        !5&]
M)'_+;B=\EMM_6V!%E=@7UGB;W6E^+,9U\.?[*[.?%[E\I1E9@L&4+
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MTW@M(%<S0,
M
M
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M":;)AVP8:I>@<.V6DL='G]2HZ>&G8JIGO5L+&(YW/RG9JJJN:[U,AGQ'M@
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M&X+V35]TN.%I:Z6>[0LAEZ*GCF;H8_6W0C((<G:N=5<[=V"0 XHF4
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M8#='-AC"-)25L>655(UU35MRYU;4U+IIF:E34K8WL9J1.3N3+<$Y@DP
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M%*N)>JGN0YVT<0FO=V*4OS:K;W=WH[H*P4U.J]+QLLLV7LZ.A]7]'Z,N@MG
M>PK$]JWG'5PKF]MT-34U(Y>ESR65U;I[;L.RS3GT\J0G37@_\ ],2(EQ@:1@
M[#OL3MJB][>N<[8*7*HKW(J[C-U6FQ>8E=*5HM%I2NE>GOO8FE.&N^U/&UV:
MZ-]W6AA=VE*U(/\ J-]._P"H33A?@T;&\+/CGAPHR]5L?VVY2/K=7LT\OTG[
MZ4R.\))-;K=;K1 B6JTP(=KMD".W$M]NMT1B# A164I;9C1(<9M+<:.A-$T2
MA"4I32G2E*' 2222O=)-(Z261<W.<NI7+W55=ZK^,G."GIZ6&.GIH64]/"UK
M6,8U&,8U-R-8QN36M3F1J(B9'T3_ "?N          #0SF1X=N@N<URP*[;I
MF["B2]=0;_;\?IA&16VQM+8R.1:I%PK<43\=G5DKHY9HGEU35NB:*72M%=:=
M.RPICN]X.CK([2D#VUSF.?QS'/WQH]&Z<GLRZ=V?.0_M/V)X-VMU%GJ,4R5L
M4ED9,R'H6>.%,JA8U?K1\,V:YQ-TJFG+?SFEWX/SP3_YQOS](&-?Z!.M]&_&
M7W*B^#R?MB+/H,MD/\*O/PV#]S'X/SP3_P"<;\_2!C7^@1Z-^,ON5%\'D_;#
MZ#+9#_"KS\-@_<Q^#\\$_P#G&_/T@8U_H$>C?C+[E1?!Y/VP^@RV0_PJ\_#8
M/W,?@_/!/_G&_/T@8U_H$>C?C+[E1?!Y/VP^@RV0_P *O/PV#]S'X/SP3_YQ
MOS](&-?Z!'HWXR^Y47P>3]L/H,MD/\*O/PV#]S'X/SP3_P"<;\_2!C7^@1Z-
M^,ON5%\'D_;#Z#+9#_"KS\-@_<Q^#\\$_P#G&_/T@8U_H$>C?C+[E1?!Y/VP
M^@RV0_PJ\_#8/W,?@_/!/_G&_/T@8U_H$>C?C+[E1?!Y/VP^@RV0_P *O/PV
M#]S/;:Q\#OACJ79>OMJXM==UN9/K/.<3V!CC=VSFP2[6Y?<,O]OR.T-W*(SA
M+2Y,"MPML:CS:'6E+;[DI<155%4^*X[8<672WUUMJ8Z-*>X0RT[]$+T<C)F.
M8_2[CG9.TJN2Z5W]@]BP<$W9;AR^V7$-OJ;JZOL-735L"254+H^.I9F3QZVI
M2-5S-;&ZVHY%<W-$<WG)CB+2S8        !C79VGM4;IL%<7VYK?"=E8_P#Q
MWE6K-L:M&118CKM&Z+DV_P!U(KBK;-Z--*2_'JV\A32%H<2I"54^^W76YVB?
MHFUU\UOJ.^AE>QSD[BZ534GK5S;X#PK]AC#N*:/YGXDL=)?J)<\HZN"*=K5=
MV6<8UVA^Y,GLTO141474B$5.U/ ?X%[!>DS<6L^R-.2WTJ71K7V<O3;3ZS52
MU>:NU[#M]\\ME2E>^9C.QFZ)3T9HT23;=M&-*%K65,U/=F-^[PZ7Y=S5 Z'\
MI6N7NYE>,0\$+9!>GOEM]+7X8D=ORHJMSX]7?<76LJ\D]:QS&]ANG<:99#Z-
MQALEQ=<4Y99-96O-1V(R'4%JR=U+-$.)<;4[;-@VBBG5/>6I*Z(I2B4U0I"Z
MJ[T]9!M]K&?7.&8YER[2J='O]^GD_P#O;$7UO :M<CO_ $[:-/2LS^W6V.HW
M99*F;*VFWZN9<MR<G2O3'Q8/HV$%N2A5RYC3)<2E'.]B%H%FWR5*JGHW5$J1
MN>4ANE%]*UI5E7=2G;UI^.G[/V_R.9E'A1&.]=6JY/R4I&_I/DBX"\3)&K/M
M.=+%V499D8OY3KI(G]1WO<YLCKST>7B/CKT>7G^QMT['D,TIYEO1=<:PS'I5
M?;W^?$M6//W%/_#V^5=6^GM[N_K3M\"OVYXGG1S:&WTEO8[MM,DST_"?(UGY
M42^\=S9.!7LWH71RWF^76^/;SL22GI87>V;' ^;\FI3W^Q*9HGA)Q1XTU;DZ
M4T7@F&WAI"FT956WO9'FU&UIHAQI.<97)G7>D==*=5-4FT:K6O7L[O:1M><7
MXFQ CFW>\35<2[^*U<7#^9B1D6?AT:BPF$-E&SK :M?A3"5):ZEO_N-"SU>2
M\Z=%U+IJG)>RG&Z? ;5'.DA                 ^-?L?L.4VF;8<GL=HR.Q
M7)JK%QLM]ML*[VF>PJM*J9G6ZX,.,RFJ^SJE:%4]G4_2&>>FD944\[Z>:-<V
MO8YS'M]AS<G(?)645'<*:6CKZ6*NI)DTOBFC9)&].]>Q[7,<G@5"-O;G@[^'
MWMQZ7/?T;#UW>IG?_P"U=1WFZX"S&\SS%5]4Q6VR%6!CHMSJG_V37IY:4?\
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M>ERW[R'($M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
:                               '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
